child,parent,child_descriptor,parent_descriptor
R-HSA-1059683,R-HSA-168256,Interleukin-6 signaling,Immune System
R-HSA-109704,R-HSA-162582,PI3K Cascade,Signal Transduction
R-HSA-110056,R-HSA-162582,MAPK3 (ERK1) activation,Signal Transduction
R-HSA-110312,R-HSA-73894,Translesion synthesis by REV1,DNA Repair
R-HSA-110314,R-HSA-73894,Recognition of DNA damage by PCNA-containing replication complex,DNA Repair
R-HSA-110320,R-HSA-73894,Translesion Synthesis by POLH,DNA Repair
R-HSA-110328,R-HSA-73894,Recognition and association of DNA glycosylase with site containing an affected pyrimidine,DNA Repair
R-HSA-110329,R-HSA-73894,Cleavage of the damaged pyrimidine ,DNA Repair
R-HSA-110330,R-HSA-73894,Recognition and association of DNA glycosylase with site containing an affected purine,DNA Repair
R-HSA-110331,R-HSA-73894,Cleavage of the damaged purine,DNA Repair
R-HSA-110357,R-HSA-73894,Displacement of DNA glycosylase by APEX1,DNA Repair
R-HSA-110362,R-HSA-73894,POLB-Dependent Long Patch Base Excision Repair,DNA Repair
R-HSA-110373,R-HSA-73894,Resolution of AP sites via the multiple-nucleotide patch replacement pathway,DNA Repair
R-HSA-110381,R-HSA-73894,Resolution of AP sites via the single-nucleotide replacement pathway,DNA Repair
R-HSA-111367,R-HSA-8953854,SLBP independent Processing of Histone Pre-mRNAs,Metabolism of RNA
R-HSA-111446,R-HSA-5357801,Activation of BIM and translocation to mitochondria ,Programmed Cell Death
R-HSA-111447,R-HSA-5357801,Activation of BAD and translocation to mitochondria ,Programmed Cell Death
R-HSA-111448,R-HSA-5357801,Activation of NOXA and translocation to mitochondria,Programmed Cell Death
R-HSA-111452,R-HSA-5357801,Activation and oligomerization of BAK protein,Programmed Cell Death
R-HSA-111453,R-HSA-5357801,BH3-only proteins associate with and inactivate anti-apoptotic BCL-2 members,Programmed Cell Death
R-HSA-111457,R-HSA-5357801,Release of apoptotic factors from the mitochondria,Programmed Cell Death
R-HSA-111458,R-HSA-5357801,Formation of apoptosome,Programmed Cell Death
R-HSA-111459,R-HSA-5357801,Activation of caspases through apoptosome-mediated cleavage,Programmed Cell Death
R-HSA-111463,R-HSA-5357801,SMAC (DIABLO) binds to IAPs ,Programmed Cell Death
R-HSA-111464,R-HSA-5357801,SMAC(DIABLO)-mediated dissociation of IAP:caspase complexes ,Programmed Cell Death
R-HSA-111465,R-HSA-5357801,Apoptotic cleavage of cellular proteins,Programmed Cell Death
R-HSA-111469,R-HSA-5357801,"SMAC, XIAP-regulated apoptotic response",Programmed Cell Death
R-HSA-111471,R-HSA-5357801,Apoptotic factor-mediated response,Programmed Cell Death
R-HSA-111885,R-HSA-162582,Opioid Signalling,Signal Transduction
R-HSA-111931,R-HSA-162582,PKA-mediated phosphorylation of CREB,Signal Transduction
R-HSA-111932,R-HSA-162582,CaMK IV-mediated phosphorylation of CREB,Signal Transduction
R-HSA-111933,R-HSA-162582,Calmodulin induced events,Signal Transduction
R-HSA-111957,R-HSA-162582,Cam-PDE 1 activation,Signal Transduction
R-HSA-111995,R-HSA-162582,phospho-PLA2 pathway,Signal Transduction
R-HSA-111997,R-HSA-162582,CaM pathway,Signal Transduction
R-HSA-112043,R-HSA-162582,PLC beta mediated events,Signal Transduction
R-HSA-112122,R-HSA-73894,ALKBH2 mediated reversal of alkylation damage,DNA Repair
R-HSA-112126,R-HSA-73894,ALKBH3 mediated reversal of alkylation damage,DNA Repair
R-HSA-112303,R-HSA-112316,Electric Transmission Across Gap Junctions,Neuronal System
R-HSA-112308,R-HSA-112316,Presynaptic depolarization and calcium channel opening,Neuronal System
R-HSA-112310,R-HSA-112316,Neurotransmitter release cycle,Neuronal System
R-HSA-112311,R-HSA-112316,Neurotransmitter clearance,Neuronal System
R-HSA-112314,R-HSA-112316,Neurotransmitter receptors and postsynaptic signal transmission,Neuronal System
R-HSA-112382,R-HSA-74160,Formation of RNA Pol II elongation complex ,Gene expression (Transcription)
R-HSA-112399,R-HSA-162582,IRS-mediated signalling,Signal Transduction
R-HSA-112409,R-HSA-162582,RAF-independent MAPK1/3 activation,Signal Transduction
R-HSA-112411,R-HSA-162582,MAPK1 (ERK2) activation,Signal Transduction
R-HSA-112412,R-HSA-162582,SOS-mediated signalling,Signal Transduction
R-HSA-113418,R-HSA-74160,Formation of the Early Elongation Complex,Gene expression (Transcription)
R-HSA-113501,R-HSA-1640170,Inhibition of replication initiation of damaged DNA by RB1/E2F1,Cell Cycle
R-HSA-113507,R-HSA-1640170,E2F-enabled inhibition of pre-replication complex formation,Cell Cycle
R-HSA-114294,R-HSA-5357801,"Activation, translocation and oligomerization of BAX",Programmed Cell Death
R-HSA-114508,R-HSA-109582,Effects of PIP2 hydrolysis,Hemostasis
R-HSA-114508,R-HSA-162582,Effects of PIP2 hydrolysis,Signal Transduction
R-HSA-114516,R-HSA-109582,Disinhibition of SNARE formation,Hemostasis
R-HSA-114604,R-HSA-109582,GPVI-mediated activation cascade,Hemostasis
R-HSA-114608,R-HSA-109582,Platelet degranulation ,Hemostasis
R-HSA-1169091,R-HSA-168256,Activation of NF-kappaB in B cells,Immune System
R-HSA-1169092,R-HSA-168256,Activation of RAS in B cells,Immune System
R-HSA-1169408,R-HSA-168256,ISG15 antiviral mechanism,Immune System
R-HSA-1170546,R-HSA-168256,Prolactin receptor signaling,Immune System
R-HSA-1181150,R-HSA-1266738,Signaling by NODAL,Developmental Biology
R-HSA-1221632,R-HSA-1640170,Meiotic synapsis,Cell Cycle
R-HSA-1221632,R-HSA-1474165,Meiotic synapsis,Reproduction
R-HSA-1222387,R-HSA-1643685,Tolerance of reactive oxygen produced by macrophages,Disease
R-HSA-1222449,R-HSA-1643685,Mtb iron assimilation by chelation,Disease
R-HSA-1222538,R-HSA-1643685,Tolerance by Mtb to nitric oxide produced by macrophages,Disease
R-HSA-1222541,R-HSA-1643685,Cell redox homeostasis,Disease
R-HSA-1222556,R-HSA-168256,ROS and RNS production in phagocytes,Immune System
R-HSA-1227986,R-HSA-162582,Signaling by ERBB2,Signal Transduction
R-HSA-1234158,R-HSA-8953897,Regulation of gene expression by Hypoxia-inducible Factor,Cellular responses to external stimuli
R-HSA-1234174,R-HSA-8953897,Cellular response to hypoxia,Cellular responses to external stimuli
R-HSA-1234176,R-HSA-8953897,Oxygen-dependent proline hydroxylation of Hypoxia-inducible Factor Alpha,Cellular responses to external stimuli
R-HSA-1236382,R-HSA-1643685,Constitutive Signaling by Ligand-Responsive EGFR Cancer Variants,Disease
R-HSA-1236394,R-HSA-162582,Signaling by ERBB4,Signal Transduction
R-HSA-1236973,R-HSA-168256,Cross-presentation of particulate exogenous antigens (phagosomes),Immune System
R-HSA-1236974,R-HSA-168256,ER-Phagosome pathway,Immune System
R-HSA-1236977,R-HSA-168256,Endosomal/Vacuolar pathway,Immune System
R-HSA-1236978,R-HSA-168256,Cross-presentation of soluble exogenous antigens (endosomes),Immune System
R-HSA-1237044,R-HSA-382551,Erythrocytes take up carbon dioxide and release oxygen,Transport of small molecules
R-HSA-1237112,R-HSA-1430728,Methionine salvage pathway,Metabolism
R-HSA-1247673,R-HSA-382551,Erythrocytes take up oxygen and release carbon dioxide,Transport of small molecules
R-HSA-1250196,R-HSA-162582,SHC1 events in ERBB2 signaling,Signal Transduction
R-HSA-1250342,R-HSA-162582,PI3K events in ERBB4 signaling,Signal Transduction
R-HSA-1250347,R-HSA-162582,SHC1 events in ERBB4 signaling,Signal Transduction
R-HSA-1251932,R-HSA-162582,PLCG1 events in ERBB2 signaling,Signal Transduction
R-HSA-1251985,R-HSA-162582,Nuclear signaling by ERBB4,Signal Transduction
R-HSA-1253288,R-HSA-162582,Downregulation of ERBB4 signaling,Signal Transduction
R-HSA-1257604,R-HSA-162582,PIP3 activates AKT signaling,Signal Transduction
R-HSA-1266695,R-HSA-168256,Interleukin-7 signaling,Immune System
R-HSA-1268020,R-HSA-9609507,Mitochondrial protein import,Protein localization
R-HSA-1295596,R-HSA-162582,Spry regulation of FGF signaling,Signal Transduction
R-HSA-1296025,R-HSA-112316,ATP sensitive Potassium channels,Neuronal System
R-HSA-1296041,R-HSA-112316,Activation of G protein gated Potassium channels,Neuronal System
R-HSA-1296052,R-HSA-112316,Ca2+ activated K+ channels,Neuronal System
R-HSA-1296053,R-HSA-112316,Classical Kir channels,Neuronal System
R-HSA-1296061,R-HSA-112316,HCN channels,Neuronal System
R-HSA-1296067,R-HSA-112316,Potassium transport channels,Neuronal System
R-HSA-1296072,R-HSA-112316,Voltage gated Potassium channels,Neuronal System
R-HSA-1299287,R-HSA-112316,Tandem pore domain halothane-inhibited K+ channel (THIK),Neuronal System
R-HSA-1299308,R-HSA-112316,Tandem of pore domain in a weak inwardly rectifying K+ channels (TWIK),Neuronal System
R-HSA-1299316,R-HSA-112316,TWIK-releated acid-sensitive K+ channel (TASK),Neuronal System
R-HSA-1299344,R-HSA-112316,TWIK-related spinal cord K+ channel (TRESK),Neuronal System
R-HSA-1299361,R-HSA-112316,TWIK-related alkaline pH activated K+ channel (TALK),Neuronal System
R-HSA-1299503,R-HSA-112316,TWIK related potassium channel (TREK),Neuronal System
R-HSA-1300642,R-HSA-1474165,Sperm Motility And Taxes,Reproduction
R-HSA-1300645,R-HSA-1474165,Acrosome Reaction and Sperm:Oocyte Membrane Binding,Reproduction
R-HSA-1306955,R-HSA-162582,GRB7 events in ERBB2 signaling,Signal Transduction
R-HSA-1307965,R-HSA-162582,betaKlotho-mediated ligand binding,Signal Transduction
R-HSA-1358803,R-HSA-162582,Downregulation of ERBB2:ERBB3 signaling,Signal Transduction
R-HSA-1362277,R-HSA-1640170,Transcription of E2F targets under negative control by DREAM complex,Cell Cycle
R-HSA-1362300,R-HSA-1640170,Transcription of E2F targets under negative control by p107 (RBL1) and p130 (RBL2) in complex with HDAC1,Cell Cycle
R-HSA-1362409,R-HSA-1430728,Mitochondrial iron-sulfur cluster biogenesis,Metabolism
R-HSA-1368071,R-HSA-400253,NR1D1 (REV-ERBA) represses gene expression,Circadian Clock
R-HSA-1368082,R-HSA-400253,RORA activates gene expression,Circadian Clock
R-HSA-1368108,R-HSA-400253,"BMAL1:CLOCK,NPAS2 activates circadian gene expression",Circadian Clock
R-HSA-1369007,R-HSA-382551,Mitochondrial ABC transporters,Transport of small molecules
R-HSA-1369062,R-HSA-382551,ABC transporters in lipid homeostasis,Transport of small molecules
R-HSA-139853,R-HSA-109582,Elevation of cytosolic Ca2+ levels,Hemostasis
R-HSA-139910,R-HSA-5357801,Activation of BMF and translocation to mitochondria,Programmed Cell Death
R-HSA-139915,R-HSA-5357801,Activation of PUMA and translocation to mitochondria,Programmed Cell Death
R-HSA-140180,R-HSA-1430728,COX reactions,Metabolism
R-HSA-140342,R-HSA-5357801,Apoptosis induced DNA fragmentation,Programmed Cell Death
R-HSA-140534,R-HSA-5357801,Caspase activation via Death Receptors in the presence of ligand,Programmed Cell Death
R-HSA-140834,R-HSA-109582,Extrinsic Pathway of Fibrin Clot Formation,Hemostasis
R-HSA-140837,R-HSA-109582,Intrinsic Pathway of Fibrin Clot Formation,Hemostasis
R-HSA-140875,R-HSA-109582,Common Pathway of Fibrin Clot Formation,Hemostasis
R-HSA-141333,R-HSA-1430728,Biogenic amines are oxidatively deaminated to aldehydes by MAOA and MAOB,Metabolism
R-HSA-141334,R-HSA-1430728,PAOs oxidise polyamines to amines,Metabolism
R-HSA-141405,R-HSA-1640170,Inhibition of the proteolytic activity of APC/C required for the onset of anaphase by mitotic spindle checkpoint components,Cell Cycle
R-HSA-141430,R-HSA-1640170,Inactivation of APC/C via direct inhibition of the APC/C complex,Cell Cycle
R-HSA-141444,R-HSA-1640170,Amplification  of signal from unattached  kinetochores via a MAD2  inhibitory signal,Cell Cycle
R-HSA-1433557,R-HSA-162582,Signaling by SCF-KIT,Signal Transduction
R-HSA-1433559,R-HSA-162582,Regulation of KIT signaling,Signal Transduction
R-HSA-1433617,R-HSA-1266738,Regulation of signaling by NODAL,Developmental Biology
R-HSA-1442490,R-HSA-1474244,Collagen degradation,Extracellular matrix organization
R-HSA-1445148,R-HSA-5653656,Translocation of SLC2A4 (GLUT4) to the plasma membrane,Vesicle-mediated transport
R-HSA-1461957,R-HSA-168256,Beta defensins,Immune System
R-HSA-1461973,R-HSA-168256,Defensins,Immune System
R-HSA-1462054,R-HSA-168256,Alpha-defensins,Immune System
R-HSA-1474151,R-HSA-1430728,"Tetrahydrobiopterin (BH4) synthesis, recycling, salvage and regulation",Metabolism
R-HSA-1474228,R-HSA-1474244,Degradation of the extracellular matrix,Extracellular matrix organization
R-HSA-1474244,R-HSA-1474244,Extracellular matrix organization,Extracellular matrix organization
R-HSA-1475029,R-HSA-1430728,Reversible hydration of carbon dioxide,Metabolism
R-HSA-1482788,R-HSA-1430728,Acyl chain remodelling of PC,Metabolism
R-HSA-1482798,R-HSA-1430728,Acyl chain remodeling of CL,Metabolism
R-HSA-1482801,R-HSA-1430728,Acyl chain remodelling of PS,Metabolism
R-HSA-1482839,R-HSA-1430728,Acyl chain remodelling of PE,Metabolism
R-HSA-1482883,R-HSA-1430728,Acyl chain remodeling of DAG and TAG,Metabolism
R-HSA-1482922,R-HSA-1430728,Acyl chain remodelling of PI,Metabolism
R-HSA-1482925,R-HSA-1430728,Acyl chain remodelling of PG,Metabolism
R-HSA-1483076,R-HSA-1430728,Synthesis of CL,Metabolism
R-HSA-1483101,R-HSA-1430728,Synthesis of PS,Metabolism
R-HSA-1483115,R-HSA-1430728,Hydrolysis of LPC,Metabolism
R-HSA-1483148,R-HSA-1430728,Synthesis of PG,Metabolism
R-HSA-1483152,R-HSA-1430728,Hydrolysis of LPE,Metabolism
R-HSA-1483166,R-HSA-1430728,Synthesis of PA,Metabolism
R-HSA-1483191,R-HSA-1430728,Synthesis of PC,Metabolism
R-HSA-1483196,R-HSA-1430728,PI and PC transport between ER and Golgi membranes,Metabolism
R-HSA-1483206,R-HSA-1430728,Glycerophospholipid biosynthesis,Metabolism
R-HSA-1483213,R-HSA-1430728,Synthesis of PE,Metabolism
R-HSA-1483226,R-HSA-1430728,Synthesis of PI,Metabolism
R-HSA-1483248,R-HSA-1430728,Synthesis of PIPs at the ER membrane,Metabolism
R-HSA-1483255,R-HSA-1430728,PI Metabolism,Metabolism
R-HSA-1489509,R-HSA-162582,DAG and IP3 signaling,Signal Transduction
R-HSA-1502540,R-HSA-162582,Signaling by Activin,Signal Transduction
R-HSA-1538133,R-HSA-1640170,G0 and Early G1,Cell Cycle
R-HSA-156581,R-HSA-1430728,Methylation,Metabolism
R-HSA-156582,R-HSA-1430728,Acetylation,Metabolism
R-HSA-156584,R-HSA-1430728,Cytosolic sulfonation of small molecules,Metabolism
R-HSA-156588,R-HSA-1430728,Glucuronidation,Metabolism
R-HSA-156590,R-HSA-1430728,Glutathione conjugation,Metabolism
R-HSA-1566948,R-HSA-1474244,Elastic fibre formation,Extracellular matrix organization
R-HSA-1566977,R-HSA-1474244,Fibronectin matrix formation,Extracellular matrix organization
R-HSA-156711,R-HSA-1640170,Polo-like kinase mediated events,Cell Cycle
R-HSA-156827,R-HSA-392499,L13a-mediated translational silencing of Ceruloplasmin expression,Metabolism of proteins
R-HSA-156842,R-HSA-392499,Eukaryotic Translation Elongation,Metabolism of proteins
R-HSA-156902,R-HSA-392499,Peptide chain elongation,Metabolism of proteins
R-HSA-159227,R-HSA-8953854,Transport of the SLBP independent Mature mRNA,Metabolism of RNA
R-HSA-159230,R-HSA-8953854,Transport of the SLBP Dependant Mature mRNA,Metabolism of RNA
R-HSA-159231,R-HSA-8953854,Transport of Mature mRNA Derived from an Intronless Transcript,Metabolism of RNA
R-HSA-159236,R-HSA-8953854,Transport of Mature mRNA derived from an Intron-Containing Transcript,Metabolism of RNA
R-HSA-1592389,R-HSA-1474244,Activation of Matrix Metalloproteinases,Extracellular matrix organization
R-HSA-159418,R-HSA-1430728,Recycling of bile acids and salts,Metabolism
R-HSA-159740,R-HSA-392499,Gamma-carboxylation of protein precursors,Metabolism of proteins
R-HSA-159763,R-HSA-392499,Transport of gamma-carboxylated protein precursors from the endoplasmic reticulum to the Golgi apparatus,Metabolism of proteins
R-HSA-159782,R-HSA-392499,Removal of aminoterminal propeptides from gamma-carboxylated proteins,Metabolism of proteins
R-HSA-1606322,R-HSA-168256,ZBP1(DAI) mediated induction of type I IFNs,Immune System
R-HSA-1606341,R-HSA-168256,IRF3 mediated activation of type 1 IFN,Immune System
R-HSA-1614517,R-HSA-1430728,Sulfide oxidation to sulfate,Metabolism
R-HSA-1614558,R-HSA-1430728,Degradation of cysteine and homocysteine,Metabolism
R-HSA-1614603,R-HSA-1430728,Cysteine formation from homocysteine,Metabolism
R-HSA-1614635,R-HSA-1430728,Sulfur amino acid metabolism,Metabolism
R-HSA-162585,R-HSA-1643685,Uncoating of the HIV Virion,Disease
R-HSA-162588,R-HSA-1643685,Budding and maturation of HIV virion,Disease
R-HSA-162592,R-HSA-1643685,Integration of provirus,Disease
R-HSA-162594,R-HSA-1643685,Early Phase of HIV Life Cycle,Disease
R-HSA-162599,R-HSA-1643685,Late Phase of HIV Life Cycle,Disease
R-HSA-162658,R-HSA-1640170,Golgi Cisternae Pericentriolar Stack Reorganization,Cell Cycle
R-HSA-162699,R-HSA-392499,Synthesis of dolichyl-phosphate mannose,Metabolism of proteins
R-HSA-162710,R-HSA-392499,Synthesis of glycosylphosphatidylinositol (GPI),Metabolism of proteins
R-HSA-162791,R-HSA-392499,Attachment of GPI anchor to uPAR,Metabolism of proteins
R-HSA-163125,R-HSA-392499,Post-translational modification: synthesis of GPI-anchored proteins,Metabolism of proteins
R-HSA-163210,R-HSA-1430728,Formation of ATP by chemiosmotic coupling,Metabolism
R-HSA-163282,R-HSA-74160,Mitochondrial transcription initiation,Gene expression (Transcription)
R-HSA-1632852,R-HSA-9612973,Macroautophagy,Autophagy
R-HSA-163316,R-HSA-74160,Mitochondrial transcription termination,Gene expression (Transcription)
R-HSA-163358,R-HSA-1430728,PKA-mediated phosphorylation of key metabolic factors,Metabolism
R-HSA-163359,R-HSA-1430728,Glucagon signaling in metabolic regulation,Metabolism
R-HSA-163560,R-HSA-1430728,Triglyceride catabolism,Metabolism
R-HSA-163615,R-HSA-162582,PKA activation,Signal Transduction
R-HSA-163680,R-HSA-1430728,AMPK inhibits chREBP transcriptional activation activity,Metabolism
R-HSA-163685,R-HSA-1430728,Integration of energy metabolism,Metabolism
R-HSA-163754,R-HSA-1430728,Insulin effects increased synthesis of Xylulose-5-Phosphate,Metabolism
R-HSA-163765,R-HSA-1430728,ChREBP activates metabolic gene expression,Metabolism
R-HSA-163767,R-HSA-1430728,PP2A-mediated dephosphorylation of key metabolic factors,Metabolism
R-HSA-163841,R-HSA-392499,"Gamma carboxylation, hypusine formation and arylsulfatase activation",Metabolism of proteins
R-HSA-164378,R-HSA-1430728,PKA activation in glucagon signalling,Metabolism
R-HSA-164516,R-HSA-1643685,Minus-strand DNA synthesis,Disease
R-HSA-164525,R-HSA-1643685,Plus-strand DNA synthesis,Disease
R-HSA-164843,R-HSA-1643685,2-LTR circle formation,Disease
R-HSA-164939,R-HSA-1643685,Nef mediated downregulation of CD28 cell surface expression,Disease
R-HSA-164940,R-HSA-1643685,Nef mediated downregulation of MHC class I complex cell surface expression,Disease
R-HSA-164944,R-HSA-1643685,Nef and signal transduction,Disease
R-HSA-165054,R-HSA-1643685,Rev-mediated nuclear export of HIV RNA,Disease
R-HSA-1650814,R-HSA-1474244,Collagen biosynthesis and modifying enzymes,Extracellular matrix organization
R-HSA-165158,R-HSA-162582,Activation of AKT2,Signal Transduction
R-HSA-165159,R-HSA-162582,MTOR signalling,Signal Transduction
R-HSA-165160,R-HSA-162582,PDE3B signalling,Signal Transduction
R-HSA-165181,R-HSA-162582,Inhibition of TSC complex formation by PKB,Signal Transduction
R-HSA-1655829,R-HSA-1430728,Regulation of cholesterol biosynthesis by SREBP (SREBF),Metabolism
R-HSA-166016,R-HSA-168256,Toll Like Receptor 4 (TLR4) Cascade,Immune System
R-HSA-166020,R-HSA-168256,Transfer of LPS from LBP carrier to CD14,Immune System
R-HSA-1660499,R-HSA-1430728,Synthesis of PIPs at the plasma membrane,Metabolism
R-HSA-1660514,R-HSA-1430728,Synthesis of PIPs at the Golgi membrane,Metabolism
R-HSA-1660516,R-HSA-1430728,Synthesis of PIPs at the early endosome membrane,Metabolism
R-HSA-1660517,R-HSA-1430728,Synthesis of PIPs at the late endosome membrane,Metabolism
R-HSA-166058,R-HSA-168256,MyD88:MAL(TIRAP) cascade initiated on plasma membrane,Immune System
R-HSA-1660661,R-HSA-1430728,Sphingolipid de novo biosynthesis,Metabolism
R-HSA-1660662,R-HSA-1430728,Glycosphingolipid metabolism,Metabolism
R-HSA-166166,R-HSA-168256,MyD88-independent TLR4 cascade ,Immune System
R-HSA-166208,R-HSA-162582,mTORC1-mediated signalling,Signal Transduction
R-HSA-1663150,R-HSA-392499,The activation of arylsulfatases,Metabolism of proteins
R-HSA-166662,R-HSA-168256,Lectin pathway of complement activation,Immune System
R-HSA-166663,R-HSA-168256,Initial triggering of complement,Immune System
R-HSA-166665,R-HSA-168256,Terminal pathway of complement,Immune System
R-HSA-167021,R-HSA-162582,PLC-gamma1 signalling,Signal Transduction
R-HSA-167044,R-HSA-162582,Signalling to RAS,Signal Transduction
R-HSA-167060,R-HSA-162582,NGF processing,Signal Transduction
R-HSA-167152,R-HSA-1643685,Formation of HIV elongation complex in the absence of HIV Tat,Disease
R-HSA-167158,R-HSA-1643685,Formation of the HIV-1 Early Elongation Complex,Disease
R-HSA-167160,R-HSA-1643685,RNA Pol II CTD phosphorylation and interaction with CE during HIV infection,Disease
R-HSA-167161,R-HSA-1643685,HIV Transcription Initiation,Disease
R-HSA-167162,R-HSA-1643685,RNA Polymerase II HIV Promoter Escape,Disease
R-HSA-167172,R-HSA-1643685,Transcription of the HIV genome,Disease
R-HSA-167200,R-HSA-1643685,Formation of HIV-1 elongation complex containing HIV-1 Tat,Disease
R-HSA-167238,R-HSA-1643685,Pausing and recovery of Tat-mediated HIV elongation,Disease
R-HSA-167242,R-HSA-1643685,Abortive elongation of HIV-1 transcript in the absence of Tat,Disease
R-HSA-167243,R-HSA-1643685,Tat-mediated HIV elongation arrest and recovery,Disease
R-HSA-167246,R-HSA-1643685,Tat-mediated elongation of the HIV-1 transcript,Disease
R-HSA-167287,R-HSA-1643685,HIV elongation arrest and recovery,Disease
R-HSA-167290,R-HSA-1643685,Pausing and recovery of HIV elongation,Disease
R-HSA-167590,R-HSA-1643685,Nef Mediated CD4 Down-regulation,Disease
R-HSA-167826,R-HSA-1430728,The fatty acid cycling model,Metabolism
R-HSA-167827,R-HSA-1430728,The proton buffering model,Metabolism
R-HSA-1679131,R-HSA-168256,Trafficking and processing of endosomal TLR,Immune System
R-HSA-168138,R-HSA-168256,Toll Like Receptor 9 (TLR9) Cascade,Immune System
R-HSA-168142,R-HSA-168256,Toll Like Receptor 10 (TLR10) Cascade,Immune System
R-HSA-168164,R-HSA-168256,Toll Like Receptor 3 (TLR3) Cascade,Immune System
R-HSA-168176,R-HSA-168256,Toll Like Receptor 5 (TLR5) Cascade,Immune System
R-HSA-168179,R-HSA-168256,Toll Like Receptor TLR1:TLR2 Cascade,Immune System
R-HSA-168181,R-HSA-168256,Toll Like Receptor 7/8 (TLR7/8) Cascade,Immune System
R-HSA-168188,R-HSA-168256,Toll Like Receptor TLR6:TLR2 Cascade,Immune System
R-HSA-168255,R-HSA-1643685,Influenza Infection,Disease
R-HSA-168271,R-HSA-1643685,Transport of Ribonucleoproteins into the Host Nucleus,Disease
R-HSA-168275,R-HSA-1643685,Entry of Influenza Virion into Host Cell via Endocytosis,Disease
R-HSA-168276,R-HSA-1643685,NS1 Mediated Effects on Host Pathways,Disease
R-HSA-168277,R-HSA-1643685,Influenza Virus Induced Apoptosis,Disease
R-HSA-168288,R-HSA-1643685,Fusion of the Influenza Virion to the Host Cell Endosome,Disease
R-HSA-168298,R-HSA-1643685,Release,Disease
R-HSA-168302,R-HSA-1643685,Budding,Disease
R-HSA-168303,R-HSA-1643685,Packaging of Eight RNA Segments,Disease
R-HSA-168315,R-HSA-1643685,Inhibition of Host mRNA Processing and RNA Silencing,Disease
R-HSA-168316,R-HSA-1643685,Assembly of Viral Components at the Budding Site,Disease
R-HSA-168325,R-HSA-1643685,Viral Messenger RNA Synthesis,Disease
R-HSA-168330,R-HSA-1643685,Viral RNP Complexes in the Host Cell Nucleus,Disease
R-HSA-168333,R-HSA-1643685,NEP/NS2 Interacts with the Cellular Export Machinery,Disease
R-HSA-168336,R-HSA-1643685,Uncoating of the Influenza Virion,Disease
R-HSA-168638,R-HSA-168256,NOD1/2 Signaling Pathway,Immune System
R-HSA-168874,R-HSA-1643685,"Transport of HA trimer, NA tetramer and M2 tetramer from the endoplasmic reticulum to the Golgi Apparatus",Disease
R-HSA-168888,R-HSA-1643685,Inhibition of IFN-beta,Disease
R-HSA-168927,R-HSA-168256,"TICAM1, RIP1-mediated IKK complex recruitment",Immune System
R-HSA-168928,R-HSA-168256,DDX58/IFIH1-mediated induction of interferon-alpha/beta,Immune System
R-HSA-169131,R-HSA-1643685,Inhibition of PKR,Disease
R-HSA-169911,R-HSA-5357801,Regulation of Apoptosis,Programmed Cell Death
R-HSA-170145,R-HSA-1640170,Phosphorylation of proteins involved in the G2/M transition by Cyclin A:Cdc2 complexes,Cell Cycle
R-HSA-170660,R-HSA-162582,Adenylate cyclase activating pathway,Signal Transduction
R-HSA-170670,R-HSA-112316,Adenylate cyclase inhibitory pathway,Neuronal System
R-HSA-170670,R-HSA-162582,Adenylate cyclase inhibitory pathway,Signal Transduction
R-HSA-170822,R-HSA-1430728,Regulation of Glucokinase by Glucokinase Regulatory Protein,Metabolism
R-HSA-170968,R-HSA-162582,Frs2-mediated activation,Signal Transduction
R-HSA-170984,R-HSA-162582,ARMS-mediated activation,Signal Transduction
R-HSA-171007,R-HSA-162582,p38MAPK events,Signal Transduction
R-HSA-171286,R-HSA-1643685,Synthesis and processing of ENV and VPU,Disease
R-HSA-171306,R-HSA-1640170,Packaging Of Telomere Ends,Cell Cycle
R-HSA-171319,R-HSA-1640170,Telomere Extension By Telomerase,Cell Cycle
R-HSA-173107,R-HSA-1643685,Binding and entry of HIV virion,Disease
R-HSA-173599,R-HSA-1430728,"Formation of the active cofactor, UDP-glucuronate",Metabolism
R-HSA-173623,R-HSA-168256,Classical antibody-mediated complement activation,Immune System
R-HSA-173736,R-HSA-168256,Alternative complement activation,Immune System
R-HSA-174048,R-HSA-1640170,APC/C:Cdc20 mediated degradation of Cyclin B,Cell Cycle
R-HSA-174084,R-HSA-1640170,Autodegradation of Cdh1 by Cdh1:APC/C,Cell Cycle
R-HSA-174113,R-HSA-1640170,SCF-beta-TrCP mediated degradation of Emi1,Cell Cycle
R-HSA-174154,R-HSA-1640170,APC/C:Cdc20 mediated degradation of Securin,Cell Cycle
R-HSA-174178,R-HSA-1640170,APC/C:Cdh1 mediated degradation of Cdc20 and other APC/C:Cdh1 targeted proteins in late mitosis/early G1,Cell Cycle
R-HSA-174184,R-HSA-1640170,Cdc20:Phospho-APC/C mediated degradation of Cyclin A,Cell Cycle
R-HSA-174362,R-HSA-1430728,Transport and synthesis of PAPS,Metabolism
R-HSA-174403,R-HSA-1430728,Glutathione synthesis and recycling,Metabolism
R-HSA-174411,R-HSA-1640170,Polymerase switching on the C-strand of the telomere,Cell Cycle
R-HSA-174414,R-HSA-1640170,Processive synthesis on the C-strand of the telomere,Cell Cycle
R-HSA-174417,R-HSA-1640170,Telomere C-strand (Lagging Strand) Synthesis,Cell Cycle
R-HSA-174430,R-HSA-1640170,Telomere C-strand synthesis initiation,Cell Cycle
R-HSA-174437,R-HSA-1640170,Removal of the Flap Intermediate from the C-strand,Cell Cycle
R-HSA-174490,R-HSA-1643685,Membrane binding and targetting of GAG proteins,Disease
R-HSA-174495,R-HSA-1643685,"Synthesis And Processing Of GAG, GAGPOL Polyproteins",Disease
R-HSA-174577,R-HSA-168256,Activation of C3 and C5,Immune System
R-HSA-175474,R-HSA-1643685,Assembly Of The HIV Virion,Disease
R-HSA-175567,R-HSA-1643685,Integration of viral DNA into host genomic DNA,Disease
R-HSA-176034,R-HSA-1643685,Interactions of Tat with host cellular proteins,Disease
R-HSA-176187,R-HSA-1640170,Activation of ATR in response to replication stress,Cell Cycle
R-HSA-176407,R-HSA-1640170,Conversion from APC/C:Cdc20 to APC/C:Cdh1 in late anaphase,Cell Cycle
R-HSA-176408,R-HSA-1640170,Regulation of APC/C activators between G1/S and early anaphase,Cell Cycle
R-HSA-176409,R-HSA-1640170,APC/C:Cdc20 mediated degradation of mitotic proteins,Cell Cycle
R-HSA-176412,R-HSA-1640170,Phosphorylation of the APC/C,Cell Cycle
R-HSA-176417,R-HSA-1640170,Phosphorylation of Emi1,Cell Cycle
R-HSA-176974,R-HSA-69306,Unwinding of DNA,DNA Replication
R-HSA-176974,R-HSA-1640170,Unwinding of DNA,Cell Cycle
R-HSA-177128,R-HSA-1430728,Conjugation of salicylate with glycine,Metabolism
R-HSA-177135,R-HSA-1430728,Conjugation of benzoate with glycine,Metabolism
R-HSA-177162,R-HSA-1430728,Conjugation of phenylacetate with glutamine,Metabolism
R-HSA-177504,R-HSA-162582,Retrograde neurotrophin signalling,Signal Transduction
R-HSA-177539,R-HSA-1643685,Autointegration results in viral DNA circles,Disease
R-HSA-177929,R-HSA-162582,Signaling by EGFR,Signal Transduction
R-HSA-179409,R-HSA-1640170,APC-Cdc20 mediated degradation of Nek2A,Cell Cycle
R-HSA-179812,R-HSA-162582,GRB2 events in EGFR signaling,Signal Transduction
R-HSA-1799339,R-HSA-392499,SRP-dependent cotranslational protein targeting to membrane,Metabolism of proteins
R-HSA-180024,R-HSA-162582,DARPP-32 events,Signal Transduction
R-HSA-180292,R-HSA-162582,GAB1 signalosome,Signal Transduction
R-HSA-180336,R-HSA-162582,SHC1 events in EGFR signaling,Signal Transduction
R-HSA-180534,R-HSA-1643685,Vpu mediated degradation of CD4,Disease
R-HSA-180585,R-HSA-1643685,Vif-mediated degradation of APOBEC3G,Disease
R-HSA-180689,R-HSA-1643685,APOBEC3G mediated resistance to HIV-1 infection,Disease
R-HSA-180746,R-HSA-1643685,Nuclear import of Rev protein,Disease
R-HSA-180897,R-HSA-1643685,Vpr-mediated induction of apoptosis by mitochondrial outer membrane permeabilization,Disease
R-HSA-180910,R-HSA-1643685,Vpr-mediated nuclear import of PICs,Disease
R-HSA-1810476,R-HSA-168256,RIP-mediated NFkB activation via ZBP1,Immune System
R-HSA-181429,R-HSA-112316,Serotonin Neurotransmitter Release Cycle,Neuronal System
R-HSA-181430,R-HSA-112316,Norepinephrine Neurotransmitter Release Cycle,Neuronal System
R-HSA-182218,R-HSA-1643685,Nef Mediated CD8 Down-regulation,Disease
R-HSA-182971,R-HSA-162582,EGFR downregulation,Signal Transduction
R-HSA-1834941,R-HSA-168256,STING mediated induction of host immune responses,Immune System
R-HSA-1834949,R-HSA-168256,Cytosolic sensors of pathogen-associated DNA ,Immune System
R-HSA-1839117,R-HSA-1643685,Signaling by cytosolic FGFR1 fusion mutants,Disease
R-HSA-1839120,R-HSA-1643685,Signaling by FGFR1 amplification mutants,Disease
R-HSA-1839122,R-HSA-1643685,Signaling by activated point mutants of FGFR1,Disease
R-HSA-1839128,R-HSA-1643685,FGFR4 mutant receptor activation,Disease
R-HSA-1839130,R-HSA-1643685,Signaling by activated point mutants of FGFR3,Disease
R-HSA-1855167,R-HSA-1430728,Synthesis of pyrophosphates in the cytosol,Metabolism
R-HSA-1855183,R-HSA-1430728,"Synthesis of IP2, IP, and Ins in the cytosol",Metabolism
R-HSA-1855191,R-HSA-1430728,Synthesis of IPs in the nucleus,Metabolism
R-HSA-1855204,R-HSA-1430728,Synthesis of IP3 and IP4 in the cytosol,Metabolism
R-HSA-1855231,R-HSA-1430728,Synthesis of IPs in the ER lumen,Metabolism
R-HSA-186763,R-HSA-162582,Downstream signal transduction,Signal Transduction
R-HSA-186797,R-HSA-162582,Signaling by PDGF,Signal Transduction
R-HSA-187024,R-HSA-162582,NGF-independant TRKA activation,Signal Transduction
R-HSA-187042,R-HSA-162582,TRKA activation by NGF,Signal Transduction
R-HSA-187577,R-HSA-1640170,SCF(Skp2)-mediated degradation of p27/p21,Cell Cycle
R-HSA-187706,R-HSA-162582,Signalling to p38 via RIT and RIN,Signal Transduction
R-HSA-189085,R-HSA-8963743,Digestion of dietary carbohydrate,Digestion and absorption
R-HSA-189200,R-HSA-382551,Cellular hexose transport,Transport of small molecules
R-HSA-189451,R-HSA-1430728,Heme biosynthesis,Metabolism
R-HSA-189483,R-HSA-1430728,Heme degradation,Metabolism
R-HSA-190322,R-HSA-162582,FGFR4 ligand binding and activation,Signal Transduction
R-HSA-190370,R-HSA-162582,FGFR1b ligand binding and activation,Signal Transduction
R-HSA-190371,R-HSA-162582,FGFR3b ligand binding and activation,Signal Transduction
R-HSA-190372,R-HSA-162582,FGFR3c ligand binding and activation,Signal Transduction
R-HSA-190373,R-HSA-162582,FGFR1c ligand binding and activation,Signal Transduction
R-HSA-190374,R-HSA-162582,FGFR1c and Klotho ligand binding and activation,Signal Transduction
R-HSA-190375,R-HSA-162582,FGFR2c ligand binding and activation,Signal Transduction
R-HSA-190377,R-HSA-162582,FGFR2b ligand binding and activation,Signal Transduction
R-HSA-190704,R-HSA-5653656,Oligomerization of connexins into connexons,Vesicle-mediated transport
R-HSA-190827,R-HSA-5653656,Transport of connexins along the secretory pathway,Vesicle-mediated transport
R-HSA-190840,R-HSA-5653656,Microtubule-dependent trafficking of connexons from Golgi to the plasma membrane,Vesicle-mediated transport
R-HSA-190861,R-HSA-5653656,Gap junction assembly,Vesicle-mediated transport
R-HSA-190872,R-HSA-5653656,Transport of connexons to the plasma membrane,Vesicle-mediated transport
R-HSA-190873,R-HSA-5653656,Gap junction degradation,Vesicle-mediated transport
R-HSA-1912399,R-HSA-162582,Pre-NOTCH Processing in the Endoplasmic Reticulum,Signal Transduction
R-HSA-1912408,R-HSA-162582,Pre-NOTCH Transcription and Translation,Signal Transduction
R-HSA-1912420,R-HSA-162582,Pre-NOTCH Processing in Golgi,Signal Transduction
R-HSA-191273,R-HSA-1430728,Cholesterol biosynthesis,Metabolism
R-HSA-191650,R-HSA-5653656,Regulation of gap junction activity,Vesicle-mediated transport
R-HSA-191859,R-HSA-8953854,snRNP Assembly,Metabolism of RNA
R-HSA-192105,R-HSA-1430728,Synthesis of bile acids and bile salts,Metabolism
R-HSA-192456,R-HSA-8963743,Digestion of dietary lipid,Digestion and absorption
R-HSA-192814,R-HSA-1643685,vRNA Synthesis,Disease
R-HSA-192823,R-HSA-1643685,Viral mRNA Translation,Disease
R-HSA-192869,R-HSA-1643685,cRNA Synthesis,Disease
R-HSA-192905,R-HSA-1643685,vRNP Assembly,Disease
R-HSA-193048,R-HSA-1430728,Androgen biosynthesis,Metabolism
R-HSA-193144,R-HSA-1430728,Estrogen biosynthesis,Metabolism
R-HSA-193368,R-HSA-1430728,Synthesis of bile acids and bile salts via 7alpha-hydroxycholesterol,Metabolism
R-HSA-193634,R-HSA-162582,Axonal growth inhibition (RHOA activation),Signal Transduction
R-HSA-193648,R-HSA-162582,NRAGE signals death through JNK,Signal Transduction
R-HSA-193670,R-HSA-162582,p75NTR negatively regulates cell cycle via SC1,Signal Transduction
R-HSA-193681,R-HSA-162582,Ceramide signalling,Signal Transduction
R-HSA-193692,R-HSA-162582,Regulated proteolysis of p75NTR,Signal Transduction
R-HSA-193775,R-HSA-1430728,Synthesis of bile acids and bile salts via 24-hydroxycholesterol,Metabolism
R-HSA-193807,R-HSA-1430728,Synthesis of bile acids and bile salts via 27-hydroxycholesterol,Metabolism
R-HSA-193993,R-HSA-1430728,Mineralocorticoid biosynthesis,Metabolism
R-HSA-194002,R-HSA-1430728,Glucocorticoid biosynthesis,Metabolism
R-HSA-194138,R-HSA-162582,Signaling by VEGF,Signal Transduction
R-HSA-194306,R-HSA-162582,Neurophilin interactions with VEGF and VEGFR,Signal Transduction
R-HSA-194313,R-HSA-162582,VEGF ligand-receptor interactions,Signal Transduction
R-HSA-194840,R-HSA-162582,Rho GTPase cycle,Signal Transduction
R-HSA-195253,R-HSA-162582,Degradation of beta-catenin by the destruction complex,Signal Transduction
R-HSA-195399,R-HSA-162582,VEGF binds to VEGFR leading to receptor dimerization,Signal Transduction
R-HSA-196025,R-HSA-5653656,Formation of annular gap junctions,Vesicle-mediated transport
R-HSA-196108,R-HSA-1430728,Pregnenolone biosynthesis,Metabolism
R-HSA-196299,R-HSA-162582,Beta-catenin phosphorylation cascade,Signal Transduction
R-HSA-1963640,R-HSA-162582,GRB2 events in ERBB2 signaling,Signal Transduction
R-HSA-1963642,R-HSA-162582,PI3K events in ERBB2 signaling,Signal Transduction
R-HSA-196741,R-HSA-1430728,"Cobalamin (Cbl, vitamin B12) transport and metabolism",Metabolism
R-HSA-196757,R-HSA-1430728,Metabolism of folate and pterines,Metabolism
R-HSA-196780,R-HSA-1430728,Biotin transport and metabolism,Metabolism
R-HSA-196783,R-HSA-1430728,Coenzyme A biosynthesis,Metabolism
R-HSA-196791,R-HSA-1430728,Vitamin D (calciferol) metabolism,Metabolism
R-HSA-196807,R-HSA-1430728,Nicotinate metabolism,Metabolism
R-HSA-196819,R-HSA-1430728,Vitamin B1 (thiamin) metabolism,Metabolism
R-HSA-196836,R-HSA-1430728,Vitamin C (ascorbate) metabolism,Metabolism
R-HSA-196843,R-HSA-1430728,Vitamin B2 (riboflavin) metabolism,Metabolism
R-HSA-1971475,R-HSA-1430728,A tetrasaccharide linker sequence is required for GAG synthesis,Metabolism
R-HSA-197264,R-HSA-1430728,Nicotinamide salvaging,Metabolism
R-HSA-198203,R-HSA-162582,PI3K/AKT activation,Signal Transduction
R-HSA-198323,R-HSA-162582,AKT phosphorylates targets in the cytosol,Signal Transduction
R-HSA-198693,R-HSA-162582,AKT phosphorylates targets in the nucleus,Signal Transduction
R-HSA-198745,R-HSA-162582,Signalling to STAT3,Signal Transduction
R-HSA-198753,R-HSA-162582,ERK/MAPK targets,Signal Transduction
R-HSA-198753,R-HSA-168256,ERK/MAPK targets,Immune System
R-HSA-198765,R-HSA-162582,Signalling to ERK5,Signal Transduction
R-HSA-198933,R-HSA-168256,Immunoregulatory interactions between a Lymphoid and a non-Lymphoid cell,Immune System
R-HSA-1989781,R-HSA-1430728,PPARA activates gene expression,Metabolism
R-HSA-199220,R-HSA-1430728,Vitamin B5 (pantothenate) metabolism,Metabolism
R-HSA-199418,R-HSA-162582,Negative regulation of the PI3K/AKT network,Signal Transduction
R-HSA-199920,R-HSA-162582,CREB phosphorylation,Signal Transduction
R-HSA-199920,R-HSA-168256,CREB phosphorylation,Immune System
R-HSA-199992,R-HSA-5653656,trans-Golgi Network Vesicle Budding,Vesicle-mediated transport
R-HSA-200425,R-HSA-1430728,Carnitine metabolism,Metabolism
R-HSA-201451,R-HSA-162582,Signaling by BMP,Signal Transduction
R-HSA-201681,R-HSA-162582,TCF dependent signaling in response to WNT,Signal Transduction
R-HSA-201688,R-HSA-162582,WNT mediated activation of DVL,Signal Transduction
R-HSA-201722,R-HSA-162582,Formation of the beta-catenin:TCF transactivating complex,Signal Transduction
R-HSA-202040,R-HSA-162582,G-protein activation,Signal Transduction
R-HSA-2022090,R-HSA-1474244,Assembly of collagen fibrils and other multimeric structures,Extracellular matrix organization
R-HSA-2022377,R-HSA-392499,Metabolism of Angiotensinogen to Angiotensins,Metabolism of proteins
R-HSA-2022854,R-HSA-1430728,Keratan sulfate biosynthesis,Metabolism
R-HSA-2022857,R-HSA-1430728,Keratan sulfate degradation,Metabolism
R-HSA-2022870,R-HSA-1430728,Chondroitin sulfate biosynthesis,Metabolism
R-HSA-2022923,R-HSA-1430728,Dermatan sulfate biosynthesis,Metabolism
R-HSA-2022928,R-HSA-1430728,HS-GAG biosynthesis,Metabolism
R-HSA-2023837,R-HSA-1643685,Signaling by FGFR2 amplification mutants,Disease
R-HSA-2024096,R-HSA-1430728,HS-GAG degradation,Metabolism
R-HSA-2024101,R-HSA-1430728,CS/DS degradation,Metabolism
R-HSA-202424,R-HSA-168256,Downstream TCR signaling,Immune System
R-HSA-202427,R-HSA-168256,Phosphorylation of CD3 and TCR zeta chains,Immune System
R-HSA-202430,R-HSA-168256,Translocation of ZAP-70 to Immunological synapse,Immune System
R-HSA-202433,R-HSA-168256,Generation of second messenger molecules,Immune System
R-HSA-2025928,R-HSA-168256,Calcineurin activates NFAT,Immune System
R-HSA-202670,R-HSA-162582,ERKs are inactivated,Signal Transduction
R-HSA-202670,R-HSA-168256,ERKs are inactivated,Immune System
R-HSA-202733,R-HSA-109582,Cell surface interactions at the vascular wall,Hemostasis
R-HSA-2028269,R-HSA-162582,Signaling by Hippo,Signal Transduction
R-HSA-2029481,R-HSA-168256,FCGR activation,Immune System
R-HSA-2029482,R-HSA-168256,Regulation of actin dynamics for phagocytic cup formation,Immune System
R-HSA-2029485,R-HSA-168256,Role of phospholipids in phagocytosis,Immune System
R-HSA-2032785,R-HSA-74160,YAP1- and WWTR1 (TAZ)-stimulated gene expression,Gene expression (Transcription)
R-HSA-2033514,R-HSA-1643685,FGFR3 mutant receptor activation,Disease
R-HSA-2033515,R-HSA-1643685,t(4;14) translocations of FGFR3,Disease
R-HSA-2033519,R-HSA-1643685,Activated point mutants of FGFR2,Disease
R-HSA-203615,R-HSA-1430728,eNOS activation,Metabolism
R-HSA-203641,R-HSA-1430728,NOSTRIN mediated eNOS trafficking,Metabolism
R-HSA-203754,R-HSA-1430728,NOSIP mediated eNOS trafficking,Metabolism
R-HSA-203927,R-HSA-74160,MicroRNA (miRNA) biogenesis,Gene expression (Transcription)
R-HSA-204005,R-HSA-5653656,COPII-mediated vesicle transport,Vesicle-mediated transport
R-HSA-204005,R-HSA-392499,COPII-mediated vesicle transport,Metabolism of proteins
R-HSA-204174,R-HSA-1430728,Regulation of pyruvate dehydrogenase (PDH) complex,Metabolism
R-HSA-2046105,R-HSA-1430728,Linoleic acid (LA) metabolism,Metabolism
R-HSA-2046106,R-HSA-1430728,alpha-linolenic acid (ALA) metabolism,Metabolism
R-HSA-204626,R-HSA-392499,Hypusine synthesis from eIF5A-lysine,Metabolism of proteins
R-HSA-205017,R-HSA-162582,NFG and proNGF binds to p75NTR,Signal Transduction
R-HSA-205025,R-HSA-162582,NADE modulates death signalling,Signal Transduction
R-HSA-205043,R-HSA-162582,NRIF signals cell death from the nucleus,Signal Transduction
R-HSA-209543,R-HSA-162582,p75NTR recruits signalling complexes,Signal Transduction
R-HSA-209560,R-HSA-162582,NF-kB is activated and signals survival,Signal Transduction
R-HSA-209563,R-HSA-162582,Axonal growth stimulation,Signal Transduction
R-HSA-209822,R-HSA-392499,Glycoprotein hormones,Metabolism of proteins
R-HSA-209905,R-HSA-1430728,Catecholamine biosynthesis,Metabolism
R-HSA-209931,R-HSA-1430728,Serotonin and melatonin biosynthesis,Metabolism
R-HSA-209952,R-HSA-392499,Peptide hormone biosynthesis,Metabolism of proteins
R-HSA-209968,R-HSA-1430728,Thyroxine biosynthesis,Metabolism
R-HSA-210455,R-HSA-112316,Astrocytic Glutamate-Glutamine Uptake And Metabolism,Neuronal System
R-HSA-210500,R-HSA-112316,Glutamate Neurotransmitter Release Cycle,Neuronal System
R-HSA-210744,R-HSA-1266738,Regulation of gene expression in late stage (branching morphogenesis) pancreatic bud precursor cells,Developmental Biology
R-HSA-210745,R-HSA-1266738,Regulation of gene expression in beta cells,Developmental Biology
R-HSA-210746,R-HSA-1266738,Regulation of gene expression in endocrine-committed (NEUROG3+) progenitor cells,Developmental Biology
R-HSA-210747,R-HSA-1266738,Regulation of gene expression in early pancreatic precursor cells,Developmental Biology
R-HSA-210990,R-HSA-109582,PECAM1 interactions,Hemostasis
R-HSA-210991,R-HSA-109582,Basigin interactions,Hemostasis
R-HSA-210993,R-HSA-109582,Tie2 Signaling,Hemostasis
R-HSA-211163,R-HSA-1266738,AKT-mediated inactivation of FOXO1A,Developmental Biology
R-HSA-211728,R-HSA-5357801,Regulation of PAK-2p34 activity by PS-GAP/RHG10,Programmed Cell Death
R-HSA-211733,R-HSA-5357801,Regulation of activated PAK-2p34 by proteasome mediated degradation,Programmed Cell Death
R-HSA-211736,R-HSA-5357801,Stimulation of the cell death response by PAK-2p34,Programmed Cell Death
R-HSA-211897,R-HSA-1430728,Cytochrome P450 - arranged by substrate type,Metabolism
R-HSA-211916,R-HSA-1430728,Vitamins,Metabolism
R-HSA-211935,R-HSA-1430728,Fatty acids,Metabolism
R-HSA-211945,R-HSA-1430728,Phase I - Functionalization of compounds,Metabolism
R-HSA-211957,R-HSA-1430728,Aromatic amines can be N-hydroxylated or N-dealkylated by CYP1A2,Metabolism
R-HSA-211958,R-HSA-1430728,Miscellaneous substrates,Metabolism
R-HSA-211976,R-HSA-1430728,Endogenous sterols,Metabolism
R-HSA-211979,R-HSA-1430728,Eicosanoids,Metabolism
R-HSA-211981,R-HSA-1430728,Xenobiotics,Metabolism
R-HSA-211994,R-HSA-1430728,Sterols are 12-hydroxylated by CYP8B1,Metabolism
R-HSA-211999,R-HSA-1430728,CYP2E1 reactions,Metabolism
R-HSA-2122947,R-HSA-162582,NOTCH1 Intracellular Domain Regulates Transcription,Signal Transduction
R-HSA-2122948,R-HSA-162582,Activated NOTCH1 Transmits Signal to the Nucleus,Signal Transduction
R-HSA-212300,R-HSA-74160,PRC2 methylates histones and DNA,Gene expression (Transcription)
R-HSA-212436,R-HSA-74160,Generic Transcription Pathway,Gene expression (Transcription)
R-HSA-212676,R-HSA-112316,Dopamine Neurotransmitter Release Cycle,Neuronal System
R-HSA-212718,R-HSA-162582,EGFR interacts with phospholipase C-gamma,Signal Transduction
R-HSA-2129379,R-HSA-1474244,Molecules associated with elastic fibres,Extracellular matrix organization
R-HSA-2132295,R-HSA-168256,MHC class II antigen presentation,Immune System
R-HSA-2142670,R-HSA-1430728,Synthesis of epoxy (EET) and dihydroxyeicosatrienoic acids (DHET),Metabolism
R-HSA-2142688,R-HSA-1430728,Synthesis of 5-eicosatetraenoic acids,Metabolism
R-HSA-2142691,R-HSA-1430728,Synthesis of Leukotrienes (LT) and Eoxins (EX),Metabolism
R-HSA-2142696,R-HSA-1430728,Synthesis of Hepoxilins (HX) and Trioxilins (TrX),Metabolism
R-HSA-2142700,R-HSA-1430728,Synthesis of Lipoxins (LX),Metabolism
R-HSA-2142712,R-HSA-1430728,Synthesis of 12-eicosatetraenoic acid derivatives,Metabolism
R-HSA-2142753,R-HSA-1430728,Arachidonic acid metabolism,Metabolism
R-HSA-2142770,R-HSA-1430728,Synthesis of 15-eicosatetraenoic acid derivatives,Metabolism
R-HSA-2142789,R-HSA-1430728,Ubiquinol biosynthesis,Metabolism
R-HSA-2142816,R-HSA-1430728,Synthesis of (16-20)-hydroxyeicosatetraenoic acids (HETE),Metabolism
R-HSA-2142850,R-HSA-1430728,Hyaluronan biosynthesis and export,Metabolism
R-HSA-2151201,R-HSA-1852241,Transcriptional activation of mitochondrial biogenesis,Organelle biogenesis and maintenance
R-HSA-2151209,R-HSA-1852241,Activation of PPARGC1A (PGC-1alpha) by phosphorylation,Organelle biogenesis and maintenance
R-HSA-2160456,R-HSA-1643685,Phenylketonuria,Disease
R-HSA-216083,R-HSA-1474244,Integrin cell surface interactions,Extracellular matrix organization
R-HSA-2160916,R-HSA-1430728,Hyaluronan uptake and degradation,Metabolism
R-HSA-2161517,R-HSA-1430728,Abacavir transmembrane transport,Metabolism
R-HSA-2161541,R-HSA-1430728,Abacavir metabolism,Metabolism
R-HSA-2162123,R-HSA-1430728,Synthesis of Prostaglandins (PG) and Thromboxanes (TX),Metabolism
R-HSA-2168880,R-HSA-5653656,Scavenging of heme from plasma,Vesicle-mediated transport
R-HSA-2172127,R-HSA-168256,DAP12 interactions,Immune System
R-HSA-217271,R-HSA-1430728,FMO oxidises nucleophiles,Metabolism
R-HSA-2173788,R-HSA-162582,Downregulation of TGF-beta receptor signaling,Signal Transduction
R-HSA-2173789,R-HSA-162582,TGF-beta receptor signaling activates SMADs,Signal Transduction
R-HSA-2173791,R-HSA-162582,TGF-beta receptor signaling in EMT (epithelial to mesenchymal transition),Signal Transduction
R-HSA-2173795,R-HSA-74160,Downregulation of SMAD2/3:SMAD4 transcriptional activity,Gene expression (Transcription)
R-HSA-2173795,R-HSA-162582,Downregulation of SMAD2/3:SMAD4 transcriptional activity,Signal Transduction
R-HSA-2173796,R-HSA-74160,SMAD2/SMAD3:SMAD4 heterotrimer regulates transcription,Gene expression (Transcription)
R-HSA-2173796,R-HSA-162582,SMAD2/SMAD3:SMAD4 heterotrimer regulates transcription,Signal Transduction
R-HSA-2179392,R-HSA-162582,EGFR Transactivation by Gastrin,Signal Transduction
R-HSA-2187335,R-HSA-162582,The retinoid cycle in cones (daylight vision),Signal Transduction
R-HSA-2197563,R-HSA-162582,NOTCH2 intracellular domain regulates transcription,Signal Transduction
R-HSA-2206280,R-HSA-1643685,MPS IX - Natowicz syndrome,Disease
R-HSA-2206282,R-HSA-1643685,MPS IIIB - Sanfilippo syndrome B,Disease
R-HSA-2206285,R-HSA-1643685,MPS VI - Maroteaux-Lamy syndrome,Disease
R-HSA-2206290,R-HSA-1643685,MPS IV - Morquio syndrome A,Disease
R-HSA-2206291,R-HSA-1643685,MPS IIIC - Sanfilippo syndrome C,Disease
R-HSA-2206292,R-HSA-1643685,MPS VII - Sly syndrome,Disease
R-HSA-2206296,R-HSA-1643685,MPS II - Hunter syndrome,Disease
R-HSA-2206302,R-HSA-1643685,MPS I - Hurler syndrome,Disease
R-HSA-2206305,R-HSA-1643685,MPS IIID - Sanfilippo syndrome D,Disease
R-HSA-2206307,R-HSA-1643685,MPS IIIA - Sanfilippo syndrome A,Disease
R-HSA-2206308,R-HSA-1643685,MPS IV - Morquio syndrome B,Disease
R-HSA-2214320,R-HSA-1474244,Anchoring fibril formation,Extracellular matrix organization
R-HSA-2219530,R-HSA-1643685,Constitutive Signaling by Aberrant PI3K in Cancer,Disease
R-HSA-2243919,R-HSA-1474244,Crosslinking of collagen fibrils,Extracellular matrix organization
R-HSA-2299718,R-HSA-1640170,Condensation of Prophase Chromosomes,Cell Cycle
R-HSA-2393930,R-HSA-1430728,Phosphate bond hydrolysis by NUDT proteins,Metabolism
R-HSA-2395516,R-HSA-1430728,Electron transport from NADPH to Ferredoxin,Metabolism
R-HSA-2404192,R-HSA-162582,Signaling by Type 1 Insulin-like Growth Factor 1 Receptor (IGF1R),Signal Transduction
R-HSA-2408508,R-HSA-1430728,"Metabolism of ingested SeMet, Sec, MeSec into H2Se",Metabolism
R-HSA-2408522,R-HSA-1430728,Selenoamino acid metabolism,Metabolism
R-HSA-2408550,R-HSA-1430728,Metabolism of ingested H2SeO4 and H2SeO3 into H2Se,Metabolism
R-HSA-2408552,R-HSA-1430728,Methylation of MeSeH for excretion,Metabolism
R-HSA-2408557,R-HSA-1430728,Selenocysteine synthesis,Metabolism
R-HSA-2424491,R-HSA-168256,DAP12 signaling,Immune System
R-HSA-2426168,R-HSA-1430728,Activation of gene expression by SREBF (SREBP),Metabolism
R-HSA-2428928,R-HSA-162582,IRS-related events triggered by IGF1R,Signal Transduction
R-HSA-2428933,R-HSA-162582,SHC-related events triggered by IGF1R,Signal Transduction
R-HSA-2453864,R-HSA-1643685,Retinoid cycle disease events,Disease
R-HSA-2453902,R-HSA-162582,The canonical retinoid cycle in rods (twilight vision),Signal Transduction
R-HSA-2454202,R-HSA-168256,Fc epsilon receptor (FCERI) signaling,Immune System
R-HSA-2465910,R-HSA-1640170,MASTL Facilitates Mitotic Progression,Cell Cycle
R-HSA-2466712,R-HSA-162582,"Biosynthesis of A2E, implicated in retinal degradation",Signal Transduction
R-HSA-2466712,R-HSA-1643685,"Biosynthesis of A2E, implicated in retinal degradation",Disease
R-HSA-2467813,R-HSA-1640170,Separation of Sister Chromatids,Cell Cycle
R-HSA-2468052,R-HSA-1640170,Establishment of Sister Chromatid Cohesion,Cell Cycle
R-HSA-2470946,R-HSA-1640170,Cohesin Loading onto Chromatin,Cell Cycle
R-HSA-2473224,R-HSA-162582,Antagonism of Activin by Follistatin,Signal Transduction
R-HSA-2485179,R-HSA-162582,Activation of the phototransduction cascade,Signal Transduction
R-HSA-2500257,R-HSA-1640170,Resolution of Sister Chromatid Cohesion,Cell Cycle
R-HSA-2514853,R-HSA-1640170,Condensation of Prometaphase Chromosomes,Cell Cycle
R-HSA-2514859,R-HSA-162582,"Inactivation, recovery and regulation of the phototransduction cascade",Signal Transduction
R-HSA-2534343,R-HSA-1474165,Interaction With Cumulus Cells And The Zona Pellucida,Reproduction
R-HSA-2559580,R-HSA-8953897,Oxidative Stress Induced Senescence,Cellular responses to external stimuli
R-HSA-2559582,R-HSA-8953897,Senescence-Associated Secretory Phenotype (SASP),Cellular responses to external stimuli
R-HSA-2559584,R-HSA-8953897,Formation of Senescence-Associated Heterochromatin Foci (SAHF),Cellular responses to external stimuli
R-HSA-2559585,R-HSA-8953897,Oncogene Induced Senescence,Cellular responses to external stimuli
R-HSA-2559586,R-HSA-8953897,DNA Damage/Telomere Stress Induced Senescence,Cellular responses to external stimuli
R-HSA-2562578,R-HSA-168256,TRIF-mediated programmed cell death,Immune System
R-HSA-2564830,R-HSA-1430728,Cytosolic iron-sulfur cluster assembly,Metabolism
R-HSA-2565942,R-HSA-1640170,Regulation of PLK1 Activity at G2/M Transition,Cell Cycle
R-HSA-2586552,R-HSA-162582,Signaling by Leptin,Signal Transduction
R-HSA-2644606,R-HSA-1643685,Constitutive Signaling by NOTCH1 PEST Domain Mutants,Disease
R-HSA-2644607,R-HSA-1643685,Loss of Function of FBXW7 in Cancer and NOTCH1 Signaling,Disease
R-HSA-264642,R-HSA-112316,Acetylcholine Neurotransmitter Release Cycle,Neuronal System
R-HSA-264870,R-HSA-5357801,Caspase-mediated cleavage of cytoskeletal proteins,Programmed Cell Death
R-HSA-264876,R-HSA-392499,Insulin processing,Metabolism of proteins
R-HSA-2660826,R-HSA-1643685,Constitutive Signaling by NOTCH1 t(7;9)(NOTCH1:M1580_K2555) Translocation Mutant,Disease
R-HSA-2672351,R-HSA-382551,Stimuli-sensing channels,Transport of small molecules
R-HSA-2682334,R-HSA-1266738,EPH-Ephrin signaling,Developmental Biology
R-HSA-2691232,R-HSA-1643685,Constitutive Signaling by NOTCH1 HD Domain Mutants,Disease
R-HSA-2730905,R-HSA-168256,Role of LAT2/NTAL/LAB on calcium mobilization,Immune System
R-HSA-2855086,R-HSA-168256,Ficolins bind to repetitive carbohydrate structures on the target cell surface,Immune System
R-HSA-2871796,R-HSA-168256,FCERI mediated MAPK activation,Immune System
R-HSA-2871809,R-HSA-168256,FCERI mediated Ca+2 mobilization,Immune System
R-HSA-2871837,R-HSA-168256,FCERI mediated NF-kB activation,Immune System
R-HSA-2892245,R-HSA-1266738,"POU5F1 (OCT4), SOX2, NANOG repress genes related to differentiation",Developmental Biology
R-HSA-2892247,R-HSA-1266738,"POU5F1 (OCT4), SOX2, NANOG activate genes related to proliferation",Developmental Biology
R-HSA-2894862,R-HSA-1643685,Constitutive Signaling by NOTCH1 HD+PEST Domain Mutants,Disease
R-HSA-2978092,R-HSA-1643685,Abnormal conversion of 2-oxoglutarate to 2-hydroxyglutarate,Disease
R-HSA-2979096,R-HSA-162582,NOTCH2 Activation and Transmission of Signal to the Nucleus,Signal Transduction
R-HSA-2980766,R-HSA-1640170,Nuclear Envelope Breakdown,Cell Cycle
R-HSA-2980767,R-HSA-1640170,"Activation of NIMA Kinases NEK9, NEK6, NEK7",Cell Cycle
R-HSA-2995383,R-HSA-1640170,Initiation of Nuclear Envelope (NE) Reformation,Cell Cycle
R-HSA-3000157,R-HSA-1474244,Laminin interactions,Extracellular matrix organization
R-HSA-3000170,R-HSA-1474244,Syndecan interactions,Extracellular matrix organization
R-HSA-3000171,R-HSA-1474244,Non-integrin membrane-ECM interactions,Extracellular matrix organization
R-HSA-3000178,R-HSA-1474244,ECM proteoglycans,Extracellular matrix organization
R-HSA-3000471,R-HSA-5653656,Scavenging by Class B Receptors,Vesicle-mediated transport
R-HSA-3000480,R-HSA-5653656,Scavenging by Class A Receptors,Vesicle-mediated transport
R-HSA-3000484,R-HSA-5653656,Scavenging by Class F Receptors,Vesicle-mediated transport
R-HSA-3000497,R-HSA-5653656,Scavenging by Class H Receptors,Vesicle-mediated transport
R-HSA-3065676,R-HSA-392499,SUMO is conjugated to E1 (UBA2:SAE1),Metabolism of proteins
R-HSA-3065678,R-HSA-392499,"SUMO is transferred from E1 to E2 (UBE2I, UBC9)",Metabolism of proteins
R-HSA-3065679,R-HSA-392499,SUMO is proteolytically processed,Metabolism of proteins
R-HSA-3108214,R-HSA-392499,SUMOylation of DNA damage response and repair proteins,Metabolism of proteins
R-HSA-3108232,R-HSA-392499,SUMO E3 ligases SUMOylate target proteins,Metabolism of proteins
R-HSA-3134963,R-HSA-168256,DEx/H-box helicases activate type I IFN and inflammatory cytokines production ,Immune System
R-HSA-3134973,R-HSA-168256,LRR FLII-interacting protein 1 (LRRFIP1) activates type I IFN production,Immune System
R-HSA-3134975,R-HSA-168256,Regulation of innate immune responses to cytosolic DNA,Immune System
R-HSA-3214815,R-HSA-4839726,HDACs deacetylate histones,Chromatin organization
R-HSA-3214841,R-HSA-4839726,PKMTs methylate histone lysines,Chromatin organization
R-HSA-3214842,R-HSA-4839726,HDMs demethylate histones,Chromatin organization
R-HSA-3214847,R-HSA-4839726,HATs acetylate histones,Chromatin organization
R-HSA-3214858,R-HSA-4839726,RMTs methylate histone arginines,Chromatin organization
R-HSA-3229133,R-HSA-1643685,Glycogen storage disease type Ib (SLC37A4),Disease
R-HSA-3232118,R-HSA-392499,SUMOylation of transcription factors,Metabolism of proteins
R-HSA-3232142,R-HSA-392499,SUMOylation of ubiquitinylation proteins,Metabolism of proteins
R-HSA-3238698,R-HSA-162582,WNT ligand biogenesis and trafficking,Signal Transduction
R-HSA-3247509,R-HSA-4839726,Chromatin modifying enzymes,Chromatin organization
R-HSA-3248023,R-HSA-168256,Regulation by TREX1,Immune System
R-HSA-3249367,R-HSA-168256,STAT6-mediated induction of chemokines,Immune System
R-HSA-3270619,R-HSA-168256,IRF3-mediated induction of type I IFN,Immune System
R-HSA-3274531,R-HSA-1643685,Glycogen storage disease type Ia (G6PC),Disease
R-HSA-3282872,R-HSA-1643685,Severe congenital neutropenia type 4 (G6PC3),Disease
R-HSA-3295583,R-HSA-382551,TRP channels,Transport of small molecules
R-HSA-3296197,R-HSA-162582,Hydroxycarboxylic acid-binding receptors,Signal Transduction
R-HSA-3299685,R-HSA-8953897,Detoxification of Reactive Oxygen Species,Cellular responses to external stimuli
R-HSA-3301854,R-HSA-1640170,Nuclear Pore Complex (NPC) Disassembly,Cell Cycle
R-HSA-3304356,R-HSA-1643685,SMAD2/3 Phosphorylation Motif Mutants in Cancer,Disease
R-HSA-3311021,R-HSA-1643685,SMAD4 MH2 Domain Mutants in Cancer,Disease
R-HSA-3315487,R-HSA-1643685,SMAD2/3 MH2 Domain Mutants in Cancer,Disease
R-HSA-3322077,R-HSA-1430728,Glycogen synthesis,Metabolism
R-HSA-3359454,R-HSA-1643685,Defective TCN2 causes hereditary megaloblastic anemia,Disease
R-HSA-3359457,R-HSA-1643685,Defective GIF causes intrinsic factor deficiency,Disease
R-HSA-3359458,R-HSA-1643685,Defective LMBRD1 causes methylmalonic aciduria and homocystinuria type cblF,Disease
R-HSA-3359462,R-HSA-1643685,Defective AMN causes hereditary megaloblastic anemia 1,Disease
R-HSA-3359463,R-HSA-1643685,Defective CUBN causes hereditary megaloblastic anemia 1,Disease
R-HSA-3359467,R-HSA-1643685,Defective MTRR causes methylmalonic aciduria and homocystinuria type cblE,Disease
R-HSA-3359469,R-HSA-1643685,Defective MTR causes methylmalonic aciduria and homocystinuria type cblG,Disease
R-HSA-3359471,R-HSA-1643685,Defective MMAB causes methylmalonic aciduria type cblB,Disease
R-HSA-3359473,R-HSA-1643685,Defective MMADHC causes methylmalonic aciduria and homocystinuria type cblD,Disease
R-HSA-3359474,R-HSA-1643685,Defective MMACHC causes methylmalonic aciduria and homocystinuria type cblC,Disease
R-HSA-3359475,R-HSA-1643685,Defective MMAA causes methylmalonic aciduria type cblA,Disease
R-HSA-3359478,R-HSA-1643685,Defective MUT causes methylmalonic aciduria mut type,Disease
R-HSA-3359485,R-HSA-1643685,Defective CD320 causes methylmalonic aciduria,Disease
R-HSA-3371378,R-HSA-5357801,Regulation by c-FLIP,Programmed Cell Death
R-HSA-3371453,R-HSA-8953897,Regulation of HSF1-mediated heat shock response,Cellular responses to external stimuli
R-HSA-3371497,R-HSA-8953897,HSP90 chaperone cycle for steroid hormone receptors (SHR),Cellular responses to external stimuli
R-HSA-3371511,R-HSA-8953897,HSF1 activation,Cellular responses to external stimuli
R-HSA-3371568,R-HSA-8953897,Attenuation phase,Cellular responses to external stimuli
R-HSA-3371571,R-HSA-8953897,HSF1-dependent transactivation,Cellular responses to external stimuli
R-HSA-3371598,R-HSA-1643685,Defective BTD causes biotidinase deficiency,Disease
R-HSA-3371599,R-HSA-1643685,Defective HLCS causes multiple carboxylase deficiency,Disease
R-HSA-349425,R-HSA-1640170,Autodegradation of the E3 ubiquitin ligase COP1,Cell Cycle
R-HSA-350054,R-HSA-74160,Notch-HLH transcription pathway,Gene expression (Transcription)
R-HSA-350562,R-HSA-1430728,Regulation of ornithine decarboxylase (ODC),Metabolism
R-HSA-350864,R-HSA-1430728,Regulation of thyroid hormone activity,Metabolism
R-HSA-351143,R-HSA-1430728,Agmatine biosynthesis,Metabolism
R-HSA-351200,R-HSA-1430728,Interconversion of polyamines,Metabolism
R-HSA-351202,R-HSA-1430728,Metabolism of polyamines,Metabolism
R-HSA-351906,R-HSA-5357801,Apoptotic cleavage of cell adhesion  proteins,Programmed Cell Death
R-HSA-352230,R-HSA-382551,Amino acid transport across the plasma membrane,Transport of small molecules
R-HSA-352238,R-HSA-5357801,Breakdown of the nuclear lamina,Programmed Cell Death
R-HSA-354192,R-HSA-109582,Integrin signaling,Hemostasis
R-HSA-354192,R-HSA-162582,Integrin signaling,Signal Transduction
R-HSA-354194,R-HSA-109582,GRB2:SOS provides linkage to MAPK signaling for Integrins ,Hemostasis
R-HSA-354194,R-HSA-162582,GRB2:SOS provides linkage to MAPK signaling for Integrins ,Signal Transduction
R-HSA-3560783,R-HSA-1643685,"Defective B4GALT7 causes EDS, progeroid type",Disease
R-HSA-3560792,R-HSA-1643685,Defective SLC26A2 causes chondrodysplasias,Disease
R-HSA-3560796,R-HSA-1643685,Defective PAPSS2 causes SEMD-PA,Disease
R-HSA-3560801,R-HSA-1643685,Defective B3GAT3 causes JDSSDHD,Disease
R-HSA-3595172,R-HSA-1643685,Defective CHST3 causes SEDCJD,Disease
R-HSA-3595174,R-HSA-1643685,"Defective CHST14 causes EDS, musculocontractural type",Disease
R-HSA-3595177,R-HSA-1643685,Defective CHSY1 causes TPBS,Disease
R-HSA-3642279,R-HSA-1643685,TGFBR2 MSI Frameshift Mutants in Cancer,Disease
R-HSA-3645790,R-HSA-1643685,TGFBR2 Kinase Domain Mutants in Cancer,Disease
R-HSA-3656225,R-HSA-1643685,Defective CHST6 causes MCDC1,Disease
R-HSA-3656234,R-HSA-1643685,Defective HEXA causes GM2G1,Disease
R-HSA-3656237,R-HSA-1643685,Defective EXT2 causes exostoses 2,Disease
R-HSA-3656243,R-HSA-1643685,Defective ST3GAL3 causes MCT12 and EIEE15,Disease
R-HSA-3656244,R-HSA-1643685,Defective B4GALT1 causes B4GALT1-CDG (CDG-2d),Disease
R-HSA-3656248,R-HSA-1643685,Defective HEXB causes GM2G2,Disease
R-HSA-3656253,R-HSA-1643685,"Defective EXT1 causes exostoses 1, TRPS2 and CHDS",Disease
R-HSA-3656532,R-HSA-1643685,TGFBR1 KD Mutants in Cancer,Disease
R-HSA-3656535,R-HSA-1643685,TGFBR1 LBD Mutants in Cancer,Disease
R-HSA-372708,R-HSA-109582,p130Cas linkage to MAPK signaling for integrins,Hemostasis
R-HSA-372708,R-HSA-162582,p130Cas linkage to MAPK signaling for integrins,Signal Transduction
R-HSA-373076,R-HSA-162582,Class A/1 (Rhodopsin-like receptors),Signal Transduction
R-HSA-373080,R-HSA-162582,Class B/2 (Secretin family receptors),Signal Transduction
R-HSA-373752,R-HSA-1266738,Netrin-1 signaling,Developmental Biology
R-HSA-373753,R-HSA-1500931,Nephrin family interactions,Cell-Cell communication
R-HSA-373756,R-HSA-1500931,SDK interactions,Cell-Cell communication
R-HSA-373760,R-HSA-1266738,L1CAM interactions,Developmental Biology
R-HSA-375165,R-HSA-1266738,NCAM signaling for neurite out-growth,Developmental Biology
R-HSA-375276,R-HSA-162582,Peptide ligand-binding receptors,Signal Transduction
R-HSA-375280,R-HSA-162582,Amine ligand-binding receptors,Signal Transduction
R-HSA-375281,R-HSA-162582,Hormone ligand-binding receptors,Signal Transduction
R-HSA-376172,R-HSA-1266738,DSCAM interactions,Developmental Biology
R-HSA-376176,R-HSA-1266738,Signaling by ROBO receptors,Developmental Biology
R-HSA-3769402,R-HSA-162582,Deactivation of the beta-catenin transactivating complex,Signal Transduction
R-HSA-3772470,R-HSA-162582,Negative regulation of TCF-dependent signaling by WNT ligand antagonists,Signal Transduction
R-HSA-3785653,R-HSA-1643685,Myoclonic epilepsy of Lafora,Disease
R-HSA-379397,R-HSA-112316,Enzymatic degradation of dopamine by COMT,Neuronal System
R-HSA-379398,R-HSA-112316,Enzymatic degradation of Dopamine by monoamine oxidase,Neuronal System
R-HSA-379401,R-HSA-112316,Dopamine clearance from the synaptic cleft,Neuronal System
R-HSA-379716,R-HSA-392499,Cytosolic tRNA aminoacylation,Metabolism of proteins
R-HSA-379726,R-HSA-392499,Mitochondrial tRNA aminoacylation,Metabolism of proteins
R-HSA-380095,R-HSA-162582,Tachykinin receptors bind tachykinins,Signal Transduction
R-HSA-380108,R-HSA-162582,Chemokine receptors bind chemokines,Signal Transduction
R-HSA-380259,R-HSA-1640170,Loss of Nlp from mitotic centrosomes,Cell Cycle
R-HSA-380270,R-HSA-1640170,Recruitment of mitotic centrosome proteins and complexes,Cell Cycle
R-HSA-380284,R-HSA-1640170,Loss of proteins required for interphase microtubule organization from the centrosome,Cell Cycle
R-HSA-380320,R-HSA-1640170,Recruitment of NuMA to mitotic centrosomes,Cell Cycle
R-HSA-380612,R-HSA-112316,Metabolism of serotonin,Neuronal System
R-HSA-380615,R-HSA-112316,Serotonin clearance from the synaptic cleft,Neuronal System
R-HSA-380972,R-HSA-162582,Energy dependent regulation of mTOR by LKB1-AMPK,Signal Transduction
R-HSA-380994,R-HSA-392499,ATF4 activates genes in response to endoplasmic reticulum  stress,Metabolism of proteins
R-HSA-381033,R-HSA-392499,ATF6 (ATF6-alpha) activates chaperones,Metabolism of proteins
R-HSA-381038,R-HSA-392499,XBP1(S) activates chaperone genes,Metabolism of proteins
R-HSA-381042,R-HSA-392499,PERK regulates gene expression,Metabolism of proteins
R-HSA-381070,R-HSA-392499,IRE1alpha activates chaperones,Metabolism of proteins
R-HSA-381183,R-HSA-392499,ATF6 (ATF6-alpha) activates chaperone genes,Metabolism of proteins
R-HSA-381340,R-HSA-1266738,Transcriptional regulation of white adipocyte differentiation,Developmental Biology
R-HSA-381426,R-HSA-392499,Regulation of Insulin-like Growth Factor (IGF) transport and uptake by Insulin-like Growth Factor Binding Proteins (IGFBPs),Metabolism of proteins
R-HSA-3814836,R-HSA-1643685,Glycogen storage disease type XV (GYG1),Disease
R-HSA-381676,R-HSA-1430728,Glucagon-like Peptide-1 (GLP1) regulates insulin secretion,Metabolism
R-HSA-381753,R-HSA-162582,Olfactory Signaling Pathway,Signal Transduction
R-HSA-381771,R-HSA-392499,"Synthesis, secretion, and inactivation of Glucagon-like Peptide-1 (GLP-1)",Metabolism of proteins
R-HSA-382556,R-HSA-382551,ABC-family proteins mediated transport,Transport of small molecules
R-HSA-3828062,R-HSA-1643685,Glycogen storage disease type 0 (muscle GYS1),Disease
R-HSA-383280,R-HSA-74160,Nuclear Receptor transcription pathway,Gene expression (Transcription)
R-HSA-3858516,R-HSA-1643685,Glycogen storage disease type 0 (liver GYS2),Disease
R-HSA-3878781,R-HSA-1643685,Glycogen storage disease type IV (GBE1),Disease
R-HSA-388479,R-HSA-162582,Vasopressin-like receptors,Signal Transduction
R-HSA-388841,R-HSA-168256,Costimulation by the CD28 family,Immune System
R-HSA-388844,R-HSA-112316,Receptor-type tyrosine-protein phosphatases,Neuronal System
R-HSA-389356,R-HSA-168256,CD28 co-stimulation,Immune System
R-HSA-389357,R-HSA-168256,CD28 dependent PI3K/Akt signaling,Immune System
R-HSA-389359,R-HSA-168256,CD28 dependent Vav1 pathway,Immune System
R-HSA-389397,R-HSA-162582,Orexin and neuropeptides FF and QRFP bind to their respective receptors,Signal Transduction
R-HSA-389513,R-HSA-168256,CTLA4 inhibitory signaling,Immune System
R-HSA-389542,R-HSA-1430728,NADPH regeneration,Metabolism
R-HSA-389599,R-HSA-1430728,Alpha-oxidation of phytanate,Metabolism
R-HSA-389661,R-HSA-1430728,Glyoxylate metabolism and glycine degradation,Metabolism
R-HSA-389887,R-HSA-1430728,Beta-oxidation of pristanoyl-CoA,Metabolism
R-HSA-3899300,R-HSA-392499,SUMOylation of transcription cofactors,Metabolism of proteins
R-HSA-389948,R-HSA-168256,PD-1 signaling,Immune System
R-HSA-389957,R-HSA-392499,Prefoldin mediated transfer of substrate  to CCT/TriC,Metabolism of proteins
R-HSA-389960,R-HSA-392499,Formation of tubulin folding intermediates by CCT/TriC,Metabolism of proteins
R-HSA-389977,R-HSA-392499,Post-chaperonin tubulin folding pathway,Metabolism of proteins
R-HSA-390247,R-HSA-1430728,Beta-oxidation of very long chain fatty acids,Metabolism
R-HSA-390450,R-HSA-392499,Folding of actin by CCT/TriC,Metabolism of proteins
R-HSA-390471,R-HSA-392499,Association of TriC/CCT with target proteins during biosynthesis,Metabolism of proteins
R-HSA-390522,R-HSA-397014,Striated Muscle Contraction,Muscle contraction
R-HSA-390648,R-HSA-162582,Muscarinic acetylcholine receptors,Signal Transduction
R-HSA-390650,R-HSA-162582,Histamine receptors,Signal Transduction
R-HSA-390651,R-HSA-162582,Dopamine receptors,Signal Transduction
R-HSA-390666,R-HSA-162582,Serotonin receptors,Signal Transduction
R-HSA-390696,R-HSA-162582,Adrenoceptors,Signal Transduction
R-HSA-390918,R-HSA-1430728,Peroxisomal lipid metabolism,Metabolism
R-HSA-391160,R-HSA-1500931,Signal regulatory protein family interactions,Cell-Cell communication
R-HSA-391903,R-HSA-162582,Eicosanoid ligand-binding receptors,Signal Transduction
R-HSA-391906,R-HSA-162582,Leukotriene receptors,Signal Transduction
R-HSA-391908,R-HSA-162582,Prostanoid ligand receptors,Signal Transduction
R-HSA-392023,R-HSA-109582,Adrenaline signalling through Alpha-2 adrenergic receptor,Hemostasis
R-HSA-392154,R-HSA-109582,Nitric oxide stimulates guanylate cyclase,Hemostasis
R-HSA-392170,R-HSA-109582,ADP signalling through P2Y purinoceptor 12,Hemostasis
R-HSA-392451,R-HSA-162582,G beta:gamma signalling through PI3Kgamma,Signal Transduction
R-HSA-392517,R-HSA-168256,Rap1 signalling,Immune System
R-HSA-392851,R-HSA-109582,Prostacyclin signalling through prostacyclin receptor,Hemostasis
R-HSA-3928662,R-HSA-1266738,EPHB-mediated forward signaling,Developmental Biology
R-HSA-3928663,R-HSA-1266738,EPHA-mediated growth cone collapse,Developmental Biology
R-HSA-3928664,R-HSA-1266738,Ephrin signaling,Developmental Biology
R-HSA-3928665,R-HSA-1266738,EPH-ephrin mediated repulsion of cells,Developmental Biology
R-HSA-399710,R-HSA-112316,Activation of AMPA receptors,Neuronal System
R-HSA-399719,R-HSA-112316,Trafficking of AMPA receptors,Neuronal System
R-HSA-399954,R-HSA-1266738,Sema3A PAK dependent Axon repulsion,Developmental Biology
R-HSA-399955,R-HSA-1266738,SEMA3A-Plexin repulsion signaling by inhibiting Integrin adhesion,Developmental Biology
R-HSA-399956,R-HSA-1266738,CRMPs in Sema3A signaling,Developmental Biology
R-HSA-399997,R-HSA-1430728,Acetylcholine regulates insulin secretion,Metabolism
R-HSA-400042,R-HSA-1430728,"Adrenaline,noradrenaline inhibits insulin secretion",Metabolism
R-HSA-400206,R-HSA-1430728,Regulation of lipid metabolism by PPARalpha,Metabolism
R-HSA-400253,R-HSA-400253,Circadian Clock,Circadian Clock
R-HSA-400511,R-HSA-392499,"Synthesis, secretion, and inactivation of Glucose-dependent Insulinotropic Polypeptide (GIP)",Metabolism of proteins
R-HSA-4043911,R-HSA-1643685,Defective PMM2 causes PMM2-CDG (CDG-1a),Disease
R-HSA-4043916,R-HSA-1643685,Defective MPI causes MPI-CDG (CDG-1b),Disease
R-HSA-4085001,R-HSA-392499,Sialic acid metabolism,Metabolism of proteins
R-HSA-4085011,R-HSA-1643685,"Defective GNE causes sialuria, Nonaka myopathy and inclusion body myopathy 2",Disease
R-HSA-4085023,R-HSA-1643685,Defective GFPT1 causes CMSTA1,Disease
R-HSA-4085377,R-HSA-392499,SUMOylation of SUMOylation proteins,Metabolism of proteins
R-HSA-4086398,R-HSA-162582,Ca2+ pathway,Signal Transduction
R-HSA-4086400,R-HSA-162582,PCP/CE pathway,Signal Transduction
R-HSA-4090294,R-HSA-392499,SUMOylation of intracellular receptors,Metabolism of proteins
R-HSA-416476,R-HSA-162582,G alpha (q) signalling events,Signal Transduction
R-HSA-416482,R-HSA-162582,G alpha (12/13) signalling events,Signal Transduction
R-HSA-416550,R-HSA-1266738,Sema4D mediated inhibition of cell attachment and migration,Developmental Biology
R-HSA-416572,R-HSA-1266738,Sema4D induced cell migration and growth-cone collapse,Developmental Biology
R-HSA-416700,R-HSA-1266738,Other semaphorin interactions,Developmental Biology
R-HSA-416993,R-HSA-112316,Trafficking of GluR2-containing AMPA receptors,Neuronal System
R-HSA-417957,R-HSA-162582,P2Y receptors,Signal Transduction
R-HSA-417973,R-HSA-162582,Adenosine P1 receptors,Signal Transduction
R-HSA-418217,R-HSA-162582,G beta:gamma signalling through PLC beta,Signal Transduction
R-HSA-418346,R-HSA-109582,Platelet homeostasis,Hemostasis
R-HSA-418359,R-HSA-109582,Reduction of cytosolic Ca++ levels,Hemostasis
R-HSA-418457,R-HSA-109582,cGMP effects,Hemostasis
R-HSA-418555,R-HSA-162582,G alpha (s) signalling events,Signal Transduction
R-HSA-418592,R-HSA-109582,ADP signalling through P2Y purinoceptor 1,Hemostasis
R-HSA-418594,R-HSA-162582,G alpha (i) signalling events,Signal Transduction
R-HSA-418597,R-HSA-162582,G alpha (z) signalling events,Signal Transduction
R-HSA-418885,R-HSA-1266738,DCC mediated attractive signaling,Developmental Biology
R-HSA-418886,R-HSA-1266738,Netrin mediated repulsion signals,Developmental Biology
R-HSA-418889,R-HSA-5357801,Caspase activation via Dependence Receptors in the absence of ligand,Programmed Cell Death
R-HSA-418890,R-HSA-1266738,Role of second messengers in netrin-1 signaling,Developmental Biology
R-HSA-418990,R-HSA-1500931,Adherens junctions interactions,Cell-Cell communication
R-HSA-419037,R-HSA-1266738,NCAM1 interactions,Developmental Biology
R-HSA-419408,R-HSA-162582,Lysosphingolipid and LPA receptors,Signal Transduction
R-HSA-419771,R-HSA-162582,Opsins,Signal Transduction
R-HSA-419812,R-HSA-162582,Calcitonin-like ligand receptors,Signal Transduction
R-HSA-420029,R-HSA-1500931,Tight junction interactions,Cell-Cell communication
R-HSA-420092,R-HSA-162582,Glucagon-type ligand receptors,Signal Transduction
R-HSA-420499,R-HSA-162582,Class C/3 (Metabotropic glutamate/pheromone receptors),Signal Transduction
R-HSA-420597,R-HSA-1500931,Nectin/Necl  trans heterodimerization,Cell-Cell communication
R-HSA-422085,R-HSA-392499,"Synthesis, secretion, and deacylation of Ghrelin",Metabolism of proteins
R-HSA-422356,R-HSA-1430728,Regulation of insulin secretion,Metabolism
R-HSA-425366,R-HSA-382551,"Transport of bile salts and organic acids, metal ions and amine compounds",Transport of small molecules
R-HSA-425381,R-HSA-382551,Bicarbonate transporters,Transport of small molecules
R-HSA-425393,R-HSA-382551,Transport of inorganic cations/anions and amino acids/oligopeptides,Transport of small molecules
R-HSA-425397,R-HSA-382551,"Transport of vitamins, nucleosides, and related molecules",Transport of small molecules
R-HSA-425410,R-HSA-382551,Metal ion SLC transporters,Transport of small molecules
R-HSA-425561,R-HSA-382551,Sodium/Calcium exchangers,Transport of small molecules
R-HSA-425986,R-HSA-382551,Sodium/Proton exchangers,Transport of small molecules
R-HSA-426048,R-HSA-109582,Arachidonate production from DAG,Hemostasis
R-HSA-426048,R-HSA-162582,Arachidonate production from DAG,Signal Transduction
R-HSA-426117,R-HSA-382551,Cation-coupled Chloride cotransporters,Transport of small molecules
R-HSA-426486,R-HSA-74160,Small interfering RNA (siRNA) biogenesis,Gene expression (Transcription)
R-HSA-426496,R-HSA-74160,Post-transcriptional silencing by small RNAs,Gene expression (Transcription)
R-HSA-427359,R-HSA-74160,SIRT1 negatively regulates rRNA expression,Gene expression (Transcription)
R-HSA-427389,R-HSA-74160,ERCC6 (CSB) and EHMT2 (G9a) positively regulate rRNA expression,Gene expression (Transcription)
R-HSA-427413,R-HSA-74160,NoRC negatively regulates rRNA expression,Gene expression (Transcription)
R-HSA-427589,R-HSA-382551,Type II Na+/Pi cotransporters,Transport of small molecules
R-HSA-427601,R-HSA-382551,Multifunctional anion exchangers,Transport of small molecules
R-HSA-427652,R-HSA-382551,Sodium-coupled phosphate cotransporters,Transport of small molecules
R-HSA-427975,R-HSA-382551,Proton/oligopeptide cotransporters,Transport of small molecules
R-HSA-428359,R-HSA-8953854,Insulin-like Growth Factor-2 mRNA Binding Proteins (IGF2BPs/IMPs/VICKZs) bind RNA,Metabolism of RNA
R-HSA-428540,R-HSA-1266738,Activation of RAC1,Developmental Biology
R-HSA-428542,R-HSA-1266738,Regulation of commissural axon pathfinding by SLIT and ROBO,Developmental Biology
R-HSA-428543,R-HSA-1266738,Inactivation of CDC42 and RAC1,Developmental Biology
R-HSA-428559,R-HSA-382551,Proton-coupled neutral amino acid transporters,Transport of small molecules
R-HSA-428643,R-HSA-382551,Organic anion transporters,Transport of small molecules
R-HSA-428890,R-HSA-1266738,Role of ABL in ROBO-SLIT signaling,Developmental Biology
R-HSA-428930,R-HSA-109582,Thromboxane signalling through TP receptor,Hemostasis
R-HSA-429593,R-HSA-382551,Inositol transporters,Transport of small molecules
R-HSA-429947,R-HSA-8953854,Deadenylation of mRNA,Metabolism of RNA
R-HSA-429958,R-HSA-8953854,mRNA decay by 3' to 5' exoribonuclease,Metabolism of RNA
R-HSA-430039,R-HSA-8953854,mRNA decay by 5' to 3' exoribonuclease,Metabolism of RNA
R-HSA-430116,R-HSA-109582,GP1b-IX-V activation signalling,Hemostasis
R-HSA-432030,R-HSA-382551,Transport of glycerol from adipocytes to the liver by Aquaporins,Transport of small molecules
R-HSA-432040,R-HSA-382551,Vasopressin regulates renal water homeostasis via Aquaporins,Transport of small molecules
R-HSA-432047,R-HSA-382551,Passive transport by Aquaporins,Transport of small molecules
R-HSA-432142,R-HSA-109582,Platelet sensitization by LDL,Hemostasis
R-HSA-432720,R-HSA-5653656,Lysosome Vesicle Biogenesis,Vesicle-mediated transport
R-HSA-432722,R-HSA-5653656,Golgi Associated Vesicle Biogenesis,Vesicle-mediated transport
R-HSA-433137,R-HSA-382551,"Sodium-coupled sulphate, di- and tri-carboxylate transporters",Transport of small molecules
R-HSA-433692,R-HSA-382551,Proton-coupled monocarboxylate transport,Transport of small molecules
R-HSA-4341670,R-HSA-1643685,Defective NEU1 causes sialidosis,Disease
R-HSA-434313,R-HSA-1430728,Intracellular metabolism of fatty acids regulates insulin secretion,Metabolism
R-HSA-434316,R-HSA-1430728,Fatty Acids bound to GPR40 (FFAR1) regulate insulin secretion,Metabolism
R-HSA-435368,R-HSA-382551,Zinc efflux and compartmentalization by the SLC30 family,Transport of small molecules
R-HSA-437239,R-HSA-1266738,Recycling pathway of L1,Developmental Biology
R-HSA-438066,R-HSA-112316,"Unblocking of NMDA receptors, glutamate binding and activation",Neuronal System
R-HSA-4411364,R-HSA-162582,Binding of TCF/LEF:CTNNB1 to target gene promoters,Signal Transduction
R-HSA-4419969,R-HSA-1640170,Depolymerisation of the Nuclear Lamina,Cell Cycle
R-HSA-4420097,R-HSA-162582,VEGFA-VEGFR2 Pathway,Signal Transduction
R-HSA-4420332,R-HSA-1643685,Defective B3GALT6 causes EDSP2 and SEMDJL1,Disease
R-HSA-442380,R-HSA-382551,Zinc influx into cells by the SLC39 gene family,Transport of small molecules
R-HSA-442660,R-HSA-382551,Na+/Cl- dependent neurotransmitter transporters,Transport of small molecules
R-HSA-442720,R-HSA-112316,CREB1 phosphorylation through the activation of Adenylate Cyclase,Neuronal System
R-HSA-442729,R-HSA-112316,CREB1 phosphorylation through the activation of CaMKII/CaMKK/CaMKIV cascasde,Neuronal System
R-HSA-442742,R-HSA-112316,CREB1 phosphorylation through NMDA receptor-mediated activation of RAS signaling,Neuronal System
R-HSA-442982,R-HSA-112316,Ras activation upon Ca2+ influx through NMDA receptor,Neuronal System
R-HSA-444209,R-HSA-162582,Free fatty acid receptors,Signal Transduction
R-HSA-444257,R-HSA-112316,RSK activation,Neuronal System
R-HSA-444411,R-HSA-382551,Rhesus glycoproteins mediate ammonium transport.,Transport of small molecules
R-HSA-444473,R-HSA-162582,Formyl peptide receptors bind formyl peptides and many other ligands,Signal Transduction
R-HSA-444821,R-HSA-162582,Relaxin receptors,Signal Transduction
R-HSA-445095,R-HSA-1266738,Interaction between L1 and Ankyrins,Developmental Biology
R-HSA-445144,R-HSA-1266738,Signal transduction by L1,Developmental Biology
R-HSA-445355,R-HSA-397014,Smooth Muscle Contraction,Muscle contraction
R-HSA-445989,R-HSA-168256,TAK1 activates NFkB by phosphorylation and activation of IKKs complex,Immune System
R-HSA-446107,R-HSA-1500931,Type I hemidesmosome assembly,Cell-Cell communication
R-HSA-446193,R-HSA-392499,"Biosynthesis of the N-glycan precursor (dolichol lipid-linked oligosaccharide, LLO) and transfer to a nascent protein",Metabolism of proteins
R-HSA-446199,R-HSA-392499,Synthesis of Dolichyl-phosphate,Metabolism of proteins
R-HSA-446203,R-HSA-392499,Asparagine N-linked glycosylation,Metabolism of proteins
R-HSA-446205,R-HSA-392499,Synthesis of GDP-mannose,Metabolism of proteins
R-HSA-446210,R-HSA-392499,Synthesis of UDP-N-acetyl-glucosamine,Metabolism of proteins
R-HSA-446343,R-HSA-1500931,Localization of the PINCH-ILK-PARVIN complex to focal adhesions,Cell-Cell communication
R-HSA-446353,R-HSA-1500931,Cell-extracellular matrix interactions,Cell-Cell communication
R-HSA-446388,R-HSA-1500931,Regulation of cytoskeletal remodeling and cell spreading by IPP complex components,Cell-Cell communication
R-HSA-447038,R-HSA-1266738,NrCAM interactions,Developmental Biology
R-HSA-447041,R-HSA-1266738,CHL1 interactions,Developmental Biology
R-HSA-447043,R-HSA-1266738,Neurofascin interactions,Developmental Biology
R-HSA-448424,R-HSA-168256,Interleukin-17 signaling,Immune System
R-HSA-448706,R-HSA-168256,Interleukin-1 processing,Immune System
R-HSA-449836,R-HSA-168256,Other interleukin signaling,Immune System
R-HSA-450302,R-HSA-168256,activated TAK1 mediates p38 MAPK activation,Immune System
R-HSA-450321,R-HSA-168256,JNK (c-Jun kinases) phosphorylation and  activation mediated by activated human TAK1,Immune System
R-HSA-450341,R-HSA-168256,Activation of the AP-1 family of transcription factors,Immune System
R-HSA-450385,R-HSA-8953854,Butyrate Response Factor 1 (BRF1) binds and destabilizes mRNA,Metabolism of RNA
R-HSA-450408,R-HSA-8953854,AUF1 (hnRNP D0) binds and destabilizes mRNA,Metabolism of RNA
R-HSA-450513,R-HSA-8953854,"Tristetraprolin (TTP, ZFP36) binds and destabilizes mRNA",Metabolism of RNA
R-HSA-450520,R-HSA-8953854,HuR (ELAVL1) binds and stabilizes mRNA,Metabolism of RNA
R-HSA-450604,R-HSA-8953854,KSRP (KHSRP) binds and destabilizes mRNA,Metabolism of RNA
R-HSA-451307,R-HSA-112316,Activation of Na-permeable kainate receptors,Neuronal System
R-HSA-451308,R-HSA-112316,Activation of Ca-permeable Kainate Receptor,Neuronal System
R-HSA-451927,R-HSA-168256,Interleukin-2 family signaling,Immune System
R-HSA-452723,R-HSA-1266738,Transcriptional regulation of pluripotent stem cells,Developmental Biology
R-HSA-4549349,R-HSA-1643685,Defective ALG2 causes ALG2-CDG (CDG-1i),Disease
R-HSA-4549356,R-HSA-1643685,Defective DPAGT1 causes DPAGT1-CDG (CDG-1j) and CMSTA2,Disease
R-HSA-4549380,R-HSA-1643685,Defective ALG1 causes ALG1-CDG (CDG-1k),Disease
R-HSA-4551295,R-HSA-1643685,Defective ALG11 causes ALG11-CDG (CDG-1p),Disease
R-HSA-4551638,R-HSA-392499,SUMOylation of chromatin organization proteins,Metabolism of proteins
R-HSA-456926,R-HSA-109582,Thrombin signalling through proteinase activated receptors (PARs),Hemostasis
R-HSA-4570464,R-HSA-392499,SUMOylation of RNA binding proteins,Metabolism of proteins
R-HSA-4570571,R-HSA-1643685,Defective RFT1 causes RFT1-CDG (CDG-1n),Disease
R-HSA-4608870,R-HSA-162582,Asymmetric localization of PCP proteins,Signal Transduction
R-HSA-4615885,R-HSA-392499,SUMOylation of DNA replication proteins,Metabolism of proteins
R-HSA-4641257,R-HSA-162582,Degradation of AXIN,Signal Transduction
R-HSA-4641258,R-HSA-162582,Degradation of DVL,Signal Transduction
R-HSA-4641262,R-HSA-162582,Disassembly of the destruction complex and recruitment of AXIN to the membrane,Signal Transduction
R-HSA-4641263,R-HSA-162582,Regulation of FZD by ubiquitination,Signal Transduction
R-HSA-4641265,R-HSA-162582,Repression of WNT target genes,Signal Transduction
R-HSA-4655427,R-HSA-392499,SUMOylation of DNA methylation proteins,Metabolism of proteins
R-HSA-4687000,R-HSA-1643685,Defective MPDU1 causes MPDU1-CDG (CDG-1f),Disease
R-HSA-4717374,R-HSA-1643685,Defective DPM1 causes DPM1-CDG (CDG-1e),Disease
R-HSA-4719360,R-HSA-1643685,Defective DPM3 causes DPM3-CDG (CDG-1o),Disease
R-HSA-4719377,R-HSA-1643685,Defective DPM2 causes DPM2-CDG (CDG-1u),Disease
R-HSA-4720454,R-HSA-1643685,Defective ALG9 causes ALG9-CDG (CDG-1l),Disease
R-HSA-4720475,R-HSA-1643685,Defective ALG3 causes ALG3-CDG (CDG-1d),Disease
R-HSA-4720489,R-HSA-1643685,Defective ALG12 causes ALG12-CDG (CDG-1g),Disease
R-HSA-4724289,R-HSA-1643685,Defective ALG6 causes ALG6-CDG (CDG-1c),Disease
R-HSA-4724325,R-HSA-1643685,Defective ALG8 causes ALG8-CDG (CDG-1h),Disease
R-HSA-4755510,R-HSA-392499,SUMOylation of immune response proteins,Metabolism of proteins
R-HSA-4755579,R-HSA-1643685,Defective SRD5A3 causes SRD5A3-CDG (CDG-1q) and KHRZ,Disease
R-HSA-4755583,R-HSA-1643685,Defective DOLK causes DOLK-CDG (CDG-1m),Disease
R-HSA-4755609,R-HSA-1643685,Defective DHDDS causes retinitis pigmentosa 59,Disease
R-HSA-4793950,R-HSA-1643685,Defective MAN1B1 causes MRT15,Disease
R-HSA-4793952,R-HSA-1643685,Defective MGAT2 causes MGAT2-CDG (CDG-2a),Disease
R-HSA-4793953,R-HSA-1643685,Defective B4GALT1 causes B4GALT1-CDG (CDG-2d),Disease
R-HSA-4793954,R-HSA-1643685,Defective MOGS causes MOGS-CDG (CDG-2b),Disease
R-HSA-480985,R-HSA-392499,Synthesis of dolichyl-phosphate-glucose,Metabolism of proteins
R-HSA-499943,R-HSA-1430728,Interconversion of nucleotide di- and triphosphates,Metabolism
R-HSA-500657,R-HSA-112316,Presynaptic function of Kainate receptors,Neuronal System
R-HSA-500753,R-HSA-1430728,Pyrimidine biosynthesis,Metabolism
R-HSA-5083625,R-HSA-1643685,Defective GALNT3 causes familial hyperphosphatemic tumoral calcinosis (HFTC),Disease
R-HSA-5083627,R-HSA-1643685,Defective LARGE causes MDDGA6 and MDDGB6,Disease
R-HSA-5083628,R-HSA-1643685,"Defective POMGNT1 causes MDDGA3, MDDGB3 and MDDGC3",Disease
R-HSA-5083629,R-HSA-1643685,"Defective POMT2 causes MDDGA2, MDDGB2 and MDDGC2",Disease
R-HSA-5083630,R-HSA-1643685,Defective LFNG causes SCDO3,Disease
R-HSA-5083632,R-HSA-1643685,Defective C1GALT1C1 causes Tn polyagglutination syndrome (TNPS),Disease
R-HSA-5083633,R-HSA-1643685,"Defective POMT1 causes MDDGA1, MDDGB1 and MDDGC1",Disease
R-HSA-5083635,R-HSA-1643685,Defective B3GALTL causes Peters-plus syndrome (PpS),Disease
R-HSA-5083636,R-HSA-1643685,Defective GALNT12 causes colorectal cancer 1 (CRCS1),Disease
R-HSA-5099900,R-HSA-162582,WNT5A-dependent internalization of FZD4,Signal Transduction
R-HSA-512988,R-HSA-168256,"Interleukin-3, Interleukin-5 and GM-CSF signaling",Immune System
R-HSA-5140745,R-HSA-162582,"WNT5A-dependent internalization of FZD2, FZD5 and ROR2",Signal Transduction
R-HSA-5173105,R-HSA-392499,O-linked glycosylation,Metabolism of proteins
R-HSA-5173214,R-HSA-392499,O-glycosylation of TSR domain-containing proteins,Metabolism of proteins
R-HSA-5205685,R-HSA-9612973,PINK1-PRKN Mediated Mitophagy,Autophagy
R-HSA-5210891,R-HSA-1643685,Uptake and function of anthrax toxins,Disease
R-HSA-5213460,R-HSA-5357801,RIPK1-mediated regulated necrosis,Programmed Cell Death
R-HSA-5218900,R-HSA-5357801,CASP8 activity is inhibited,Programmed Cell Death
R-HSA-5218920,R-HSA-162582,VEGFR2 mediated vascular permeability,Signal Transduction
R-HSA-5218921,R-HSA-162582,VEGFR2 mediated cell proliferation,Signal Transduction
R-HSA-5221030,R-HSA-74160,"TET1,2,3 and TDG demethylate DNA",Gene expression (Transcription)
R-HSA-5223345,R-HSA-382551,Miscellaneous transport and binding events,Transport of small molecules
R-HSA-5250924,R-HSA-74160,B-WICH complex positively regulates rRNA expression,Gene expression (Transcription)
R-HSA-5250955,R-HSA-1643685,Toxicity of botulinum toxin type D (botD),Disease
R-HSA-5250958,R-HSA-1643685,Toxicity of botulinum toxin type B (botB),Disease
R-HSA-5250968,R-HSA-1643685,Toxicity of botulinum toxin type A (botA),Disease
R-HSA-5250971,R-HSA-1643685,Toxicity of botulinum toxin type C (botC),Disease
R-HSA-5250981,R-HSA-1643685,Toxicity of botulinum toxin type F (botF),Disease
R-HSA-5250982,R-HSA-1643685,Toxicity of tetanus toxin (tetX),Disease
R-HSA-5250989,R-HSA-1643685,Toxicity of botulinum toxin type G (botG),Disease
R-HSA-5250992,R-HSA-1643685,Toxicity of botulinum toxin type E (botE),Disease
R-HSA-525793,R-HSA-1266738,Myogenesis,Developmental Biology
R-HSA-5263617,R-HSA-1430728,Metabolism of ingested MeSeO2H into MeSeH,Metabolism
R-HSA-532668,R-HSA-392499,N-glycan trimming in the ER and Calnexin/Calreticulin cycle,Metabolism of proteins
R-HSA-5334118,R-HSA-74160,DNA methylation,Gene expression (Transcription)
R-HSA-5336415,R-HSA-1643685,Uptake and function of diphtheria toxin,Disease
R-HSA-5339700,R-HSA-1643685,Signaling by TCF7L2 mutants,Disease
R-HSA-5339716,R-HSA-1643685,Signaling by GSK3beta mutants,Disease
R-HSA-5339717,R-HSA-1643685,Signaling by LRP5 mutants ,Disease
R-HSA-5340573,R-HSA-1643685,LGK974 inhibits PORCN,Disease
R-HSA-5340588,R-HSA-1643685,Signaling by RNF43 mutants,Disease
R-HSA-5357609,R-HSA-1643685,Glycogen storage disease type II (GAA),Disease
R-HSA-5357786,R-HSA-162582,TNFR1-induced proapoptotic signaling,Signal Transduction
R-HSA-5357905,R-HSA-162582,Regulation of TNFR1 signaling,Signal Transduction
R-HSA-5357956,R-HSA-162582,TNFR1-induced NFkappaB signaling pathway,Signal Transduction
R-HSA-5358346,R-HSA-162582,Hedgehog ligand biogenesis,Signal Transduction
R-HSA-5358493,R-HSA-392499,Synthesis of diphthamide-EEF2,Metabolism of proteins
R-HSA-5358565,R-HSA-73894,Mismatch repair (MMR) directed by MSH2:MSH6 (MutSalpha),DNA Repair
R-HSA-5358606,R-HSA-73894,Mismatch repair (MMR) directed by MSH2:MSH3 (MutSbeta),DNA Repair
R-HSA-5358747,R-HSA-1643685,S33 mutants of beta-catenin aren't phosphorylated,Disease
R-HSA-5358749,R-HSA-1643685,S37 mutants of beta-catenin aren't phosphorylated,Disease
R-HSA-5358751,R-HSA-1643685,S45 mutants of beta-catenin aren't phosphorylated,Disease
R-HSA-5358752,R-HSA-1643685,T41 mutants of beta-catenin aren't phosphorylated,Disease
R-HSA-5362517,R-HSA-162582,Signaling by Retinoic Acid,Signal Transduction
R-HSA-5362768,R-HSA-1643685,Hh mutants are degraded by ERAD,Disease
R-HSA-5362798,R-HSA-162582,Release of Hh-Np from the secreting cell,Signal Transduction
R-HSA-5365859,R-HSA-162582,RA biosynthesis pathway,Signal Transduction
R-HSA-5368286,R-HSA-392499,Mitochondrial translation initiation,Metabolism of proteins
R-HSA-5368598,R-HSA-162582,Negative regulation of TCF-dependent signaling by DVL-interacting proteins,Signal Transduction
R-HSA-5389840,R-HSA-392499,Mitochondrial translation elongation,Metabolism of proteins
R-HSA-5419276,R-HSA-392499,Mitochondrial translation termination,Metabolism of proteins
R-HSA-5423646,R-HSA-1430728,Aflatoxin activation and detoxification,Metabolism
R-HSA-5467333,R-HSA-1643685,APC truncation mutants are not K63 polyubiquitinated,Disease
R-HSA-5467337,R-HSA-1643685,APC truncation mutants have impaired AXIN binding,Disease
R-HSA-5467340,R-HSA-1643685,AXIN missense mutants destabilize the destruction complex,Disease
R-HSA-5467348,R-HSA-1643685,Truncations of AMER1 destabilize the destruction complex,Disease
R-HSA-549127,R-HSA-382551,Organic cation transport,Transport of small molecules
R-HSA-5545483,R-HSA-1643685,Defective Mismatch Repair Associated With MLH1,Disease
R-HSA-5545619,R-HSA-1643685,XAV939 stabilizes AXIN,Disease
R-HSA-5576886,R-HSA-397014,Phase 4 - resting membrane potential,Muscle contraction
R-HSA-5576890,R-HSA-397014,Phase 3 - rapid repolarisation,Muscle contraction
R-HSA-5576892,R-HSA-397014,Phase 0 - rapid depolarisation,Muscle contraction
R-HSA-5576893,R-HSA-397014,Phase 2 - plateau phase,Muscle contraction
R-HSA-5576894,R-HSA-397014,Phase 1 - inactivation of fast Na+ channels,Muscle contraction
R-HSA-5578749,R-HSA-74160,Transcriptional regulation by small RNAs,Gene expression (Transcription)
R-HSA-5578768,R-HSA-397014,Physiological factors,Muscle contraction
R-HSA-5578775,R-HSA-397014,Ion homeostasis,Muscle contraction
R-HSA-5578995,R-HSA-1643685,Defective TPMT causes Thiopurine S-methyltransferase deficiency (TPMT deficiency),Disease
R-HSA-5578996,R-HSA-1643685,Defective CYP27A1 causes Cerebrotendinous xanthomatosis (CTX),Disease
R-HSA-5578997,R-HSA-1643685,Defective AHCY causes Hypermethioninemia with S-adenosylhomocysteine hydrolase deficiency (HMAHCHD),Disease
R-HSA-5578998,R-HSA-1643685,Defective OPLAH causes 5-oxoprolinase deficiency (OPLAHD),Disease
R-HSA-5578999,R-HSA-1643685,Defective GCLC causes Hemolytic anemia due to gamma-glutamylcysteine synthetase deficiency (HAGGSD),Disease
R-HSA-5579000,R-HSA-1643685,Defective CYP1B1 causes Glaucoma,Disease
R-HSA-5579002,R-HSA-1643685,Defective UGT1A1 causes hyperbilirubinemia,Disease
R-HSA-5579004,R-HSA-1643685,Defective CYP26C1 causes Focal facial dermal dysplasia 4 (FFDD4),Disease
R-HSA-5579005,R-HSA-1643685,"Defective CYP4F22 causes Ichthyosis, congenital, autosomal recessive 5 (ARCI5)",Disease
R-HSA-5579006,R-HSA-1643685,Defective GSS causes Glutathione synthetase deficiency (GSS deficiency),Disease
R-HSA-5579007,R-HSA-1643685,Defective ACY1 causes encephalopathy,Disease
R-HSA-5579009,R-HSA-1643685,Defective CYP11B2 causes Corticosterone methyloxidase 1 deficiency (CMO-1 deficiency),Disease
R-HSA-5579010,R-HSA-1643685,"Defective CYP24A1 causes Hypercalcemia, infantile (HCAI)",Disease
R-HSA-5579011,R-HSA-1643685,"Defective CYP2U1 causes Spastic paraplegia 56, autosomal recessive (SPG56)",Disease
R-HSA-5579012,R-HSA-1643685,Defective MAOA causes Brunner syndrome (BRUNS),Disease
R-HSA-5579013,R-HSA-1643685,"Defective CYP7B1 causes Spastic paraplegia 5A, autosomal recessive (SPG5A) and Congenital bile acid synthesis defect 3 (CBAS3)",Disease
R-HSA-5579014,R-HSA-1643685,Defective CYP27B1 causes Rickets vitamin D-dependent 1A (VDDR1A),Disease
R-HSA-5579015,R-HSA-1643685,Defective CYP26B1 causes Radiohumeral fusions with other skeletal and craniofacial anomalies (RHFCA),Disease
R-HSA-5579016,R-HSA-1643685,Defective UGT1A4 causes hyperbilirubinemia,Disease
R-HSA-5579017,R-HSA-1643685,Defective CYP11B1 causes Adrenal hyperplasia 4 (AH4),Disease
R-HSA-5579019,R-HSA-1643685,Defective FMO3 causes Trimethylaminuria (TMAU),Disease
R-HSA-5579020,R-HSA-1643685,Defective SLC35D1 causes Schneckenbecken dysplasia (SCHBCKD),Disease
R-HSA-5579021,R-HSA-1643685,Defective CYP21A2 causes Adrenal hyperplasia 3 (AH3),Disease
R-HSA-5579022,R-HSA-1643685,Defective GGT1 causes Glutathionuria (GLUTH),Disease
R-HSA-5579024,R-HSA-1643685,Defective MAT1A causes Methionine adenosyltransferase deficiency (MATD),Disease
R-HSA-5579026,R-HSA-1643685,"Defective CYP11A1 causes Adrenal insufficiency, congenital, with 46,XY sex reversal (AICSR)",Disease
R-HSA-5579027,R-HSA-1643685,Defective CYP2R1 causes Rickets vitamin D-dependent 1B (VDDR1B),Disease
R-HSA-5579028,R-HSA-1643685,Defective CYP17A1 causes Adrenal hyperplasia 5 (AH5),Disease
R-HSA-5579030,R-HSA-1643685,Defective CYP19A1 causes Aromatase excess syndrome (AEXS),Disease
R-HSA-5579031,R-HSA-1643685,Defective ACTH causes Obesity and Pro-opiomelanocortinin deficiency (POMCD),Disease
R-HSA-5579032,R-HSA-1643685,Defective TBXAS1 causes Ghosal hematodiaphyseal dysplasia (GHDD),Disease
R-HSA-5601884,R-HSA-74160,PIWI-interacting RNA (piRNA) biogenesis,Gene expression (Transcription)
R-HSA-5602410,R-HSA-1643685,TLR3 deficiency - HSE,Disease
R-HSA-5602415,R-HSA-1643685,UNC93B1 deficiency - HSE,Disease
R-HSA-5602498,R-HSA-1643685,MyD88 deficiency (TLR2/4),Disease
R-HSA-5602566,R-HSA-1643685,TICAM1 deficiency - HSE,Disease
R-HSA-5602571,R-HSA-1643685,TRAF3 deficiency - HSE,Disease
R-HSA-5602636,R-HSA-1643685,IKBKB deficiency causes SCID,Disease
R-HSA-5602680,R-HSA-1643685,MyD88 deficiency (TLR5),Disease
R-HSA-5603027,R-HSA-1643685,IKBKG deficiency causes anhidrotic ectodermal dysplasia with immunodeficiency (EDA-ID) (via TLR),Disease
R-HSA-5603029,R-HSA-1643685,IkBA variant leads to EDA-ID,Disease
R-HSA-5603037,R-HSA-1643685,IRAK4 deficiency (TLR5),Disease
R-HSA-5603041,R-HSA-1643685,IRAK4 deficiency (TLR2/4),Disease
R-HSA-5607761,R-HSA-168256,Dectin-1 mediated noncanonical NF-kB signaling,Immune System
R-HSA-5607763,R-HSA-168256,CLEC7A (Dectin-1) induces NFAT activation,Immune System
R-HSA-5607764,R-HSA-168256,CLEC7A (Dectin-1) signaling,Immune System
R-HSA-5609974,R-HSA-1643685,Defective PGM1 causes PGM1-CDG (CDG1t),Disease
R-HSA-5609976,R-HSA-1643685,Defective GALK1 can cause Galactosemia II (GALCT2),Disease
R-HSA-5609977,R-HSA-1643685,Defective GALE can cause Epimerase-deficiency galactosemia (EDG),Disease
R-HSA-5609978,R-HSA-1643685,Defective GALT can cause Galactosemia,Disease
R-HSA-561048,R-HSA-382551,Organic anion transport,Transport of small molecules
R-HSA-5610780,R-HSA-162582,Degradation of GLI1 by the proteasome,Signal Transduction
R-HSA-5610783,R-HSA-162582,Degradation of GLI2 by the proteasome,Signal Transduction
R-HSA-5610785,R-HSA-162582,GLI3 is processed to GLI3R by the proteasome,Signal Transduction
R-HSA-5610787,R-HSA-162582,Hedgehog 'off' state,Signal Transduction
R-HSA-5617472,R-HSA-1266738,Activation of anterior HOX genes in hindbrain development during early embryogenesis,Developmental Biology
R-HSA-5617833,R-HSA-1852241,Cilium Assembly,Organelle biogenesis and maintenance
R-HSA-5619035,R-HSA-1643685,Defective SLC17A5 causes Salla disease (SD) and ISSD,Disease
R-HSA-5619036,R-HSA-1643685,Defective SLC24A5 causes oculocutaneous albinism 6 (OCA6),Disease
R-HSA-5619037,R-HSA-1643685,Defective SLC35A1 causes congenital disorder of glycosylation 2F (CDG2F),Disease
R-HSA-5619039,R-HSA-1643685,"Defective SLC12A6 causes agenesis of the corpus callosum, with peripheral neuropathy (ACCPN)",Disease
R-HSA-5619040,R-HSA-1643685,Defective SLC34A1 causes hypophosphatemic nephrolithiasis/osteoporosis 1 (NPHLOP1),Disease
R-HSA-5619041,R-HSA-1643685,Defective SLC36A2 causes iminoglycinuria (IG) and hyperglycinuria (HG),Disease
R-HSA-5619042,R-HSA-1643685,Defective RHAG causes regulator type Rh-null hemolytic anemia (RHN),Disease
R-HSA-5619043,R-HSA-1643685,Defective SLC2A1 causes GLUT1 deficiency syndrome 1 (GLUT1DS1),Disease
R-HSA-5619044,R-HSA-1643685,Defective SLC6A19 causes Hartnup disorder (HND),Disease
R-HSA-5619045,R-HSA-1643685,Defective SLC34A2 causes pulmonary alveolar microlithiasis (PALM),Disease
R-HSA-5619046,R-HSA-1643685,Defective SLC26A4 causes Pendred syndrome (PDS),Disease
R-HSA-5619047,R-HSA-1643685,Defective SLC2A9 causes hypouricemia renal 2 (RHUC2),Disease
R-HSA-5619048,R-HSA-1643685,"Defective SLC11A2 causes hypochromic microcytic anemia, with iron overload 1 (AHMIO1)",Disease
R-HSA-5619049,R-HSA-1643685,Defective SLC40A1 causes hemochromatosis 4 (HFE4) (macrophages),Disease
R-HSA-5619050,R-HSA-1643685,"Defective SLC4A1 causes hereditary spherocytosis type 4 (HSP4),  distal renal tubular acidosis (dRTA) and dRTA with hemolytic anemia (dRTA-HA)",Disease
R-HSA-5619052,R-HSA-1643685,Defective SLC9A9 causes autism 16 (AUTS16),Disease
R-HSA-5619053,R-HSA-1643685,Defective SLC22A5 causes systemic primary carnitine deficiency (CDSP),Disease
R-HSA-5619054,R-HSA-1643685,"Defective SLC4A4 causes renal tubular acidosis, proximal, with ocular abnormalities and mental retardation (pRTA-OA)",Disease
R-HSA-5619055,R-HSA-1643685,Defective SLC24A4 causes hypomineralized amelogenesis imperfecta (AI),Disease
R-HSA-5619056,R-HSA-1643685,Defective HK1 causes hexokinase deficiency (HK deficiency),Disease
R-HSA-5619058,R-HSA-1643685,"Defective SLCO1B3 causes hyperbilirubinemia, Rotor type (HBLRR)",Disease
R-HSA-5619060,R-HSA-1643685,Defective CP causes aceruloplasminemia (ACERULOP),Disease
R-HSA-5619061,R-HSA-1643685,Defective SLC33A1 causes spastic paraplegia 42 (SPG42),Disease
R-HSA-5619062,R-HSA-1643685,Defective SLC1A3 causes episodic ataxia 6 (EA6),Disease
R-HSA-5619063,R-HSA-1643685,Defective SLC29A3 causes histiocytosis-lymphadenopathy plus syndrome (HLAS),Disease
R-HSA-5619066,R-HSA-1643685,Defective SLC22A18 causes lung cancer (LNCR) and embryonal rhabdomyosarcoma 1 (RMSE1),Disease
R-HSA-5619067,R-HSA-1643685,Defective SLC1A1 is implicated in schizophrenia 18 (SCZD18) and dicarboxylic aminoaciduria (DCBXA),Disease
R-HSA-5619068,R-HSA-1643685,Defective SLC2A10 causes arterial tortuosity syndrome (ATS),Disease
R-HSA-5619070,R-HSA-1643685,Defective SLC16A1 causes symptomatic deficiency in lactate transport (SDLT),Disease
R-HSA-5619071,R-HSA-1643685,Defective SLC22A12 causes renal hypouricemia 1 (RHUC1),Disease
R-HSA-5619072,R-HSA-1643685,Defective SLC35A2 causes congenital disorder of glycosylation 2M (CDG2M),Disease
R-HSA-5619073,R-HSA-1643685,Defective GCK causes maturity-onset diabetes of the young 2 (MODY2),Disease
R-HSA-5619076,R-HSA-1643685,Defective SLC17A8 causes autosomal dominant deafness 25 (DFNA25),Disease
R-HSA-5619077,R-HSA-1643685,Defective SLC24A1 causes congenital stationary night blindness 1D (CSNB1D),Disease
R-HSA-5619078,R-HSA-1643685,Defective SLC35C1 causes congenital disorder of glycosylation 2C (CDG2C),Disease
R-HSA-5619079,R-HSA-1643685,Defective SLC6A18 may confer susceptibility to iminoglycinuria and/or hyperglycinuria,Disease
R-HSA-5619081,R-HSA-1643685,Defective SLC6A3 causes Parkinsonism-dystonia infantile (PKDYS),Disease
R-HSA-5619083,R-HSA-1643685,"Defective SLC35A3 causes arthrogryposis, mental retardation, and seizures (AMRS)",Disease
R-HSA-5619085,R-HSA-1643685,Defective SLC26A3 causes congenital secretory chloride diarrhea 1 (DIAR1),Disease
R-HSA-5619087,R-HSA-1643685,Defective SLC12A3 causes Gitelman syndrome (GS),Disease
R-HSA-5619088,R-HSA-1643685,"Defective SLC39A4 causes acrodermatitis enteropathica, zinc-deficiency type (AEZ)",Disease
R-HSA-5619089,R-HSA-1643685,Defective SLC6A5 causes hyperekplexia 3 (HKPX3),Disease
R-HSA-5619092,R-HSA-1643685,"Defective SLC9A6 causes  X-linked, syndromic mental retardation,, Christianson type (MRXSCH)",Disease
R-HSA-5619094,R-HSA-1643685,Variant SLC6A14 may confer susceptibility towards obesity,Disease
R-HSA-5619095,R-HSA-1643685,"Defective SLCO2A1 causes primary, autosomal recessive hypertrophic osteoarthropathy 2 (PHOAR2)",Disease
R-HSA-5619096,R-HSA-1643685,Defective SLC5A5 causes thyroid dyshormonogenesis 1 (TDH1),Disease
R-HSA-5619097,R-HSA-1643685,Defective SLC34A3 causes Hereditary hypophosphatemic rickets with hypercalciuria (HHRH),Disease
R-HSA-5619098,R-HSA-1643685,Defective SLC2A2 causes Fanconi-Bickel syndrome (FBS),Disease
R-HSA-5619099,R-HSA-1643685,"Defective AVP does not bind AVPR1A,B and causes neurohypophyseal diabetes insipidus (NDI)",Disease
R-HSA-5619101,R-HSA-1643685,Variant SLC6A20 contributes towards hyperglycinuria (HG) and iminoglycinuria (IG),Disease
R-HSA-5619104,R-HSA-1643685,Defective SLC12A1 causes Bartter syndrome 1 (BS1),Disease
R-HSA-5619107,R-HSA-1643685,Defective TPR may confer susceptibility towards thyroid papillary carcinoma (TPC),Disease
R-HSA-5619108,R-HSA-1643685,Defective SLC27A4 causes ichthyosis prematurity syndrome (IPS),Disease
R-HSA-5619109,R-HSA-1643685,Defective SLC6A2 causes orthostatic intolerance (OI),Disease
R-HSA-5619110,R-HSA-1643685,"Defective SLCO1B1 causes hyperbilirubinemia, Rotor type (HBLRR)",Disease
R-HSA-5619111,R-HSA-1643685,Defective SLC20A2 causes idiopathic basal ganglia calcification 1 (IBGC1),Disease
R-HSA-5619113,R-HSA-1643685,Defective SLC3A1 causes cystinuria (CSNU),Disease
R-HSA-5619114,R-HSA-1643685,Defective SLC5A7 causes distal hereditary motor neuronopathy 7A (HMN7A),Disease
R-HSA-5620912,R-HSA-1852241,Anchoring of the basal body to the plasma membrane,Organelle biogenesis and maintenance
R-HSA-5620916,R-HSA-1852241,VxPx cargo-targeting to cilium,Organelle biogenesis and maintenance
R-HSA-5620922,R-HSA-1852241,BBSome-mediated cargo-targeting to cilium,Organelle biogenesis and maintenance
R-HSA-5620924,R-HSA-1852241,Intraflagellar transport,Organelle biogenesis and maintenance
R-HSA-5621480,R-HSA-168256,Dectin-2 family,Immune System
R-HSA-5621575,R-HSA-168256,CD209 (DC-SIGN) signaling,Immune System
R-HSA-5624138,R-HSA-1852241,Trafficking of myristoylated proteins to the cilium,Organelle biogenesis and maintenance
R-HSA-5624958,R-HSA-1852241,ARL13B-mediated ciliary trafficking of INPP5E,Organelle biogenesis and maintenance
R-HSA-5625740,R-HSA-162582,RHO GTPases activate PKNs,Signal Transduction
R-HSA-5625886,R-HSA-162582,Activated PKN1 stimulates transcription of AR (androgen receptor) regulated genes KLK2 and KLK3,Signal Transduction
R-HSA-5625900,R-HSA-162582,RHO GTPases activate CIT,Signal Transduction
R-HSA-5625970,R-HSA-162582,RHO GTPases activate KTN1,Signal Transduction
R-HSA-5626467,R-HSA-162582,RHO GTPases activate IQGAPs,Signal Transduction
R-HSA-5626978,R-HSA-162582,TNFR1-mediated ceramide production,Signal Transduction
R-HSA-5627083,R-HSA-162582,RHO GTPases regulate CFTR trafficking,Signal Transduction
R-HSA-5627117,R-HSA-162582,RHO GTPases Activate ROCKs,Signal Transduction
R-HSA-5627123,R-HSA-162582,RHO GTPases activate PAKs,Signal Transduction
R-HSA-5628897,R-HSA-74160,TP53 Regulates Metabolic Genes,Gene expression (Transcription)
R-HSA-5632681,R-HSA-162582,Ligand-receptor interactions,Signal Transduction
R-HSA-5632684,R-HSA-162582,Hedgehog 'on' state,Signal Transduction
R-HSA-5632927,R-HSA-1643685,Defective Mismatch Repair Associated With MSH3,Disease
R-HSA-5632928,R-HSA-1643685,Defective Mismatch Repair Associated With MSH2,Disease
R-HSA-5632968,R-HSA-1643685,Defective Mismatch Repair Associated With MSH6,Disease
R-HSA-5632987,R-HSA-1643685,Defective Mismatch Repair Associated With PMS2,Disease
R-HSA-5633231,R-HSA-1643685,Defective ALG14 causes congenital myasthenic syndrome (ALG14-CMS),Disease
R-HSA-5635838,R-HSA-162582,Activation of SMO,Signal Transduction
R-HSA-5635851,R-HSA-162582,GLI proteins bind promoters of Hh responsive genes to promote transcription,Signal Transduction
R-HSA-5637810,R-HSA-1643685,Constitutive Signaling by EGFRvIII,Disease
R-HSA-5638303,R-HSA-1643685,Inhibition of Signaling by Overexpressed EGFR,Disease
R-HSA-5649702,R-HSA-73894,APEX1-Independent Resolution of AP Sites via the Single Nucleotide Replacement Pathway,DNA Repair
R-HSA-5651801,R-HSA-73894,PCNA-Dependent Long Patch Base Excision Repair,DNA Repair
R-HSA-5652227,R-HSA-1430728,Fructose biosynthesis,Metabolism
R-HSA-5653890,R-HSA-1430728,Lactose synthesis,Metabolism
R-HSA-5654219,R-HSA-162582,Phospholipase C-mediated cascade: FGFR1,Signal Transduction
R-HSA-5654221,R-HSA-162582,Phospholipase C-mediated cascade; FGFR2,Signal Transduction
R-HSA-5654227,R-HSA-162582,Phospholipase C-mediated cascade; FGFR3,Signal Transduction
R-HSA-5654228,R-HSA-162582,Phospholipase C-mediated cascade; FGFR4,Signal Transduction
R-HSA-5654687,R-HSA-162582,Downstream signaling of activated FGFR1,Signal Transduction
R-HSA-5654688,R-HSA-162582,SHC-mediated cascade:FGFR1,Signal Transduction
R-HSA-5654689,R-HSA-162582,PI-3K cascade:FGFR1,Signal Transduction
R-HSA-5654693,R-HSA-162582,FRS-mediated FGFR1 signaling,Signal Transduction
R-HSA-5654695,R-HSA-162582,PI-3K cascade:FGFR2,Signal Transduction
R-HSA-5654699,R-HSA-162582,SHC-mediated cascade:FGFR2,Signal Transduction
R-HSA-5654700,R-HSA-162582,FRS-mediated FGFR2 signaling,Signal Transduction
R-HSA-5654704,R-HSA-162582,SHC-mediated cascade:FGFR3,Signal Transduction
R-HSA-5654706,R-HSA-162582,FRS-mediated FGFR3 signaling,Signal Transduction
R-HSA-5654710,R-HSA-162582,PI-3K cascade:FGFR3,Signal Transduction
R-HSA-5654712,R-HSA-162582,FRS-mediated FGFR4 signaling,Signal Transduction
R-HSA-5654719,R-HSA-162582,SHC-mediated cascade:FGFR4,Signal Transduction
R-HSA-5654720,R-HSA-162582,PI-3K cascade:FGFR4,Signal Transduction
R-HSA-5654726,R-HSA-162582,Negative regulation of FGFR1 signaling,Signal Transduction
R-HSA-5654727,R-HSA-162582,Negative regulation of FGFR2 signaling,Signal Transduction
R-HSA-5654732,R-HSA-162582,Negative regulation of FGFR3 signaling,Signal Transduction
R-HSA-5654733,R-HSA-162582,Negative regulation of FGFR4 signaling,Signal Transduction
R-HSA-5655253,R-HSA-1643685,Signaling by FGFR2 in disease,Disease
R-HSA-5655291,R-HSA-1643685,Signaling by FGFR4 in disease,Disease
R-HSA-5655302,R-HSA-1643685,Signaling by FGFR1 in disease,Disease
R-HSA-5655799,R-HSA-1643685,Defective SLC40A1 causes hemochromatosis 4 (HFE4) (duodenum),Disease
R-HSA-5655862,R-HSA-73894,Translesion synthesis by POLK,DNA Repair
R-HSA-5656121,R-HSA-73894,Translesion synthesis by POLI,DNA Repair
R-HSA-5656169,R-HSA-73894,Termination of translesion DNA synthesis,DNA Repair
R-HSA-5656364,R-HSA-1643685,Defective SLC5A1 causes congenital glucose/galactose malabsorption (GGM),Disease
R-HSA-5657560,R-HSA-1643685,Hereditary fructose intolerance,Disease
R-HSA-5657562,R-HSA-1643685,Essential fructosuria,Disease
R-HSA-5657655,R-HSA-73894,MGMT-mediated DNA damage reversal,DNA Repair
R-HSA-5658034,R-HSA-1643685,HHAT G278V doesn't palmitoylate Hh-Np,Disease
R-HSA-5658208,R-HSA-1643685,Defective SLC5A2 causes renal glucosuria (GLYS1),Disease
R-HSA-5658442,R-HSA-162582,Regulation of RAS by GAPs,Signal Transduction
R-HSA-5658471,R-HSA-1643685,Defective SLC5A7 causes distal hereditary motor neuronopathy 7A (HMN7A),Disease
R-HSA-5658623,R-HSA-162582,FGFRL1 modulation of FGFR1 signaling,Signal Transduction
R-HSA-5659729,R-HSA-1643685,Defective SLC6A18 may confer susceptibility to iminoglycinuria and/or hyperglycinuria,Disease
R-HSA-5659735,R-HSA-1643685,Defective SLC6A19 causes Hartnup disorder (HND),Disease
R-HSA-5659898,R-HSA-1643685,Intestinal saccharidase deficiencies,Disease
R-HSA-5659996,R-HSA-1643685,RPIA deficiency: failed conversion of R5P to RU5P,Disease
R-HSA-5660489,R-HSA-8953897,MTF1 activates gene expression,Cellular responses to external stimuli
R-HSA-5660668,R-HSA-168256,CLEC7A/inflammasome pathway,Immune System
R-HSA-5660686,R-HSA-1643685,Variant SLC6A20 contributes towards hyperglycinuria (HG) and iminoglycinuria (IG),Disease
R-HSA-5660724,R-HSA-1643685,Defective SLC6A3 causes Parkinsonism-dystonia infantile (PKDYS),Disease
R-HSA-5660862,R-HSA-1643685,Defective SLC7A7 causes lysinuric protein intolerance (LPI),Disease
R-HSA-5660883,R-HSA-1643685,Defective SLC7A9 causes cystinuria (CSNU),Disease
R-HSA-5661231,R-HSA-8953897,Metallothioneins bind metals,Cellular responses to external stimuli
R-HSA-5661270,R-HSA-1430728,Formation of xylulose-5-phosphate,Metabolism
R-HSA-5662702,R-HSA-1430728,Melanin biosynthesis,Metabolism
R-HSA-5662853,R-HSA-1643685,Essential pentosuria,Disease
R-HSA-5663020,R-HSA-1643685,Defective SLC35A1 causes congenital disorder of glycosylation 2F (CDG2F),Disease
R-HSA-5663213,R-HSA-162582,RHO GTPases Activate WASPs and WAVEs,Signal Transduction
R-HSA-5663220,R-HSA-162582,RHO GTPases Activate Formins,Signal Transduction
R-HSA-5666185,R-HSA-162582,RHO GTPases Activate Rhotekin and Rhophilins,Signal Transduction
R-HSA-5668541,R-HSA-168256,TNFR2 non-canonical NF-kB pathway,Immune System
R-HSA-5668599,R-HSA-162582,RHO GTPases Activate NADPH Oxidases,Signal Transduction
R-HSA-5669034,R-HSA-168256,TNFs bind their physiological receptors,Immune System
R-HSA-5673000,R-HSA-162582,RAF activation,Signal Transduction
R-HSA-5673001,R-HSA-162582,RAF/MAP kinase cascade,Signal Transduction
R-HSA-5674135,R-HSA-162582,MAP2K and MAPK activation,Signal Transduction
R-HSA-5674400,R-HSA-1643685,Constitutive Signaling by AKT1 E17K in Cancer,Disease
R-HSA-5674404,R-HSA-1643685,PTEN Loss of Function in Cancer,Disease
R-HSA-5674499,R-HSA-162582,Negative feedback regulation of MAPK pathway,Signal Transduction
R-HSA-5675221,R-HSA-162582,Negative regulation of MAPK pathway,Signal Transduction
R-HSA-5675482,R-HSA-5357801,Regulation of necroptotic cell death,Programmed Cell Death
R-HSA-5676590,R-HSA-168256,NIK-->noncanonical NF-kB signaling,Immune System
R-HSA-5676594,R-HSA-168256,TNF receptor superfamily (TNFSF) members mediating non-canonical NF-kB pathway,Immune System
R-HSA-5676934,R-HSA-392499,Protein repair,Metabolism of proteins
R-HSA-5678420,R-HSA-1643685,"Defective ABCC9 causes CMD10, ATFB12 and Cantu syndrome",Disease
R-HSA-5678520,R-HSA-1643685,Defective ABCB11 causes PFIC2 and BRIC2,Disease
R-HSA-5678771,R-HSA-1643685,"Defective ABCB4 causes PFIC3, ICP3 and GBD1",Disease
R-HSA-5678895,R-HSA-1643685,Defective CFTR causes cystic fibrosis,Disease
R-HSA-5679001,R-HSA-1643685,Defective ABCC2 causes DJS,Disease
R-HSA-5679090,R-HSA-1643685,Defective ABCG8 causes GBD4 and sitosterolemia,Disease
R-HSA-5679096,R-HSA-1643685,Defective ABCG5 causes sitosterolemia,Disease
R-HSA-5682113,R-HSA-1643685,Defective ABCA1 causes TGD,Disease
R-HSA-5682294,R-HSA-1643685,Defective ABCA12 causes ARCI4B,Disease
R-HSA-5682910,R-HSA-1266738,LGI-ADAM interactions,Developmental Biology
R-HSA-5683177,R-HSA-1643685,Defective ABCC8 can cause hypo- and hyper-glycemias,Disease
R-HSA-5683329,R-HSA-1643685,Defective ABCD4 causes MAHCJ,Disease
R-HSA-5683371,R-HSA-1643685,Defective ABCB6 causes MCOPCB7,Disease
R-HSA-5683678,R-HSA-1643685,Defective ABCA3 causes SMDP3,Disease
R-HSA-5683826,R-HSA-392499,Surfactant metabolism,Metabolism of proteins
R-HSA-5684045,R-HSA-1643685,Defective ABCD1 causes ALD,Disease
R-HSA-5684264,R-HSA-168256,MAP3K8 (TPL2)-dependent MAPK1/3 activation,Immune System
R-HSA-5685938,R-HSA-73894,HDR through Single Strand Annealing (SSA),DNA Repair
R-HSA-5685939,R-HSA-73894,HDR through MMEJ (alt-NHEJ),DNA Repair
R-HSA-5685942,R-HSA-73894,HDR through Homologous Recombination (HRR),DNA Repair
R-HSA-5686938,R-HSA-168256,Regulation of TLR by endogenous ligand,Immune System
R-HSA-5687128,R-HSA-162582,MAPK6/MAPK4 signaling,Signal Transduction
R-HSA-5687583,R-HSA-1643685,Defective SLC34A2 causes PALM,Disease
R-HSA-5687868,R-HSA-1643685,Defective SFTPA2 causes IPF,Disease
R-HSA-5688031,R-HSA-1643685,Defective pro-SFTPB causes SMDP1 and RDS,Disease
R-HSA-5688354,R-HSA-1643685,Defective pro-SFTPC causes SMDP2 and RDS,Disease
R-HSA-5688399,R-HSA-1643685,Defective ABCA3 causes SMDP3,Disease
R-HSA-5688849,R-HSA-1643685,Defective CSF2RB causes SMDP5,Disease
R-HSA-5688890,R-HSA-1643685,Defective CSF2RA causes SMDP4,Disease
R-HSA-5689603,R-HSA-392499,UCH proteinases,Metabolism of proteins
R-HSA-5689877,R-HSA-392499,Josephin domain DUBs,Metabolism of proteins
R-HSA-5689880,R-HSA-392499,Ub-specific processing proteases,Metabolism of proteins
R-HSA-5689896,R-HSA-392499,Ovarian tumor domain proteases,Metabolism of proteins
R-HSA-5689901,R-HSA-392499,Metalloprotease DUBs,Metabolism of proteins
R-HSA-5690338,R-HSA-1643685,Defective ABCC6 causes PXE,Disease
R-HSA-5690714,R-HSA-168256,CD22 mediated BCR regulation,Immune System
R-HSA-5693548,R-HSA-73894,Sensing of DNA Double Strand Breaks,DNA Repair
R-HSA-5693554,R-HSA-73894,Resolution of D-loop Structures through Synthesis-Dependent Strand Annealing (SDSA),DNA Repair
R-HSA-5693565,R-HSA-73894,Recruitment and ATM-mediated phosphorylation of repair and signaling proteins at DNA double strand breaks,DNA Repair
R-HSA-5693568,R-HSA-73894,Resolution of D-loop Structures through Holliday Junction Intermediates,DNA Repair
R-HSA-5693571,R-HSA-73894,Nonhomologous End-Joining (NHEJ),DNA Repair
R-HSA-5693579,R-HSA-73894,Homologous DNA Pairing and Strand Exchange,DNA Repair
R-HSA-5693607,R-HSA-73894,Processing of DNA double-strand break ends,DNA Repair
R-HSA-5693616,R-HSA-73894,Presynaptic phase of homologous DNA pairing and strand exchange,DNA Repair
R-HSA-5694530,R-HSA-5653656,Cargo concentration in the ER,Vesicle-mediated transport
R-HSA-5694530,R-HSA-392499,Cargo concentration in the ER,Metabolism of proteins
R-HSA-5696394,R-HSA-73894,DNA Damage Recognition in GG-NER,DNA Repair
R-HSA-5696395,R-HSA-73894,Formation of Incision Complex in GG-NER,DNA Repair
R-HSA-5696397,R-HSA-73894,Gap-filling DNA repair synthesis and ligation in GG-NER,DNA Repair
R-HSA-5696400,R-HSA-73894,Dual Incision in GG-NER,DNA Repair
R-HSA-606279,R-HSA-1640170,Deposition of new CENPA-containing nucleosomes at the centromere,Cell Cycle
R-HSA-611105,R-HSA-1430728,Respiratory electron transport,Metabolism
R-HSA-629587,R-HSA-112316,Highly sodium permeable postsynaptic acetylcholine nicotinic receptors,Neuronal System
R-HSA-629594,R-HSA-112316,Highly calcium permeable postsynaptic nicotinic acetylcholine receptors,Neuronal System
R-HSA-629597,R-HSA-112316,Highly calcium permeable nicotinic acetylcholine receptors,Neuronal System
R-HSA-674695,R-HSA-74160,RNA Polymerase II Pre-transcription Events,Gene expression (Transcription)
R-HSA-6781823,R-HSA-73894,Formation of TC-NER Pre-Incision Complex,DNA Repair
R-HSA-6781827,R-HSA-73894,Transcription-Coupled Nucleotide Excision Repair (TC-NER),DNA Repair
R-HSA-6782135,R-HSA-73894,Dual incision in TC-NER,DNA Repair
R-HSA-6782210,R-HSA-73894,Gap-filling DNA repair synthesis and ligation in TC-NER,DNA Repair
R-HSA-6782315,R-HSA-8953854,tRNA modification in the nucleus and cytosol,Metabolism of RNA
R-HSA-6782861,R-HSA-8953854,Synthesis of wybutosine at G37 of tRNA(Phe),Metabolism of RNA
R-HSA-6783310,R-HSA-73894,Fanconi Anemia Pathway,DNA Repair
R-HSA-6783783,R-HSA-168256,Interleukin-10 signaling,Immune System
R-HSA-6783984,R-HSA-1430728,Glycine degradation,Metabolism
R-HSA-6784531,R-HSA-8953854,tRNA processing in the nucleus,Metabolism of RNA
R-HSA-6785470,R-HSA-8953854,tRNA processing in the mitochondrion,Metabolism of RNA
R-HSA-6785631,R-HSA-162582,ERBB2 Regulates Cell Motility,Signal Transduction
R-HSA-6785807,R-HSA-168256,Interleukin-4 and Interleukin-13 signaling,Immune System
R-HSA-6787450,R-HSA-8953854,tRNA modification in the mitochondrion,Metabolism of RNA
R-HSA-6787639,R-HSA-392499,GDP-fucose biosynthesis,Metabolism of proteins
R-HSA-6788467,R-HSA-168256,IL-6-type cytokine receptor ligand interactions,Immune System
R-HSA-6790901,R-HSA-8953854,rRNA modification in the nucleus and cytosol,Metabolism of RNA
R-HSA-6791055,R-HSA-1643685,"TALDO1 deficiency: failed conversion of SH7P, GA3P to Fru(6)P, E4P",Disease
R-HSA-6791226,R-HSA-8953854,Major pathway of rRNA processing in the nucleolus and cytosol,Metabolism of RNA
R-HSA-6791461,R-HSA-1643685,RPIA deficiency: failed conversion of RU5P to R5P,Disease
R-HSA-6791462,R-HSA-1643685,"TALDO1 deficiency: failed conversion of  Fru(6)P, E4P to SH7P, GA3P",Disease
R-HSA-6793080,R-HSA-8953854,rRNA modification in the mitochondrion,Metabolism of RNA
R-HSA-6794361,R-HSA-112316,Neurexins and neuroligins,Neuronal System
R-HSA-6796648,R-HSA-74160,TP53 Regulates Transcription of DNA Repair Genes,Gene expression (Transcription)
R-HSA-6798163,R-HSA-1430728,Choline catabolism,Metabolism
R-HSA-6798695,R-HSA-168256,Neutrophil degranulation,Immune System
R-HSA-6799198,R-HSA-1430728,Complex I biogenesis,Metabolism
R-HSA-6799990,R-HSA-168256,Metal sequestration by antimicrobial proteins,Immune System
R-HSA-6802946,R-HSA-1643685,Signaling by moderate kinase activity BRAF mutants,Disease
R-HSA-6802948,R-HSA-1643685,Signaling by high-kinase activity BRAF mutants,Disease
R-HSA-6802952,R-HSA-1643685,Signaling by BRAF and RAF fusions,Disease
R-HSA-6802953,R-HSA-1643685,RAS signaling downstream of NF1 loss-of-function variants,Disease
R-HSA-6802955,R-HSA-1643685,Paradoxical activation of RAF signaling by kinase inactive BRAF,Disease
R-HSA-6803157,R-HSA-168256,Antimicrobial peptides,Immune System
R-HSA-6803204,R-HSA-74160,TP53 Regulates Transcription of Genes Involved in Cytochrome C Release,Gene expression (Transcription)
R-HSA-6803205,R-HSA-74160,TP53 regulates transcription of several additional cell death genes whose specific roles in p53-dependent apoptosis remain uncertain,Gene expression (Transcription)
R-HSA-6803207,R-HSA-74160,TP53 Regulates Transcription of Caspase Activators and Caspases,Gene expression (Transcription)
R-HSA-6803211,R-HSA-74160,TP53 Regulates Transcription of Death Receptors and Ligands,Gene expression (Transcription)
R-HSA-6803529,R-HSA-162582,FGFR2 alternative splicing,Signal Transduction
R-HSA-6803544,R-HSA-168256,Ion influx/efflux at host-pathogen interface,Immune System
R-HSA-6804114,R-HSA-74160,TP53 Regulates Transcription of Genes Involved in G2 Cell Cycle Arrest,Gene expression (Transcription)
R-HSA-6804115,R-HSA-74160,TP53 regulates transcription of additional cell cycle genes whose exact role in the p53 pathway remain uncertain,Gene expression (Transcription)
R-HSA-6804116,R-HSA-74160,TP53 Regulates Transcription of Genes Involved in G1 Cell Cycle Arrest,Gene expression (Transcription)
R-HSA-6804754,R-HSA-74160,Regulation of TP53 Expression,Gene expression (Transcription)
R-HSA-6804756,R-HSA-74160,Regulation of TP53 Activity through Phosphorylation,Gene expression (Transcription)
R-HSA-6804757,R-HSA-74160,Regulation of TP53 Degradation,Gene expression (Transcription)
R-HSA-6804758,R-HSA-74160,Regulation of TP53 Activity through Acetylation,Gene expression (Transcription)
R-HSA-6804759,R-HSA-74160,Regulation of TP53 Activity through Association with Co-factors,Gene expression (Transcription)
R-HSA-6804760,R-HSA-74160,Regulation of TP53 Activity through Methylation,Gene expression (Transcription)
R-HSA-6805567,R-HSA-1266738,Keratinization,Developmental Biology
R-HSA-6806664,R-HSA-1430728,Metabolism of vitamin K,Metabolism
R-HSA-6806942,R-HSA-162582,MET Receptor Activation,Signal Transduction
R-HSA-6807004,R-HSA-162582,Negative regulation of MET activity,Signal Transduction
R-HSA-6807047,R-HSA-1430728,Cholesterol biosynthesis via desmosterol,Metabolism
R-HSA-6807062,R-HSA-1430728,Cholesterol biosynthesis via lathosterol,Metabolism
R-HSA-6807505,R-HSA-74160,RNA polymerase II transcribes snRNA genes,Gene expression (Transcription)
R-HSA-6807878,R-HSA-5653656,COPI-mediated anterograde transport,Vesicle-mediated transport
R-HSA-6807878,R-HSA-392499,COPI-mediated anterograde transport,Metabolism of proteins
R-HSA-6809371,R-HSA-1266738,Formation of the cornified envelope,Developmental Biology
R-HSA-6809583,R-HSA-1643685,Retinoid metabolism disease events,Disease
R-HSA-6811434,R-HSA-5653656,COPI-dependent Golgi-to-ER retrograde traffic,Vesicle-mediated transport
R-HSA-6811436,R-HSA-5653656,COPI-independent Golgi-to-ER retrograde traffic,Vesicle-mediated transport
R-HSA-6811438,R-HSA-5653656,Intra-Golgi traffic,Vesicle-mediated transport
R-HSA-6811440,R-HSA-5653656,Retrograde transport at the Trans-Golgi-Network,Vesicle-mediated transport
R-HSA-6811555,R-HSA-74160,PI5P Regulates TP53 Acetylation,Gene expression (Transcription)
R-HSA-6811558,R-HSA-162582,"PI5P, PP2A and IER3 Regulate PI3K/AKT Signaling",Signal Transduction
R-HSA-6814122,R-HSA-392499,Cooperation of PDCL (PhLP1) and TRiC/CCT in G-protein beta folding,Metabolism of proteins
R-HSA-6814848,R-HSA-1430728,Glycerophospholipid catabolism,Metabolism
R-HSA-68616,R-HSA-69306,Assembly of the ORC complex at the origin of replication,DNA Replication
R-HSA-68689,R-HSA-69306,CDC6 association with the ORC:origin complex,DNA Replication
R-HSA-68827,R-HSA-69306,CDT1 association with the CDC6:ORC:origin complex,DNA Replication
R-HSA-68867,R-HSA-69306,Assembly of the pre-replicative complex,DNA Replication
R-HSA-68875,R-HSA-1640170,Mitotic Prophase,Cell Cycle
R-HSA-68877,R-HSA-1640170,Mitotic Prometaphase,Cell Cycle
R-HSA-68881,R-HSA-1640170,Mitotic Metaphase/Anaphase Transition,Cell Cycle
R-HSA-68884,R-HSA-1640170,Mitotic Telophase/Cytokinesis,Cell Cycle
R-HSA-68911,R-HSA-1640170,G2 Phase,Cell Cycle
R-HSA-68949,R-HSA-69306,Orc1 removal from chromatin,DNA Replication
R-HSA-68949,R-HSA-1640170,Orc1 removal from chromatin,Cell Cycle
R-HSA-68952,R-HSA-69306,DNA replication initiation,DNA Replication
R-HSA-68952,R-HSA-1640170,DNA replication initiation,Cell Cycle
R-HSA-68962,R-HSA-69306,Activation of the pre-replicative complex,DNA Replication
R-HSA-68962,R-HSA-1640170,Activation of the pre-replicative complex,Cell Cycle
R-HSA-69017,R-HSA-69306,CDK-mediated phosphorylation and removal of Cdc6,DNA Replication
R-HSA-69017,R-HSA-1640170,CDK-mediated phosphorylation and removal of Cdc6,Cell Cycle
R-HSA-69052,R-HSA-69306,Switching of origins to a post-replicative state,DNA Replication
R-HSA-69052,R-HSA-1640170,Switching of origins to a post-replicative state,Cell Cycle
R-HSA-69091,R-HSA-69306,Polymerase switching,DNA Replication
R-HSA-69091,R-HSA-1640170,Polymerase switching,Cell Cycle
R-HSA-69166,R-HSA-69306,Removal of the Flap Intermediate,DNA Replication
R-HSA-69166,R-HSA-1640170,Removal of the Flap Intermediate,Cell Cycle
R-HSA-69183,R-HSA-69306,Processive synthesis on the lagging strand,DNA Replication
R-HSA-69183,R-HSA-1640170,Processive synthesis on the lagging strand,Cell Cycle
R-HSA-69200,R-HSA-1640170,Phosphorylation of proteins involved in G1/S transition by active Cyclin E:Cdk2 complexes,Cell Cycle
R-HSA-69202,R-HSA-1640170,Cyclin E associated events during G1/S transition ,Cell Cycle
R-HSA-69205,R-HSA-1640170,G1/S-Specific Transcription,Cell Cycle
R-HSA-69231,R-HSA-1640170,Cyclin D associated events in G1,Cell Cycle
R-HSA-69273,R-HSA-1640170,Cyclin A/B1/B2 associated events during G2/M transition,Cell Cycle
R-HSA-69416,R-HSA-5357801,Dimerization of procaspase-8,Programmed Cell Death
R-HSA-69473,R-HSA-1640170,G2/M DNA damage checkpoint,Cell Cycle
R-HSA-69478,R-HSA-1640170,G2/M DNA replication checkpoint,Cell Cycle
R-HSA-69481,R-HSA-1640170,G2/M Checkpoints,Cell Cycle
R-HSA-69541,R-HSA-1640170,Stabilization of p53,Cell Cycle
R-HSA-69563,R-HSA-1640170,p53-Dependent G1 DNA Damage Response,Cell Cycle
R-HSA-69601,R-HSA-1640170,Ubiquitin Mediated Degradation of Phosphorylated Cdc25A,Cell Cycle
R-HSA-69656,R-HSA-1640170,Cyclin A:Cdk2-associated events at S phase entry,Cell Cycle
R-HSA-69895,R-HSA-1640170,Transcriptional  activation of  cell cycle inhibitor p21 ,Cell Cycle
R-HSA-70171,R-HSA-1430728,Glycolysis,Metabolism
R-HSA-70221,R-HSA-1430728,Glycogen breakdown (glycogenolysis),Metabolism
R-HSA-70263,R-HSA-1430728,Gluconeogenesis,Metabolism
R-HSA-70268,R-HSA-1430728,Pyruvate metabolism,Metabolism
R-HSA-70350,R-HSA-1430728,Fructose catabolism,Metabolism
R-HSA-70370,R-HSA-1430728,Galactose catabolism,Metabolism
R-HSA-70635,R-HSA-1430728,Urea cycle,Metabolism
R-HSA-70688,R-HSA-1430728,Proline catabolism,Metabolism
R-HSA-70895,R-HSA-1430728,Branched-chain amino acid catabolism,Metabolism
R-HSA-70921,R-HSA-1430728,Histidine catabolism,Metabolism
R-HSA-71032,R-HSA-1430728,Propionyl-CoA catabolism,Metabolism
R-HSA-71064,R-HSA-1430728,Lysine catabolism,Metabolism
R-HSA-71240,R-HSA-1430728,Tryptophan catabolism,Metabolism
R-HSA-71262,R-HSA-1430728,Carnitine synthesis,Metabolism
R-HSA-71288,R-HSA-1430728,Creatine metabolism,Metabolism
R-HSA-71336,R-HSA-1430728,Pentose phosphate pathway,Metabolism
R-HSA-71384,R-HSA-1430728,Ethanol oxidation,Metabolism
R-HSA-71403,R-HSA-1430728,Citric acid cycle (TCA cycle),Metabolism
R-HSA-71737,R-HSA-1430728,Pyrophosphate hydrolysis,Metabolism
R-HSA-72086,R-HSA-8953854,mRNA Capping,Metabolism of RNA
R-HSA-72163,R-HSA-8953854,mRNA Splicing - Major Pathway,Metabolism of RNA
R-HSA-72165,R-HSA-8953854,mRNA Splicing - Minor Pathway,Metabolism of RNA
R-HSA-72187,R-HSA-8953854,mRNA 3'-end processing,Metabolism of RNA
R-HSA-72200,R-HSA-8953854,mRNA Editing: C to U Conversion,Metabolism of RNA
R-HSA-72203,R-HSA-8953854,Processing of Capped Intron-Containing Pre-mRNA,Metabolism of RNA
R-HSA-72649,R-HSA-392499,Translation initiation complex formation,Metabolism of proteins
R-HSA-72662,R-HSA-392499,"Activation of the mRNA upon binding of the cap-binding complex and eIFs, and subsequent binding to 43S",Metabolism of proteins
R-HSA-72689,R-HSA-392499,Formation of a pool of free 40S subunits,Metabolism of proteins
R-HSA-72695,R-HSA-392499,"Formation of the ternary complex, and subsequently, the 43S complex",Metabolism of proteins
R-HSA-72702,R-HSA-392499,Ribosomal scanning and start codon recognition,Metabolism of proteins
R-HSA-72706,R-HSA-392499,GTP hydrolysis and joining of the 60S ribosomal subunit,Metabolism of proteins
R-HSA-72731,R-HSA-392499,Recycling of eIF2:GDP,Metabolism of proteins
R-HSA-72764,R-HSA-392499,Eukaryotic Translation Termination,Metabolism of proteins
R-HSA-727802,R-HSA-382551,Transport of nucleotide sugars,Transport of small molecules
R-HSA-73614,R-HSA-1430728,Pyrimidine salvage,Metabolism
R-HSA-73621,R-HSA-1430728,Pyrimidine catabolism,Metabolism
R-HSA-73728,R-HSA-74160,RNA Polymerase I Promoter Opening,Gene expression (Transcription)
R-HSA-73762,R-HSA-74160,RNA Polymerase I Transcription Initiation,Gene expression (Transcription)
R-HSA-73772,R-HSA-74160,RNA Polymerase I Promoter Escape,Gene expression (Transcription)
R-HSA-73776,R-HSA-74160,RNA Polymerase II Promoter Escape,Gene expression (Transcription)
R-HSA-73779,R-HSA-74160,RNA Polymerase II Transcription Pre-Initiation And Promoter Opening,Gene expression (Transcription)
R-HSA-73780,R-HSA-74160,RNA Polymerase III Chain Elongation,Gene expression (Transcription)
R-HSA-73817,R-HSA-1430728,Purine ribonucleoside monophosphate biosynthesis,Metabolism
R-HSA-73843,R-HSA-1430728,5-Phosphoribose 1-diphosphate biosynthesis,Metabolism
R-HSA-73856,R-HSA-74160,RNA Polymerase II Transcription Termination,Gene expression (Transcription)
R-HSA-73863,R-HSA-74160,RNA Polymerase I Transcription Termination,Gene expression (Transcription)
R-HSA-73930,R-HSA-73894,Abasic sugar-phosphate removal via the single-nucleotide replacement pathway,DNA Repair
R-HSA-73933,R-HSA-73894,Resolution of Abasic Sites (AP sites),DNA Repair
R-HSA-73943,R-HSA-73894,Reversal of alkylation damage by DNA dioxygenases,DNA Repair
R-HSA-73980,R-HSA-74160,RNA Polymerase III Transcription Termination,Gene expression (Transcription)
R-HSA-74217,R-HSA-1430728,Purine salvage,Metabolism
R-HSA-74259,R-HSA-1430728,Purine catabolism,Metabolism
R-HSA-74713,R-HSA-162582,IRS activation,Signal Transduction
R-HSA-74749,R-HSA-162582,Signal attenuation,Signal Transduction
R-HSA-74751,R-HSA-162582,Insulin receptor signalling cascade,Signal Transduction
R-HSA-74752,R-HSA-162582,Signaling by Insulin receptor,Signal Transduction
R-HSA-749476,R-HSA-74160,RNA Polymerase III Abortive And Retractive Initiation,Gene expression (Transcription)
R-HSA-75035,R-HSA-1640170,Chk1/Chk2(Cds1) mediated inactivation of Cyclin B:Cdk1 complex,Cell Cycle
R-HSA-75094,R-HSA-8953854,Formation of the Editosome,Metabolism of RNA
R-HSA-75102,R-HSA-8953854,C6 deamination of adenosine,Metabolism of RNA
R-HSA-75105,R-HSA-1430728,Fatty acyl-CoA biosynthesis,Metabolism
R-HSA-75108,R-HSA-5357801,"Activation, myristolyation of BID and translocation to mitochondria",Programmed Cell Death
R-HSA-75109,R-HSA-1430728,Triglyceride biosynthesis,Metabolism
R-HSA-75153,R-HSA-5357801,Apoptotic execution phase,Programmed Cell Death
R-HSA-75157,R-HSA-162582,FasL/ CD95L signaling,Signal Transduction
R-HSA-75158,R-HSA-162582,TRAIL  signaling,Signal Transduction
R-HSA-75205,R-HSA-109582,Dissolution of Fibrin Clot,Hemostasis
R-HSA-75815,R-HSA-1640170,Ubiquitin-dependent degradation of Cyclin D,Cell Cycle
R-HSA-75876,R-HSA-1430728,Synthesis of very long-chain fatty acyl-CoAs,Metabolism
R-HSA-75892,R-HSA-109582,Platelet Adhesion to exposed collagen,Hemostasis
R-HSA-75893,R-HSA-162582,TNF signaling,Signal Transduction
R-HSA-75896,R-HSA-1430728,Plasmalogen biosynthesis,Metabolism
R-HSA-75953,R-HSA-74160,RNA Polymerase II Transcription Initiation,Gene expression (Transcription)
R-HSA-75955,R-HSA-74160,RNA Polymerase II Transcription Elongation,Gene expression (Transcription)
R-HSA-76005,R-HSA-109582,Response to elevated platelet cytosolic Ca2+,Hemostasis
R-HSA-76009,R-HSA-109582,Platelet Aggregation (Plug Formation),Hemostasis
R-HSA-76042,R-HSA-74160,RNA Polymerase II Transcription Initiation And Promoter Clearance,Gene expression (Transcription)
R-HSA-76061,R-HSA-74160,RNA Polymerase III Transcription Initiation From Type 1 Promoter,Gene expression (Transcription)
R-HSA-76066,R-HSA-74160,RNA Polymerase III Transcription Initiation From Type 2 Promoter,Gene expression (Transcription)
R-HSA-76071,R-HSA-74160,RNA Polymerase III Transcription Initiation From Type 3 Promoter,Gene expression (Transcription)
R-HSA-77042,R-HSA-8953854,Formation of editosomes by ADAR proteins,Metabolism of RNA
R-HSA-77075,R-HSA-74160,RNA Pol II CTD phosphorylation and interaction with CE,Gene expression (Transcription)
R-HSA-77108,R-HSA-1430728,Utilization of Ketone Bodies,Metabolism
R-HSA-77111,R-HSA-1430728,Synthesis of Ketone Bodies,Metabolism
R-HSA-77285,R-HSA-1430728,Beta oxidation of myristoyl-CoA to lauroyl-CoA,Metabolism
R-HSA-77288,R-HSA-1430728,mitochondrial fatty acid beta-oxidation of unsaturated fatty acids,Metabolism
R-HSA-77289,R-HSA-1430728,Mitochondrial Fatty Acid Beta-Oxidation,Metabolism
R-HSA-77305,R-HSA-1430728,Beta oxidation of palmitoyl-CoA to myristoyl-CoA,Metabolism
R-HSA-77310,R-HSA-1430728,Beta oxidation of lauroyl-CoA to decanoyl-CoA-CoA,Metabolism
R-HSA-77346,R-HSA-1430728,Beta oxidation of decanoyl-CoA to octanoyl-CoA-CoA,Metabolism
R-HSA-77348,R-HSA-1430728,Beta oxidation of octanoyl-CoA to hexanoyl-CoA,Metabolism
R-HSA-77350,R-HSA-1430728,Beta oxidation of hexanoyl-CoA to butanoyl-CoA,Metabolism
R-HSA-77352,R-HSA-1430728,Beta oxidation of butanoyl-CoA to acetyl-CoA,Metabolism
R-HSA-77387,R-HSA-162582,Insulin receptor recycling,Signal Transduction
R-HSA-77588,R-HSA-8953854,SLBP Dependent Processing of Replication-Dependent Histone Pre-mRNAs,Metabolism of RNA
R-HSA-77595,R-HSA-8953854,Processing of Intronless Pre-mRNAs,Metabolism of RNA
R-HSA-804914,R-HSA-382551,Transport of fatty acids,Transport of small molecules
R-HSA-83936,R-HSA-382551,Transport of nucleosides and free purine and pyrimidine bases across the plasma membrane,Transport of small molecules
R-HSA-844455,R-HSA-168256,The NLRP1 inflammasome,Immune System
R-HSA-844456,R-HSA-168256,The NLRP3 inflammasome,Immune System
R-HSA-844615,R-HSA-168256,The AIM2 inflammasome,Immune System
R-HSA-844623,R-HSA-168256,The IPAF inflammasome,Immune System
R-HSA-877300,R-HSA-168256,Interferon gamma signaling,Immune System
R-HSA-877312,R-HSA-168256,Regulation of IFNG signaling,Immune System
R-HSA-879415,R-HSA-168256,Advanced glycosylation endproduct receptor signaling,Immune System
R-HSA-879518,R-HSA-382551,Transport of organic anions,Transport of small molecules
R-HSA-880009,R-HSA-1430728,Interconversion of 2-oxoglutarate and 2-hydroxyglutarate,Metabolism
R-HSA-881907,R-HSA-162582,Gastrin-CREB signalling pathway via PKC and MAPK,Signal Transduction
R-HSA-8847453,R-HSA-1430728,Synthesis of PIPs in the nucleus,Metabolism
R-HSA-8847993,R-HSA-162582,ERBB2 Activates PTK6 Signaling,Signal Transduction
R-HSA-8849175,R-HSA-1430728,Threonine catabolism,Metabolism
R-HSA-8849468,R-HSA-162582,PTK6 Regulates Proteins Involved in RNA Processing,Signal Transduction
R-HSA-8849469,R-HSA-162582,PTK6 Regulates RTKs and Their Effectors AKT1 and DOK1,Signal Transduction
R-HSA-8849470,R-HSA-162582,PTK6 Regulates Cell Cycle,Signal Transduction
R-HSA-8849471,R-HSA-162582,"PTK6 Regulates RHO GTPases, RAS GTPase and MAP kinases",Signal Transduction
R-HSA-8849472,R-HSA-162582,PTK6 Down-Regulation,Signal Transduction
R-HSA-8849473,R-HSA-162582,PTK6 Expression,Signal Transduction
R-HSA-8849474,R-HSA-162582,PTK6 Activates STAT3,Signal Transduction
R-HSA-8849932,R-HSA-112316,Synaptic adhesion-like molecules,Neuronal System
R-HSA-8850843,R-HSA-1430728,Phosphate bond hydrolysis by NTPDase proteins,Metabolism
R-HSA-8851680,R-HSA-168256,Butyrophilin (BTN) family interactions,Immune System
R-HSA-8851708,R-HSA-1643685,Signaling by FGFR2 IIIa TM,Disease
R-HSA-8851805,R-HSA-162582,MET activates RAS signaling,Signal Transduction
R-HSA-8851907,R-HSA-162582,MET activates PI3K/AKT signaling,Signal Transduction
R-HSA-8852276,R-HSA-1640170,The role of GTSE1 in G2/M progression after G2 checkpoint,Cell Cycle
R-HSA-8852405,R-HSA-162582,Signaling by MST1,Signal Transduction
R-HSA-8853333,R-HSA-1643685,Signaling by FGFR2 fusions,Disease
R-HSA-8853334,R-HSA-1643685,Signaling by FGFR3 fusions in cancer,Disease
R-HSA-8853336,R-HSA-1643685,Signaling by plasma membrane FGFR1 fusions,Disease
R-HSA-8853338,R-HSA-1643685,Signaling by FGFR3 point mutants in cancer,Disease
R-HSA-8853383,R-HSA-1430728,Lysosomal oligosaccharide catabolism,Metabolism
R-HSA-8853659,R-HSA-1266738,RET signaling,Developmental Biology
R-HSA-8853884,R-HSA-74160,Transcriptional Regulation by VENTX,Gene expression (Transcription)
R-HSA-8854050,R-HSA-1640170,FBXL7 down-regulates AURKA during mitotic entry and in early mitosis,Cell Cycle
R-HSA-8854214,R-HSA-5653656,TBC/RABGAPs,Vesicle-mediated transport
R-HSA-8854518,R-HSA-1640170,AURKA Activation by TPX2,Cell Cycle
R-HSA-8854521,R-HSA-1640170,Interaction between PHLDA1 and AURKA,Cell Cycle
R-HSA-8854691,R-HSA-168256,Interleukin-20 family signaling,Immune System
R-HSA-8856825,R-HSA-5653656,Cargo recognition for clathrin-mediated endocytosis,Vesicle-mediated transport
R-HSA-8856828,R-HSA-5653656,Clathrin-mediated endocytosis,Vesicle-mediated transport
R-HSA-8857538,R-HSA-162582,PTK6 promotes HIF1A stabilization,Signal Transduction
R-HSA-8862803,R-HSA-1643685,Deregulated CDK5 triggers multiple neurodegenerative pathways in Alzheimer's disease models,Disease
R-HSA-8863795,R-HSA-162582,Downregulation of ERBB2 signaling,Signal Transduction
R-HSA-8864260,R-HSA-74160,Transcriptional regulation by the AP-2 (TFAP2) family of transcription factors,Gene expression (Transcription)
R-HSA-8865999,R-HSA-162582,MET activates PTPN11,Signal Transduction
R-HSA-8866376,R-HSA-1266738,Reelin signalling pathway,Developmental Biology
R-HSA-8866423,R-HSA-382551,VLDL assembly,Transport of small molecules
R-HSA-8866427,R-HSA-382551,VLDLR internalisation and degradation,Transport of small molecules
R-HSA-8866652,R-HSA-392499,Synthesis of active ubiquitin: roles of E1 and E2 enzymes,Metabolism of proteins
R-HSA-8866654,R-HSA-392499,E3 ubiquitin ligases ubiquitinate target proteins,Metabolism of proteins
R-HSA-8866904,R-HSA-74160,Negative regulation of activity of TFAP2 (AP-2) family transcription factors,Gene expression (Transcription)
R-HSA-8866906,R-HSA-74160,TFAP2 (AP-2) family regulates transcription of other transcription factors,Gene expression (Transcription)
R-HSA-8866907,R-HSA-74160,Activation of the TFAP2 (AP-2) family of transcription factors,Gene expression (Transcription)
R-HSA-8866910,R-HSA-74160,TFAP2 (AP-2) family regulates transcription of growth factors and their receptors,Gene expression (Transcription)
R-HSA-8866911,R-HSA-74160,TFAP2 (AP-2) family regulates transcription of cell cycle factors,Gene expression (Transcription)
R-HSA-8868766,R-HSA-8953854,rRNA processing in the mitochondrion,Metabolism of RNA
R-HSA-8869496,R-HSA-74160,TFAP2A acts as a transcriptional repressor during retinoic acid induced cell differentiation,Gene expression (Transcription)
R-HSA-8873719,R-HSA-392499,RAB geranylgeranylation,Metabolism of proteins
R-HSA-8874081,R-HSA-162582,MET activates PTK2 signaling,Signal Transduction
R-HSA-8874211,R-HSA-392499,CREB3 factors activate genes,Metabolism of proteins
R-HSA-8875360,R-HSA-1643685,InlB-mediated entry of Listeria monocytogenes into host cell,Disease
R-HSA-8875513,R-HSA-162582,MET interacts with TNS proteins,Signal Transduction
R-HSA-8875555,R-HSA-162582,MET activates RAP1 and RAC1,Signal Transduction
R-HSA-8875656,R-HSA-162582,MET receptor recycling,Signal Transduction
R-HSA-8875791,R-HSA-162582,MET activates STAT3,Signal Transduction
R-HSA-8876198,R-HSA-5653656,RAB GEFs exchange GTP for GDP on RABs,Vesicle-mediated transport
R-HSA-8876493,R-HSA-1643685,InlA-mediated entry of Listeria monocytogenes into host cells,Disease
R-HSA-8876725,R-HSA-392499,Protein methylation,Metabolism of proteins
R-HSA-8877330,R-HSA-74160,RUNX1 and FOXP3 control the development of regulatory T lymphocytes (Tregs),Gene expression (Transcription)
R-HSA-8877627,R-HSA-1430728,Vitamin E,Metabolism
R-HSA-8878166,R-HSA-74160,Transcriptional regulation by RUNX2,Gene expression (Transcription)
R-HSA-888568,R-HSA-112316,GABA synthesis,Neuronal System
R-HSA-888590,R-HSA-112316,"GABA synthesis, release, reuptake and degradation",Neuronal System
R-HSA-888593,R-HSA-112316,Reuptake of GABA,Neuronal System
R-HSA-8931987,R-HSA-74160,RUNX1 regulates estrogen receptor mediated transcription,Gene expression (Transcription)
R-HSA-8934593,R-HSA-74160,Regulation of RUNX1 Expression and Activity,Gene expression (Transcription)
R-HSA-8934903,R-HSA-9612973,Receptor Mediated Mitophagy,Autophagy
R-HSA-8935690,R-HSA-8963743,Digestion,Digestion and absorption
R-HSA-8935964,R-HSA-74160,RUNX1 regulates expression of components of tight junctions,Gene expression (Transcription)
R-HSA-8936459,R-HSA-74160,RUNX1 regulates genes involved in megakaryocyte differentiation and platelet function,Gene expression (Transcription)
R-HSA-8937144,R-HSA-1430728,Aryl hydrocarbon receptor signalling,Metabolism
R-HSA-8939211,R-HSA-162582,ESR-mediated signaling,Signal Transduction
R-HSA-8939236,R-HSA-74160,RUNX1 regulates transcription of genes involved in differentiation of HSCs,Gene expression (Transcription)
R-HSA-8939242,R-HSA-74160,RUNX1 regulates transcription of genes involved in differentiation of keratinocytes,Gene expression (Transcription)
R-HSA-8939243,R-HSA-74160,RUNX1 interacts with co-factors whose precise effect on RUNX1 targets is not known,Gene expression (Transcription)
R-HSA-8939245,R-HSA-74160,RUNX1 regulates transcription of genes involved in BCR signaling,Gene expression (Transcription)
R-HSA-8939246,R-HSA-74160,RUNX1 regulates transcription of genes involved in differentiation of myeloid cells,Gene expression (Transcription)
R-HSA-8939247,R-HSA-74160,RUNX1 regulates transcription of genes involved in interleukin signaling,Gene expression (Transcription)
R-HSA-8939256,R-HSA-74160,RUNX1 regulates transcription of genes involved in WNT signaling,Gene expression (Transcription)
R-HSA-8939902,R-HSA-74160,Regulation of RUNX2 expression and activity,Gene expression (Transcription)
R-HSA-8940973,R-HSA-74160,RUNX2 regulates osteoblast differentiation,Gene expression (Transcription)
R-HSA-8941237,R-HSA-1474244,Invadopodia formation,Extracellular matrix organization
R-HSA-8941284,R-HSA-74160,RUNX2 regulates chondrocyte maturation,Gene expression (Transcription)
R-HSA-8941326,R-HSA-74160,RUNX2 regulates bone development,Gene expression (Transcription)
R-HSA-8941332,R-HSA-74160,RUNX2 regulates genes involved in cell migration,Gene expression (Transcription)
R-HSA-8941333,R-HSA-74160,RUNX2 regulates genes involved in differentiation of myeloid cells,Gene expression (Transcription)
R-HSA-8941413,R-HSA-168256,Events associated with phagocytolytic activity of PMN cells,Immune System
R-HSA-8941855,R-HSA-74160,RUNX3 regulates CDKN1A transcription,Gene expression (Transcription)
R-HSA-8941856,R-HSA-74160,RUNX3 regulates NOTCH signaling,Gene expression (Transcription)
R-HSA-8941858,R-HSA-74160,Regulation of RUNX3 expression and activity,Gene expression (Transcription)
R-HSA-8942233,R-HSA-1643685,Intestinal infectious diseases,Disease
R-HSA-8943723,R-HSA-162582,Regulation of PTEN mRNA translation,Signal Transduction
R-HSA-8943724,R-HSA-162582,Regulation of PTEN gene transcription,Signal Transduction
R-HSA-8948216,R-HSA-1474244,Collagen chain trimerization,Extracellular matrix organization
R-HSA-8948700,R-HSA-162582,Competing endogenous RNAs (ceRNAs) regulate PTEN translation,Signal Transduction
R-HSA-8948747,R-HSA-162582,Regulation of PTEN localization,Signal Transduction
R-HSA-8948751,R-HSA-162582,Regulation of PTEN stability and activity,Signal Transduction
R-HSA-8949215,R-HSA-382551,Mitochondrial calcium ion transport,Transport of small molecules
R-HSA-8949275,R-HSA-74160,RUNX3 Regulates Immune Response and Cell Migration,Gene expression (Transcription)
R-HSA-8949613,R-HSA-1852241,Cristae formation,Organelle biogenesis and maintenance
R-HSA-8949664,R-HSA-382551,Processing of SMDT1,Transport of small molecules
R-HSA-8950505,R-HSA-168256,Gene and protein expression by JAK-STAT signaling after Interleukin-12 stimulation,Immune System
R-HSA-8951430,R-HSA-74160,RUNX3 regulates WNT signaling,Gene expression (Transcription)
R-HSA-8951664,R-HSA-392499,Neddylation,Metabolism of proteins
R-HSA-8951671,R-HSA-74160,RUNX3 regulates YAP1-mediated transcription,Gene expression (Transcription)
R-HSA-8951911,R-HSA-74160,RUNX3 regulates RUNX1-mediated transcription,Gene expression (Transcription)
R-HSA-8951936,R-HSA-74160,RUNX3 regulates p14-ARF,Gene expression (Transcription)
R-HSA-8952158,R-HSA-74160,RUNX3 regulates BCL2L11 (BIM) transcription,Gene expression (Transcription)
R-HSA-8953750,R-HSA-74160,Transcriptional Regulation by E2F6,Gene expression (Transcription)
R-HSA-8955332,R-HSA-392499,Carboxyterminal post-translational modifications of tubulin,Metabolism of proteins
R-HSA-8956319,R-HSA-1430728,Nucleobase catabolism,Metabolism
R-HSA-8957275,R-HSA-392499,Post-translational protein phosphorylation,Metabolism of proteins
R-HSA-8963678,R-HSA-8963743,Intestinal lipid absorption,Digestion and absorption
R-HSA-8963684,R-HSA-1430728,Tyrosine catabolism,Metabolism
R-HSA-8963693,R-HSA-1430728,Aspartate and asparagine metabolism,Metabolism
R-HSA-8963888,R-HSA-382551,Chylomicron assembly,Transport of small molecules
R-HSA-8963889,R-HSA-382551,Assembly of active LPL and LIPC lipase complexes,Transport of small molecules
R-HSA-8963896,R-HSA-382551,HDL assembly,Transport of small molecules
R-HSA-8963901,R-HSA-382551,Chylomicron remodeling,Transport of small molecules
R-HSA-8964011,R-HSA-382551,HDL clearance,Transport of small molecules
R-HSA-8964026,R-HSA-382551,Chylomicron clearance,Transport of small molecules
R-HSA-8964038,R-HSA-382551,LDL clearance,Transport of small molecules
R-HSA-8964041,R-HSA-382551,LDL remodeling,Transport of small molecules
R-HSA-8964046,R-HSA-382551,VLDL clearance,Transport of small molecules
R-HSA-8964058,R-HSA-382551,HDL remodeling,Transport of small molecules
R-HSA-8964208,R-HSA-1430728,Phenylalanine metabolism,Metabolism
R-HSA-8964315,R-HSA-162582,G beta:gamma signalling through BTK,Signal Transduction
R-HSA-8964539,R-HSA-1430728,Glutamate and glutamine metabolism,Metabolism
R-HSA-8964540,R-HSA-1430728,Alanine metabolism,Metabolism
R-HSA-8964572,R-HSA-1430728,Lipid particle organization,Metabolism
R-HSA-8964616,R-HSA-162582,G beta:gamma signalling through CDC42,Signal Transduction
R-HSA-8981373,R-HSA-8963743,Intestinal hexose absorption,Digestion and absorption
R-HSA-8981607,R-HSA-382551,Intracellular oxygen transport,Transport of small molecules
R-HSA-8983432,R-HSA-168256,Interleukin-15 signaling,Immune System
R-HSA-8983711,R-HSA-168256,OAS antiviral response,Immune System
R-HSA-8984722,R-HSA-168256,Interleukin-35 Signalling,Immune System
R-HSA-8985586,R-HSA-1266738,SLIT2:ROBO1 increases RHOA activity,Developmental Biology
R-HSA-8985801,R-HSA-1266738,Regulation of cortical dendrite branching,Developmental Biology
R-HSA-8985947,R-HSA-168256,Interleukin-9 signaling,Immune System
R-HSA-8986944,R-HSA-74160,Transcriptional Regulation by MECP2,Gene expression (Transcription)
R-HSA-9006335,R-HSA-162582,Signaling by Erythropoietin,Signal Transduction
R-HSA-9007892,R-HSA-168256,Interleukin-38 signaling,Immune System
R-HSA-9008059,R-HSA-168256,Interleukin-37 signaling,Immune System
R-HSA-9009391,R-HSA-162582,Extra-nuclear estrogen signaling,Signal Transduction
R-HSA-901032,R-HSA-392499,ER Quality Control Compartment (ERQC),Metabolism of proteins
R-HSA-901042,R-HSA-392499,Calnexin/calreticulin cycle,Metabolism of proteins
R-HSA-9010553,R-HSA-1266738,Regulation of expression of SLITs and ROBOs,Developmental Biology
R-HSA-9010642,R-HSA-1266738,ROBO receptors bind AKAP5,Developmental Biology
R-HSA-9012546,R-HSA-168256,Interleukin-18 signaling,Immune System
R-HSA-9013418,R-HSA-162582,RHOBTB2 GTPase cycle,Signal Transduction
R-HSA-9013422,R-HSA-162582,RHOBTB1 GTPase cycle,Signal Transduction
R-HSA-9013507,R-HSA-162582,NOTCH3 Activation and Transmission of Signal to the Nucleus,Signal Transduction
R-HSA-9013508,R-HSA-162582,NOTCH3 Intracellular Domain Regulates Transcription,Signal Transduction
R-HSA-9013695,R-HSA-162582,NOTCH4 Intracellular Domain Regulates Transcription,Signal Transduction
R-HSA-9013700,R-HSA-162582,NOTCH4 Activation and Transmission of Signal to the Nucleus,Signal Transduction
R-HSA-9013957,R-HSA-168256,TLR3-mediated TICAM1-dependent programmed cell death,Immune System
R-HSA-9013973,R-HSA-168256,TICAM1-dependent activation of IRF3/IRF7,Immune System
R-HSA-9014325,R-HSA-168256,"TICAM1,TRAF6-dependent induction of TAK1 complex",Immune System
R-HSA-9014826,R-HSA-168256,Interleukin-36 pathway,Immune System
R-HSA-9014843,R-HSA-168256,Interleukin-33 signaling,Immune System
R-HSA-9017802,R-HSA-162582,Noncanonical activation of NOTCH3,Signal Transduction
R-HSA-9018519,R-HSA-162582,Estrogen-dependent gene expression,Signal Transduction
R-HSA-9018676,R-HSA-1430728,Biosynthesis of D-series resolvins,Metabolism
R-HSA-9018677,R-HSA-1430728,Biosynthesis of DHA-derived SPMs,Metabolism
R-HSA-9018679,R-HSA-1430728,Biosynthesis of EPA-derived SPMs,Metabolism
R-HSA-9018681,R-HSA-1430728,Biosynthesis of protectins,Metabolism
R-HSA-9018682,R-HSA-1430728,Biosynthesis of maresins,Metabolism
R-HSA-9018896,R-HSA-1430728,Biosynthesis of E-series 18(S)-resolvins,Metabolism
R-HSA-9020265,R-HSA-1430728,Biosynthesis of aspirin-triggered D-series resolvins,Metabolism
R-HSA-9020558,R-HSA-168256,Interleukin-2 signaling,Immune System
R-HSA-9020591,R-HSA-168256,Interleukin-12 signaling,Immune System
R-HSA-9020702,R-HSA-168256,Interleukin-1 signaling,Immune System
R-HSA-9020933,R-HSA-168256,Interleukin-23 signaling,Immune System
R-HSA-9020956,R-HSA-168256,Interleukin-27 signaling,Immune System
R-HSA-9020958,R-HSA-168256,Interleukin-21 signaling,Immune System
R-HSA-9022534,R-HSA-1643685,Loss of MECP2 binding ability to 5hmC-DNA,Disease
R-HSA-9022535,R-HSA-1643685,Loss of phosphorylation of MECP2 at T308,Disease
R-HSA-9022537,R-HSA-1643685,Loss of MECP2 binding ability to the NCoR/SMRT complex,Disease
R-HSA-9022538,R-HSA-1643685,Loss of MECP2 binding ability to 5mC-DNA,Disease
R-HSA-9022692,R-HSA-74160,Regulation of MECP2 expression and activity,Gene expression (Transcription)
R-HSA-9022699,R-HSA-74160,MECP2 regulates neuronal receptors and channels,Gene expression (Transcription)
R-HSA-9022702,R-HSA-74160,MECP2 regulates transcription of neuronal ligands,Gene expression (Transcription)
R-HSA-9022707,R-HSA-74160,MECP2 regulates transcription factors,Gene expression (Transcription)
R-HSA-9022927,R-HSA-74160,MECP2 regulates transcription of genes involved in GABA signaling,Gene expression (Transcription)
R-HSA-9023661,R-HSA-1430728,Biosynthesis of E-series 18(R)-resolvins,Metabolism
R-HSA-9024909,R-HSA-162582,BDNF activates NTRK2 (TRKB) signaling,Signal Transduction
R-HSA-9025046,R-HSA-162582,NTF3 activates NTRK2 (TRKB) signaling,Signal Transduction
R-HSA-9025094,R-HSA-1430728,Biosynthesis of DPAn-3 SPMs,Metabolism
R-HSA-9025106,R-HSA-1430728,Biosynthesis of DPAn-6 SPMs,Metabolism
R-HSA-9026286,R-HSA-1430728,Biosynthesis of DPAn-3-derived protectins and resolvins,Metabolism
R-HSA-9026290,R-HSA-1430728,Biosynthesis of DPAn-3-derived maresins,Metabolism
R-HSA-9026357,R-HSA-162582,NTF4 activates NTRK2 (TRKB) signaling,Signal Transduction
R-HSA-9026403,R-HSA-1430728,Biosynthesis of DPAn-3-derived 13-series resolvins,Metabolism
R-HSA-9026519,R-HSA-162582,Activated NTRK2 signals through RAS,Signal Transduction
R-HSA-9026527,R-HSA-162582,Activated NTRK2 signals through PLCG1,Signal Transduction
R-HSA-9026762,R-HSA-1430728,Biosynthesis of maresin conjugates in tissue regeneration (MCTR),Metabolism
R-HSA-9026766,R-HSA-1430728,Biosynthesis of protectin and resolvin conjugates in tissue regeneration (PCTR and RCTR),Metabolism
R-HSA-9027276,R-HSA-162582,Erythropoietin activates Phosphoinositide-3-kinase (PI3K),Signal Transduction
R-HSA-9027277,R-HSA-162582,Erythropoietin activates Phospholipase C gamma (PLCG),Signal Transduction
R-HSA-9027283,R-HSA-162582,Erythropoietin activates STAT5,Signal Transduction
R-HSA-9027284,R-HSA-162582,Erythropoietin activates RAS,Signal Transduction
R-HSA-9027307,R-HSA-1430728,Biosynthesis of maresin-like SPMs,Metabolism
R-HSA-9027604,R-HSA-1430728,Biosynthesis of electrophilic -3 PUFA oxo-derivatives,Metabolism
R-HSA-9028335,R-HSA-162582,Activated NTRK2 signals through PI3K,Signal Transduction
R-HSA-9028731,R-HSA-162582,Activated NTRK2 signals through FRS2 and FRS3,Signal Transduction
R-HSA-9029558,R-HSA-162582,NR1H2 & NR1H3 regulate gene expression linked to lipogenesis,Signal Transduction
R-HSA-9029569,R-HSA-162582,NR1H3 & NR1H2 regulate gene expression linked to cholesterol transport and efflux,Signal Transduction
R-HSA-9031525,R-HSA-162582,NR1H2 & NR1H3 regulate gene expression to limit cholesterol uptake ,Signal Transduction
R-HSA-9031528,R-HSA-162582,NR1H2 & NR1H3 regulate gene expression linked to triglyceride lipolysis in adipose,Signal Transduction
R-HSA-9031628,R-HSA-162582,NGF-stimulated transcription,Signal Transduction
R-HSA-9032500,R-HSA-162582,Activated NTRK2 signals through FYN,Signal Transduction
R-HSA-9032759,R-HSA-162582,NTRK2 activates RAC1,Signal Transduction
R-HSA-9032845,R-HSA-162582,Activated NTRK2 signals through CDK5,Signal Transduction
R-HSA-9033241,R-HSA-9609507,Peroxisomal protein import,Protein localization
R-HSA-9033500,R-HSA-9609507,TYSND1 cleaves peroxisomal proteins,Protein localization
R-HSA-9033807,R-HSA-1430728,ABO blood group biosynthesis,Metabolism
R-HSA-9034013,R-HSA-162582,NTF3 activates NTRK3 signaling,Signal Transduction
R-HSA-9034015,R-HSA-162582,Signaling by NTRK3 (TRKC),Signal Transduction
R-HSA-9034793,R-HSA-162582,Activated NTRK3 signals through PLCG1,Signal Transduction
R-HSA-9034864,R-HSA-162582,Activated NTRK3 signals through RAS,Signal Transduction
R-HSA-9035968,R-HSA-1643685,Defective GGT1 causes Glutathionuria (GLUTH),Disease
R-HSA-9036092,R-HSA-1643685,Defective AVP does not bind AVPR2 and causes neurohypophyseal diabetes insipidus (NDI),Disease
R-HSA-9037628,R-HSA-1430728,Rhesus blood group biosynthesis,Metabolism
R-HSA-9037629,R-HSA-1430728,Lewis blood group biosynthesis,Metabolism
R-HSA-909733,R-HSA-168256,Interferon alpha/beta signaling,Immune System
R-HSA-912446,R-HSA-1640170,Meiotic recombination,Cell Cycle
R-HSA-912446,R-HSA-1474165,Meiotic recombination,Reproduction
R-HSA-912526,R-HSA-168256,Interleukin receptor SHC signaling,Immune System
R-HSA-912631,R-HSA-168256,Regulation of signaling by CBL,Immune System
R-HSA-912694,R-HSA-168256,Regulation of IFNA signaling,Immune System
R-HSA-913709,R-HSA-392499,O-linked glycosylation of mucins,Metabolism of proteins
R-HSA-916853,R-HSA-112316,Degradation of GABA,Neuronal System
R-HSA-917729,R-HSA-5653656,Endosomal Sorting Complex Required For Transport (ESCRT),Vesicle-mediated transport
R-HSA-917937,R-HSA-382551,Iron uptake and transport,Transport of small molecules
R-HSA-917977,R-HSA-382551,Transferrin endocytosis and recycling,Transport of small molecules
R-HSA-918233,R-HSA-168256,TRAF3-dependent IRF activation pathway,Immune System
R-HSA-933541,R-HSA-168256,TRAF6 mediated IRF7 activation,Immune System
R-HSA-933542,R-HSA-168256,TRAF6 mediated NF-kB activation,Immune System
R-HSA-933543,R-HSA-168256,NF-kB activation through FADD/RIP-1 pathway mediated by caspase-8 and -10,Immune System
R-HSA-936440,R-HSA-168256,Negative regulators of DDX58/IFIH1 signaling,Immune System
R-HSA-936837,R-HSA-382551,Ion transport by P-type ATPases,Transport of small molecules
R-HSA-936964,R-HSA-168256,Activation of IRF3/IRF7 mediated by TBK1/IKK epsilon,Immune System
R-HSA-937039,R-HSA-168256,IRAK1 recruits IKK complex,Immune System
R-HSA-937041,R-HSA-168256,IKK complex recruitment mediated by RIP1,Immune System
R-HSA-937042,R-HSA-168256,IRAK2 mediated activation of TAK1 complex,Immune System
R-HSA-937072,R-HSA-168256,TRAF6-mediated induction of TAK1 complex within TLR4 complex,Immune System
R-HSA-947581,R-HSA-1430728,Molybdenum cofactor biosynthesis,Metabolism
R-HSA-948021,R-HSA-392499,Transport to the Golgi and subsequent modification,Metabolism of proteins
R-HSA-9603381,R-HSA-162582,Activated NTRK3 signals through PI3K,Signal Transduction
R-HSA-9603505,R-HSA-162582,NTRK3 as a dependence receptor,Signal Transduction
R-HSA-9603798,R-HSA-9609507,Class I peroxisomal membrane protein import,Protein localization
R-HSA-9604323,R-HSA-162582,Negative regulation of NOTCH4 signaling,Signal Transduction
R-HSA-9607240,R-HSA-168256,FLT3 Signaling,Immune System
R-HSA-9608287,R-HSA-1643685,Defective MUTYH substrate binding,Disease
R-HSA-9608290,R-HSA-1643685,Defective MUTYH substrate processing,Disease
R-HSA-9609523,R-HSA-9609507,Insertion of tail-anchored proteins into the endoplasmic reticulum membrane,Protein localization
R-HSA-9609690,R-HSA-1643685,HCMV Early Events,Disease
R-HSA-9609736,R-HSA-112316,Assembly and cell surface presentation of NMDA receptors,Neuronal System
R-HSA-9610379,R-HSA-1643685,HCMV Late Events,Disease
R-HSA-9613354,R-HSA-9612973,Lipophagy,Autophagy
R-HSA-9613829,R-HSA-9612973,Chaperone Mediated Autophagy,Autophagy
R-HSA-9614399,R-HSA-74160,Regulation of localization of FOXO transcription factors,Gene expression (Transcription)
R-HSA-9614657,R-HSA-74160,FOXO-mediated transcription of cell death genes,Gene expression (Transcription)
R-HSA-9615017,R-HSA-74160,"FOXO-mediated transcription of oxidative stress, metabolic and neuronal genes",Gene expression (Transcription)
R-HSA-9615710,R-HSA-9612973,Late endosomal microautophagy,Autophagy
R-HSA-9615933,R-HSA-1640170,Postmitotic nuclear pore complex (NPC) reformation,Cell Cycle
R-HSA-9616222,R-HSA-1266738,Transcriptional regulation of granulopoiesis,Developmental Biology
R-HSA-9616334,R-HSA-1643685,Defective Base Excision Repair Associated with NEIL1,Disease
R-HSA-9617324,R-HSA-112316,Negative regulation of NMDA receptor-mediated neuronal transmission,Neuronal System
R-HSA-9617629,R-HSA-74160,Regulation of FOXO transcriptional activity by acetylation,Gene expression (Transcription)
R-HSA-9617828,R-HSA-74160,FOXO-mediated transcription of cell cycle genes,Gene expression (Transcription)
R-HSA-9619229,R-HSA-112316,Activation of RAC1 downstream of NMDARs,Neuronal System
R-HSA-9619483,R-HSA-112316,Activation of AMPK downstream of NMDARs,Neuronal System
R-HSA-9619665,R-HSA-1266738,EGR2 and SOX10-mediated initiation of Schwann cell myelination,Developmental Biology
R-HSA-9620244,R-HSA-112316,Long-term potentiation,Neuronal System
R-HSA-9623433,R-HSA-162582,NR1H2 & NR1H3 regulate gene expression to control bile acid homeostasis,Signal Transduction
R-HSA-9627069,R-HSA-5357801,Regulation of the apoptosome activity,Programmed Cell Death
R-HSA-9629232,R-HSA-1643685,Defective Base Excision Repair Associated with NEIL3,Disease
R-HSA-9630221,R-HSA-1643685,Defective NTHL1 substrate processing,Disease
R-HSA-9630222,R-HSA-1643685,Defective NTHL1 substrate binding,Disease
R-HSA-9630791,R-HSA-1643685,Evasion of Oncogene Induced Senescence Due to Defective p16INK4A binding to CDK4,Disease
R-HSA-9630794,R-HSA-1643685,Evasion of Oncogene Induced Senescence Due to Defective p16INK4A binding to CDK4 and CDK6,Disease
R-HSA-9632697,R-HSA-1643685,Evasion of Oxidative Stress Induced Senescence Due to Defective p16INK4A binding to CDK4,Disease
R-HSA-9632700,R-HSA-1643685,Evasion of Oxidative Stress Induced Senescence Due to Defective p16INK4A binding to CDK4 and CDK6,Disease
R-HSA-9632974,R-HSA-162582,NR1H2 & NR1H3 regulate gene expression linked to gluconeogenesis ,Signal Transduction
R-HSA-9633012,R-HSA-8953897,Response of EIF2AK4 (GCN2) to amino acid deficiency,Cellular responses to external stimuli
R-HSA-9634285,R-HSA-1643685,Constitutive Signaling by Overexpressed ERBB2,Disease
R-HSA-9634600,R-HSA-1430728,"Regulation of glycolysis by fructose 2,6-bisphosphate metabolism",Metabolism
R-HSA-9634635,R-HSA-162582,Estrogen-stimulated signaling through PRKCZ,Signal Transduction
R-HSA-9634638,R-HSA-162582,Estrogen-dependent nuclear events downstream of ESR-membrane signaling,Signal Transduction
R-HSA-9635465,R-HSA-1643685,Suppression of apoptosis,Disease
R-HSA-9635644,R-HSA-1643685,Inhibition of membrane repair,Disease
R-HSA-9636003,R-HSA-73894,NEIL3-mediated resolution of ICLs,DNA Repair
R-HSA-9636249,R-HSA-1643685,Inhibition of nitric oxide production,Disease
R-HSA-9636383,R-HSA-1643685,Prevention of phagosomal-lysosomal fusion,Disease
R-HSA-9636467,R-HSA-1643685,Blockage of phagosome acidification,Disease
R-HSA-9636569,R-HSA-1643685,Suppression of autophagy,Disease
R-HSA-9636667,R-HSA-1643685,Manipulation of host energy metabolism,Disease
R-HSA-9637628,R-HSA-1643685,Modulation by Mtb of host immune system,Disease
R-HSA-9637698,R-HSA-1643685,Phagocyte cell death caused by cytosolic Mtb,Disease
R-HSA-9639288,R-HSA-8953897,Amino acids regulate mTORC1,Cellular responses to external stimuli
R-HSA-9639775,R-HSA-1643685,Antimicrobial action and antimicrobial resistance in Mtb,Disease
R-HSA-9640463,R-HSA-1430728,Wax biosynthesis,Metabolism
R-HSA-9645135,R-HSA-168256,STAT5 Activation,Immune System
R-HSA-9645460,R-HSA-168256,Alpha-protein kinase 1 signaling pathway,Immune System
R-HSA-9645722,R-HSA-1643685,Defective Intrinsic Pathway for Apoptosis Due to p14ARF Loss of Function,Disease
R-HSA-9646303,R-HSA-1643685,Evasion of Oncogene Induced Senescence Due to p14ARF Defects,Disease
R-HSA-9646304,R-HSA-1643685,Evasion of Oxidative Stress Induced Senescence Due to p14ARF Defects,Disease
R-HSA-9646399,R-HSA-9612973,Aggrephagy,Autophagy
R-HSA-964739,R-HSA-392499,N-glycan trimming and elongation in the cis-Golgi,Metabolism of proteins
R-HSA-9648002,R-HSA-162582,RAS processing,Signal Transduction
R-HSA-9648025,R-HSA-1640170,EML4 and NUDC in mitotic spindle formation,Cell Cycle
R-HSA-964827,R-HSA-392499,"Progressive trimming of alpha-1,2-linked mannose residues from Man9/8/7GlcNAc2 to produce Man5GlcNAc2",Metabolism of proteins
R-HSA-9648895,R-HSA-8953897,Response of EIF2AK1 (HRI) to heme deficiency,Cellular responses to external stimuli
R-HSA-964975,R-HSA-1430728,Vitamins B6 activation to pyridoxal phosphate,Metabolism
R-HSA-9649913,R-HSA-1643685,RAS GTPase cycle mutants,Disease
R-HSA-9649948,R-HSA-1643685,Signaling downstream of RAS mutants,Disease
R-HSA-9652169,R-HSA-1643685,Signaling by MAP2K mutants,Disease
R-HSA-9652282,R-HSA-162582,Drug-mediated inhibition of ERBB2 signaling,Signal Transduction
R-HSA-9652817,R-HSA-1643685,Signaling by MAPK mutants,Disease
R-HSA-9656223,R-HSA-1643685,Signaling by RAF1 mutants,Disease
R-HSA-9656255,R-HSA-1643685,Defective OGG1 Substrate Binding,Disease
R-HSA-9656256,R-HSA-1643685,Defective OGG1 Substrate Processing,Disease
R-HSA-9657050,R-HSA-1643685,Defective OGG1 Localization,Disease
R-HSA-9657688,R-HSA-1643685,Defective factor XII causes hereditary angioedema,Disease
R-HSA-9657689,R-HSA-1643685,Defective SERPING1 causes hereditary angioedema,Disease
R-HSA-9660537,R-HSA-1643685,Signaling by MRAS-complex mutants,Disease
R-HSA-9660821,R-HSA-1643685,ADORA2B mediated anti-inflammatory cytokines production,Disease
R-HSA-9660826,R-HSA-1643685,Purinergic signaling in leishmaniasis infection,Disease
R-HSA-9661069,R-HSA-1643685,"Defective binding of RB1 mutants to E2F1,(E2F2, E2F3)",Disease
R-HSA-9661070,R-HSA-1643685,Defective translocation of RB1 mutants to the nucleus,Disease
R-HSA-9662834,R-HSA-1643685,CD163 mediating an anti-inflammatory response,Disease
R-HSA-9663199,R-HSA-1643685,Defective DNA double strand break response due to BRCA1 loss of function,Disease
R-HSA-9664323,R-HSA-1643685,FCGR3A-mediated IL10 synthesis,Disease
R-HSA-9664422,R-HSA-1643685,FCGR3A-mediated phagocytosis,Disease
R-HSA-9664535,R-HSA-1643685,LTC4-CYSLTR mediated IL4 production,Disease
R-HSA-9664565,R-HSA-1643685,Signaling by ERBB2 KD Mutants,Disease
R-HSA-9664873,R-HSA-9612973,Pexophagy,Autophagy
R-HSA-9665233,R-HSA-1643685,Resistance of ERBB2 KD mutants to trastuzumab,Disease
R-HSA-9665244,R-HSA-1643685,Resistance of ERBB2 KD mutants to sapitinib,Disease
R-HSA-9665245,R-HSA-1643685,Resistance of ERBB2 KD mutants to tesevatinib,Disease
R-HSA-9665246,R-HSA-1643685,Resistance of ERBB2 KD mutants to neratinib,Disease
R-HSA-9665247,R-HSA-1643685,Resistance of ERBB2 KD mutants to osimertinib,Disease
R-HSA-9665249,R-HSA-1643685,Resistance of ERBB2 KD mutants to afatinib,Disease
R-HSA-9665250,R-HSA-1643685,Resistance of ERBB2 KD mutants to AEE788,Disease
R-HSA-9665251,R-HSA-1643685,Resistance of ERBB2 KD mutants to lapatinib,Disease
R-HSA-9665348,R-HSA-1643685,Signaling by ERBB2 ECD mutants,Disease
R-HSA-9665686,R-HSA-1643685,Signaling by ERBB2 TMD/JMD mutants,Disease
R-HSA-9665737,R-HSA-1643685,Drug resistance in ERBB2 TMD/JMD mutants,Disease
R-HSA-9668328,R-HSA-1640170,Sealing of the nuclear envelope (NE) by ESCRT-III,Cell Cycle
R-HSA-9669914,R-HSA-1643685,Dasatinib-resistant KIT mutants,Disease
R-HSA-9669917,R-HSA-1643685,Imatinib-resistant KIT mutants,Disease
R-HSA-9669921,R-HSA-1643685,KIT mutants bind TKIs,Disease
R-HSA-9669924,R-HSA-1643685,Masitinib-resistant KIT mutants,Disease
R-HSA-9669926,R-HSA-1643685,Nilotinib-resistant KIT mutants,Disease
R-HSA-9669929,R-HSA-1643685,Regorafenib-resistant KIT mutants,Disease
R-HSA-9669933,R-HSA-1643685,Signaling by kinase domain mutants of KIT,Disease
R-HSA-9669934,R-HSA-1643685,Sunitinib-resistant KIT mutants,Disease
R-HSA-9669935,R-HSA-1643685,Signaling by juxtamembrane domain KIT mutants,Disease
R-HSA-9669936,R-HSA-1643685,Sorafenib-resistant KIT mutants,Disease
R-HSA-9670095,R-HSA-1640170,Inhibition of DNA recombination at telomere,Cell Cycle
R-HSA-9670439,R-HSA-1643685,"Signaling by phosphorylated juxtamembrane, extracellular and kinase domain KIT mutants",Disease
R-HSA-9670613,R-HSA-1643685,Defective Inhibition of DNA Recombination at Telomere Due to DAXX Mutations,Disease
R-HSA-9670615,R-HSA-1643685,Defective Inhibition of DNA Recombination at Telomere Due to ATRX Mutations,Disease
R-HSA-9672383,R-HSA-1643685,Defective factor IX causes thrombophilia,Disease
R-HSA-9672387,R-HSA-1643685,Defective F8 accelerates dissociation of the A2 domain,Disease
R-HSA-9672391,R-HSA-1643685,Defective F8 cleavage by thrombin,Disease
R-HSA-9672393,R-HSA-1643685,Defective F8 binding to von Willebrand factor,Disease
R-HSA-9672395,R-HSA-1643685,Defective F8 binding to the cell membrane,Disease
R-HSA-9672396,R-HSA-1643685,Defective cofactor function of FVIIIa variant,Disease
R-HSA-9672397,R-HSA-1643685,Defective F8 secretion,Disease
R-HSA-9673163,R-HSA-1430728,Oleoyl-phe metabolism,Metabolism
R-HSA-9673202,R-HSA-1643685,Defective F9 variant does not activate FX,Disease
R-HSA-9673218,R-HSA-1643685,Defective F9 secretion,Disease
R-HSA-9673221,R-HSA-1643685,Defective F9 activation,Disease
R-HSA-9673240,R-HSA-1643685,Defective gamma-carboxylation of F9,Disease
R-HSA-9673324,R-HSA-1643685,WNT5:FZD7-mediated leishmania damping,Disease
R-HSA-9673766,R-HSA-1643685,Signaling by cytosolic PDGFRA and PDGFRB fusion proteins,Disease
R-HSA-9673767,R-HSA-1643685,"Signaling by PDGFRA transmembrane, juxtamembrane and kinase domain mutants",Disease
R-HSA-9673768,R-HSA-1643685,Signaling by membrane-tethered fusions of PDGFRA or PDGFRB,Disease
R-HSA-9673770,R-HSA-1643685,Signaling by PDGFRA extracellular domain mutants,Disease
R-HSA-9674396,R-HSA-1643685,Imatinib-resistant PDGFR mutants,Disease
R-HSA-9674401,R-HSA-1643685,Sunitinib-resistant PDGFR mutants,Disease
R-HSA-9674403,R-HSA-1643685,Regorafenib-resistant PDGFR mutants,Disease
R-HSA-9674404,R-HSA-1643685,Sorafenib-resistant PDGFR mutants,Disease
R-HSA-9674428,R-HSA-1643685,PDGFR mutants bind TKIs,Disease
R-HSA-9674519,R-HSA-1643685,Defective F8 sulfation at Y1699,Disease
R-HSA-9678110,R-HSA-1643685,Attachment and Entry,Disease
R-HSA-9679191,R-HSA-1643685,Potential therapeutics for SARS,Disease
R-HSA-9679504,R-HSA-1643685,Translation of Replicase and Assembly of the Replication Transcription Complex,Disease
R-HSA-9679509,R-HSA-1643685,Virion Assembly and Release,Disease
R-HSA-9680187,R-HSA-1643685,Signaling by extracellular domain mutants of KIT,Disease
R-HSA-9682706,R-HSA-1643685,Replication of the SARS-CoV-1 genome,Disease
R-HSA-9682708,R-HSA-1643685,Transcription of SARS-CoV-1 sgRNAs,Disease
R-HSA-9683610,R-HSA-1643685,Maturation of nucleoprotein,Disease
R-HSA-9683673,R-HSA-1643685,Maturation of protein 3a,Disease
R-HSA-9683683,R-HSA-1643685,Maturation of protein E,Disease
R-HSA-9683686,R-HSA-1643685,Maturation of spike protein,Disease
R-HSA-9683701,R-HSA-1643685,Translation of structural proteins,Disease
R-HSA-9686347,R-HSA-5357801,Microbial modulation of RIPK1-mediated regulated necrosis,Programmed Cell Death
R-HSA-9687136,R-HSA-1643685,Aberrant regulation of mitotic exit in cancer due to RB1 defects,Disease
R-HSA-9690406,R-HSA-1266738,Transcriptional regulation of testis differentiation,Developmental Biology
R-HSA-9693928,R-HSA-1643685,Defective RIPK1-mediated regulated necrosis,Disease
R-HSA-9694271,R-HSA-1643685,Assembly of the SARS-CoV-2 Replication-Transcription Complex (RTC),Disease
R-HSA-9694301,R-HSA-1643685,Maturation of replicase proteins,Disease
R-HSA-9694322,R-HSA-1643685,Virion Assembly and Release,Disease
R-HSA-9694493,R-HSA-1643685,Maturation of protein E,Disease
R-HSA-9694548,R-HSA-1643685,Maturation of spike protein,Disease
R-HSA-9694594,R-HSA-1643685,Maturation of protein M,Disease
R-HSA-9694614,R-HSA-1643685,Attachment and Entry,Disease
R-HSA-9694631,R-HSA-1643685,Maturation of nucleoprotein,Disease
R-HSA-9694635,R-HSA-1643685,Translation of structural proteins,Disease
R-HSA-9694676,R-HSA-1643685,Translation of Replicase and Assembly of the Replication Transcription Complex,Disease
R-HSA-9694686,R-HSA-1643685,Replication of the SARS-CoV-2 genome,Disease
R-HSA-9694719,R-HSA-1643685,Maturation of protein 3a,Disease
R-HSA-9694786,R-HSA-1643685,Transcription of SARS-CoV-2 sgRNAs,Disease
R-HSA-9699150,R-HSA-1643685,Defective DNA double strand break response due to BARD1 loss of function,Disease
R-HSA-9702509,R-HSA-1643685,FLT3 mutants bind TKIs,Disease
R-HSA-9702518,R-HSA-1643685,STAT5 activation downstream of FLT3 ITD mutants,Disease
R-HSA-9702569,R-HSA-1643685,KW2449-resistant FLT3 mutants,Disease
R-HSA-9702577,R-HSA-1643685,semaxanib-resistant FLT3 mutants,Disease
R-HSA-9702581,R-HSA-1643685,crenolanib-resistant FLT3 mutants,Disease
R-HSA-9702590,R-HSA-1643685,gilteritinib-resistant FLT3 mutants,Disease
R-HSA-9702596,R-HSA-1643685,lestaurtinib-resistant FLT3 mutants,Disease
R-HSA-9702600,R-HSA-1643685,midostaurin-resistant FLT3 mutants,Disease
R-HSA-9702605,R-HSA-1643685,pexidartinib-resistant FLT3 mutants,Disease
R-HSA-9702614,R-HSA-1643685,ponatinib-resistant FLT3 mutants,Disease
R-HSA-9702620,R-HSA-1643685,quizartinib-resistant FLT3 mutants,Disease
R-HSA-9702624,R-HSA-1643685,sorafenib-resistant FLT3 mutants,Disease
R-HSA-9702632,R-HSA-1643685,sunitinib-resistant FLT3 mutants,Disease
R-HSA-9702636,R-HSA-1643685,tandutinib-resistant FLT3 mutants,Disease
R-HSA-9702998,R-HSA-1643685,linifanib-resistant FLT3 mutants,Disease
R-HSA-9703009,R-HSA-1643685,tamatinib-resistant FLT3 mutants,Disease
R-HSA-9703465,R-HSA-1643685,Signaling by FLT3 fusion proteins,Disease
R-HSA-9703648,R-HSA-1643685,Signaling by FLT3 ITD and TKD mutants,Disease
R-HSA-9706019,R-HSA-162582,RHOBTB3 ATPase cycle,Signal Transduction
R-HSA-9706369,R-HSA-168256,Negative regulation of FLT3,Immune System
R-HSA-9706374,R-HSA-168256,FLT3 signaling through SRC family kinases,Immune System
R-HSA-9706377,R-HSA-1643685,FLT3 signaling by CBL mutants,Disease
R-HSA-975110,R-HSA-168256,TRAF6 mediated IRF7 activation in TLR7/8 or 9 signaling,Immune System
R-HSA-975138,R-HSA-168256,TRAF6 mediated induction of NFkB and MAP kinases upon TLR7/8 or 9 activation,Immune System
R-HSA-975144,R-HSA-168256,IRAK1 recruits IKK complex upon TLR7/8 or 9 stimulation,Immune System
R-HSA-975155,R-HSA-168256,MyD88 dependent cascade initiated on endosome,Immune System
R-HSA-975163,R-HSA-168256,IRAK2 mediated activation of TAK1 complex upon TLR7/8 or 9 stimulation,Immune System
R-HSA-975574,R-HSA-392499,Reactions specific to the hybrid N-glycan synthesis pathway,Metabolism of proteins
R-HSA-975577,R-HSA-392499,N-Glycan antennae elongation,Metabolism of proteins
R-HSA-975578,R-HSA-392499,Reactions specific to the complex N-glycan synthesis pathway,Metabolism of proteins
R-HSA-975634,R-HSA-1430728,Retinoid metabolism and transport,Metabolism
R-HSA-975634,R-HSA-162582,Retinoid metabolism and transport,Signal Transduction
R-HSA-975871,R-HSA-168256,MyD88 cascade initiated on plasma membrane,Immune System
R-HSA-975956,R-HSA-8953854,Nonsense Mediated Decay (NMD) independent of the Exon Junction Complex (EJC),Metabolism of RNA
R-HSA-975957,R-HSA-8953854,Nonsense Mediated Decay (NMD) enhanced by the Exon Junction Complex (EJC),Metabolism of RNA
R-HSA-977068,R-HSA-392499,Termination of O-glycan biosynthesis,Metabolism of proteins
R-HSA-977225,R-HSA-392499,Amyloid fiber formation,Metabolism of proteins
R-HSA-977347,R-HSA-1430728,Serine biosynthesis,Metabolism
R-HSA-977443,R-HSA-112316,GABA receptor activation,Neuronal System
R-HSA-977444,R-HSA-112316,GABA B receptor activation,Neuronal System
R-HSA-977606,R-HSA-168256,Regulation of Complement cascade,Immune System
R-HSA-982772,R-HSA-168256,Growth hormone receptor signaling,Immune System
R-HSA-983168,R-HSA-168256,Antigen processing: Ubiquitination & Proteasome degradation,Immune System
R-HSA-983170,R-HSA-168256,"Antigen Presentation: Folding, assembly and peptide loading of class I MHC",Immune System
R-HSA-983189,R-HSA-109582,Kinesins,Hemostasis
R-HSA-983231,R-HSA-109582,Factors involved in megakaryocyte development and platelet production,Hemostasis
R-HSA-983695,R-HSA-168256,Antigen activates B Cell Receptor (BCR) leading to generation of second messengers,Immune System
R-HSA-983712,R-HSA-382551,Ion channel transport,Transport of small molecules
R-HSA-997272,R-HSA-112316,Inhibition  of voltage gated Ca2+ channels via Gbeta/gamma subunits,Neuronal System
